1. A Bim-Targeting Strategy Overcomes Adaptive Bortezomib Resistance In Myeloma Through A Novel Link Between Autophagy And Apoptosis
2. A Bioinformatic And Mechanistic Study Elicits The Antifibrotic Effect Of Ursolic Acid Through The Attenuation Of Oxidative Stress With The Involvement Of Erk, Pi3K …
3. A Biomolecular Network-Based Strategy Deciphers The Underlying Molecular Mechanisms Of Bupleuri Radix/Curcumae Radix Medicine Pair In The Treatment Of Hepatitis …
4. A Circadian Clock Is Essential For Homeostasis Of Group 3 Innate Lymphoid Cells In The Gut
5. A Common Bim Deletion Polymorphism Mediates Intrinsic Resistance And Inferior Responses To Tyrosine Kinase Inhibitors In Cancer
6. A Complex Oscillating Network Of Signaling Genes Underlies The Mouse Segmentation Clock
7. A Complex Scenario And Underestimated Challenge: The Tumor Microenvironment, Er Stress, And Cancer Treatment
8. A Comprehensive Molecular Interaction Map For Rheumatoid Arthritis
9. A Constitutive BCL2 Down-Regulation Aggravates The Phenotype Of Pkd1-Mutant-Induced Polycystic Kidney Disease
10. A Cooperative Microrna-Tumor Suppressor Gene Network In Acute T-Cell Lymphoblastic Leukemia (T-All)
11. A Curative Cancer Treatment
12. A Cyclin-D1 Interaction With Bax Underlies Its Oncogenic Role And Potential As A Therapeutic Target In Mantle Cell Lymphoma
13. A Delicate Balance–The BCL-2 Family And Its Role In Apoptosis, Oncogenesis, And Cancer Therapeutics
14. A Drug Library Screen Identifies Carbenoxolone As Novel Foxo Inhibitor That Overcomes Foxo3-Mediated Chemoprotection In High-Stage Neuroblastoma
15. A Fate Worse Than Death: Apoptosis As An Oncogenic Process
16. A Functional Role For Transfer Rna-Derived Micrornas In Human B Cells
17. A Genome Scale Rnai Screen Identifies Gli1 As A Novel Gene Regulating Vorinostat Sensitivity
18. A Genome-Wide Association Study Identifies Six Susceptibility Loci For Chronic Lymphocytic Leukemia
19. A Genome-Wide Search For Tumor Suppressor Micrornas In Ovarian Cancer
20. A Global Network Of Transcription Factors, Involving E2A, Ebf1 And Foxo1, That Orchestrates B Cell Fate
21. A Homeostatic Shift Facilitates Endoplasmic Reticulum Proteostasis Through Transcriptional Integration Of Proteostatic Stress Response Pathways
22. A Landscape Of Therapeutic Cooperativity In Kras Mutant Cancers Reveals Principles For Controlling Tumor Evolution
23. A License To Kill: Understanding Natural Killer Cell Licensing To Fight Cancer
24. A Male Infertility Mutation Reverts Nanos1 Activity From Anti-Apoptotic To Pro-Apoptotic By Disrupting Repression Of Gadd45A, Gadd45B, Gadd45G And Rhob Genes
25. A Microtubule Inhibitor, Abt-751, Induces Autophagy And Delays Apoptosis In Huh-7 Cells
26. A Mini Review Of Bisphenol A (Bpa) Effects On Cancer-Related Cellular Signaling Pathways
27. A Miraculous New Therapy In Myeloma?
28. A Multicenter Clinical Study Evaluating The Confirmed Complete Molecular Response Rate In Imatinib-Treated Patients With Chronic Phase Chronic Myeloid Leukemia By …
29. A Mutation In The Viral Sensor 2′-5′-Oligoadenylate Synthetase 2 Causes Failure Of Lactation
30. A Myc-Dependent Division Timer Complements A Cell-Death Timer To Regulate T Cell And B Cell Responses
31. A Myriad Of Roles Of Mir-25 In Health And Disease
32. A Neuroprotective Agent That Inactivates Prodegenerative Trka And Preserves Mitochondria
33. A New Era Of Cardiac Cell Therapy: Opportunities And Challenges
34. A New Stat3-Binding Partner, Arl3, Enhances The Phosphorylation And Nuclear Accumulation Of Stat3
35. A New Therapeutic Paradigm For Breast Cancer Exploiting Low Dose Estrogen-Induced Apoptosis
36. A Non-Invasive Test For Assessing Embryo Potential By Gene Expression Profiles Of Human Cumulus Cells: A Proof Of Concept Study
37. A Novel Biclustering Algorithm For The Discovery Of Meaningful Biological Correlations Between Micrornas And Their Target Genes
38. A Novel Bim Deletion Polymorphism: Implications And Lessons For Cancer Targeted Therapies
39. A Novel Dual Kinase Function Of The Ret Proto-Oncogene Negatively Regulates Activating Transcription Factor 4-Mediated Apoptosis
40. A Novel Mcl1 Variant Inhibits Apoptosis Via Increased Bim Sequestration
41. A Novel Method To Detect Functional Subgraphs In Biomolecular Networks
42. A Novel Role For P73 In The Regulation Of Akt-Foxo1A-Bim Signaling And Apoptosis Induced By The Plant Lectin, Concanavalin A
43. A Novel Tcr Transgenic Model Reveals That Negative Selection Involves An Immediate, Bim-Dependent Pathway And A Delayed, Bim-Independent Pathway
44. A Nuclear-Directed Human Pancreatic Ribonuclease (Pe5) Targets The Metabolic Phenotype Of Cancer Cells
45. A Polysome-Based Microrna Screen Identifies Mir-24-3P As A Novel Promigratory Mirna In Mesothelioma
46. A Prdx1-Foxo3 Signaling Pathway Acts As A Redox Sensor Controlling Foxo3 Subcellular Localization And Target Gene Transactivation
47. A Reference Map Of The Human Protein Interactome
48. A Review And An Update Of European Leukemianet Recommendations For The Management Of Chronic Myeloid Leukemia
49. A Search For Genes That May Confer Divergent Morphology And Function In The Carotid Body Between Two Strains Of Mice
50. A Signal-Based Method For Finding Driver Modules Of Breast Cancer Metastasis To The Lung
51. A Study Of Micrornas Associated With Multiple Myeloma Pathogenesis And Micorrnas/Tp53 Feedback Circuit In Human Cancers …
52. A Study Of The Epstein Barr Virus Nuclear Antigens Ebna3A And Ebna3C In Vitro And In Vivo
53. A Subset Of Platinum-Containing Chemotherapeutic Agents Kills Cells By Inducing Ribosome Biogenesis Stress
54. A Subset Of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections Through Vegfα-Mediated Recruitment Of Neutrophils
55. A Synthetic Chalcone, 2′-Hydroxy-2, 3, 5′-Trimethoxychalcone Triggers Unfolded Protein Response-Mediated Apoptosis In Breast Cancer Cells
56. A Systematic Review And Meta-Analysis Of Individual Patient Data On The Impact Of The Bim Deletion Polymorphism On Treatment Outcomes In Epidermal Growth …
57. A Systems Approach To The Different Grades And Progression Of Human Astrocytoma
58. A Systems Biology Approach To Construct A Cancer‐Perturbed Protein–Protein Interaction Network For Apoptosis By Means Of Microarray And Database Mining
59. A Targeted Genomic Alteration Analysis Predicts Survival Of Melanoma Patients Under Braf Inhibitors
60. A Tr3/Nur77 Peptide-Based High-Throughput Fluorescence Polarization Screen For Small Molecule Bcl-B Inhibitors
61. A Translational, Pharmacodynamic, And Pharmacokinetic Phase Ib Clinical Study Of Everolimus In Resectable Non–Small Cell Lung Cancer
62. A Urokinase Receptor–Bim Signaling Axis Emerges During Egfr Inhibitor Resistance In Mutant Egfr Glioblastoma
63. Aberrant Dna Methylation In Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, And Therapeutic Response
64. Aberrant Epigenetic Modifications In Peripheral Blood Mononuclear Cells From Patients With Pemphigus Vulgaris
65. Aberrant Expression Of Aldehyde Dehydrogenase 1A (Aldh 1A) Subfamily Genes In Acute Lymphoblastic Leukaemia Is A Common Feature Of T‐Lineage Tumours
66. Aberrant Expression Of Nkl Homeobox Gene Hlx In Hodgkin Lymphoma
67. Aberrant Mirnas Regulate The Biological Hallmarks Of Glioblastoma
68. Aberrant Overexpression And Function Of The Mir-17-92 Cluster In Mll-Rearranged Acute Leukemia
69. Aberrant Rna Splicing In Cancer And Drug Resistance
70. Aberrantly Expressed Long Noncoding Rnas Are Involved In Sevoflurane-Induced Developing Hippocampal Neuronal Apoptosis: A Microarray Related Study
71. Ablation Of The Mir-17-92 Microrna Cluster In Germ Cells Causes Subfertility In Female Mice
72. Abnormal Microrna Expression In The Course Of Hematological Malignancies
73. Abrogation Of Tgf-Β Signaling Enhances Chemokine Production And Correlates With Prognosis In Human Breast Cancer
74. Abstract A30: Dysregulation Of Bmi1 And Microrna-16 Collaborate To Enhance An Anti-Apoptotic Potential In The Side Population Of Refractory Mantle Cell Lymphoma
75. Abstract B9: Activated Mapk Pathway Mediates Resistance To Romidepsin Via Bim Degradation In Romidepsin-Selected Hut 78 Cells
76. Abstract# 3264:\# 8220; Bimbam\# 8221;, A Novel Glucocorticoid-Regulated Bh3-Containing Transcript From The Bcl2L11/Bim Locus
77. Abundant Expression Of Bmi1 In Follicular Lymphoma Is Associated With Reduced Overall Survival
78. Acquired Mutations In BCL2 Family Proteins Conferring Resistance To The Bh3 Mimetic Abt-199 In Lymphoma
79. Activated Nrf2 Impairs Liver Regeneration In Mice By Activation Of Genes Involved In Cell‐Cycle Control And Apoptosis
80. Activation Of Pro-Survival Camk4Β/Creb And Pro-Death Mst1 Signaling At Early And Late Times During A Mouse Model Of Prion Disease
81. Activation Of Wnt/Β-Catenin Signaling Increases Apoptosis In Melanoma Cells Treated With Trail
82. Activity Of Distinct Growth Factor Receptor Network Components In Breast Tumors Uncovers Two Biologically Relevant Subtypes
83. Adam12 Redistributes And Activates Mmp-14, Resulting In Gelatin Degradation, Reduced Apoptosis And Increased Tumor Growth
84. Adamts8 Promotes The Development Of Pulmonary Arterial Hypertension And Right Ventricular Failure
85. Adamts8 Promotes The Development Of Pulmonary Arterial Hypertension And Right Ventricular Failure: A Possible Novel Therapeutic Target
86. Adding Structural Information To The Von Hippel–Lindau (Vhl) Tumor Suppressor Interaction Network
87. Adenoid Cysticus Emlő-És Nyálmirigy Carcinomák Mirns-Expressziós És Immunhisztokémiai Vizsgálata
88. Adenosine A2A And Beta-2 Adrenergic Receptor Agonists: Novel Selective And Synergistic Multiple Myeloma Targets Discovered Through Systematic Combination …
89. Admixture Mapping Identifies An Amerindian Ancestry Locus Associated With Albuminuria In Hispanics In The United States
90. Advanced-Stage Non–Small Cell Lung Cancer: Advances In Thoracic Oncology 2018
91. Advances In Molecular Biology And Targeted Therapy Of Mantle Cell Lymphoma
92. Advances In Multiple Omics Of Natural-Killer/T Cell Lymphoma
93. Advances In The Understanding Of Myc‐Induced Lymphomagenesis
94. Advances In Understanding The Pathogenesis Of Graft‐Versus‐Host Disease
95. Advances In Understanding The Pathogenesis Of Systemic Anaplastic Large Cell Lymphomas
96. Adverse Events And Oncotargeted Kinase Inhibitors
97. Aflatoxin B1 And M1: Biological Properties And Their Involvement In Cancer Development
98. Aggressive T‐Cell Lymphomas: 2019 Updates On Diagnosis, Risk Stratification, And Management
99. Aging And Alzheimer’S Disease: Searching For Novel Molecular Cues
100. Aging And Anti-Aging Strategies
101. Aging Of Antiviral Cd8+ Memory T Cells Fosters Increased Survival, Metabolic Adaptations, And Lymphoid Tissue Homing
102. Akt Family And Mirnas Expression In Il-2 Induced Cd4+ T Cells
103. Akt Isoforms Modulate Th1‐Like Treg Generation And Function In Human Autoimmune Disease
104. Akt/Mtorc2 Inhibition Activates Foxo1 Function In Cll Cells Reducing B-Cell Receptor-Mediated Survival
105. Akt1 Regulates Vascular Smooth Muscle Cell Apoptosis Through Foxo3A And Apaf1 And Protects Against Arterial Remodeling And Atherosclerosis
106. Alcohol‐Mediated Missplicing Of Mcl‐1 Pre‐Mrna Is Involved In Neurotoxicity
107. Alkylating Anticancer Agents And Their Relations To Micrornas
108. Alopecia Areata
109. Alopecia Areata: What’S New In Epidemiology, Pathogenesis, Diagnosis, And Therapeutic Options?
110. Alteration In Mirna Gene Expression Pattern In Acute Promyelocytic Leukemia Cell Induced By Arsenic Trioxide: A Possible Mechanism To Explain Arsenic Multi-Target …
111. Alteration Of Forkhead Box O (Foxo4) Acetylation Mediates Apoptosis Of Podocytes In Diabetes Mellitus
112. Alteration Of Gene Expression In Melanoma Cells Following Combined Treatment With E2F-1 And Doxorubicin
113. Alteration Of Mammary Gland Development By Bisphenol A And Evidence Of A Mode Of Action Mediated Through Endocrine Disruption
114. Alterations Of Mitochondria And Related Metabolic Pathways In Leukemia: A Narrative Review
115. Alterations Of The Interactome Of BCL-2 Proteins In Breast Cancer At The Transcriptional, Mutational And Structural Level
116. Alterations Of The Pro-Survival BCL-2 Protein Interactome In Breast Cancer At The Transcriptional, Mutational And Structural Level
117. Altered Expression Of Mir-181 Affects Cell Fate And Targets Drug Resistance-Related Mechanisms
118. Altered Expression Of Selected Micrornas In Melanoma: Antiproliferative And Proapoptotic Activity Of Mirna-155
119. Altered Foxo3 Expression And Apoptosis In Granulosa Cells Of Women With Polycystic Ovary Syndrome
120. Altered Immune Regulation In Type 1 Diabetes
121. Altered Mirna Expression In T Regulatory Cells In Course Of Multiple Sclerosis
122. Altered T‐Cell Subpopulations In Recurrent Pregnancy Loss Patients With Cellular Immune Abnormalities
123. Alternative Splicing Events Implicated In Carcinogenesis And Prognosis Of Thyroid Gland Cancer
124. Alternative Splicing In Tumors—A Path To Immunogenicity?
125. Alternative Splicing Regulation: Implications In Cancer Diagnosis And Treatment
126. Alternative Transcription And Alternative Splicing In Cancer
127. Alternative‐Splicing Defects In Cancer: Splicing Regulators And Their Downstream Targets, Guiding The Way To Novel Cancer Therapeutics
128. Ambra1, A Novel Bh3-Like Protein: New Insights Into The Ambra1–Bcl2-Family Proteins Relationship
129. Ameliorative Effect Of Omega-3 On Spermatogenesis, Testicular Antioxidant Status And Preimplantation Embryo Development In Streptozotocin-Induced Diabetes In Rats
130. An Early Developmental Role For Mirnas In The Maintenance Of Extraembryonic Stem Cells In The Mouse Embryo
131. An Epigenetic Screening Determines Bet Proteins As Targets To Suppress Self-Renewal And Tumorigenicity In Canine Mammary Cancer Cells
132. An Evolutionary Analysis Of Rac2 Identifies Haplotypes Associated With Human Autoimmune Diseases
133. An Integrated Analysis Of Key Micrornas, Regulatory Pathways And Clinical Relevance In Bladder Cancer
134. An Integrated Bioinformatics And Computational Biology Approach Identifies New Bh3-Only Protein Candidates
135. An Integrated Deep Sequencing Analysis Of Micrornas In Transplanted Corneas
136. An Overview Of Gene Expression Dynamics During Early Ovarian Folliculogenesis: Specificity Of Follicular Compartments And Bi-Directional Dialog
137. Analysis Of “Bimbam”, A Novel Glucocorticoid-Induced Bh3-Only Transcript In Cell Lines And Children With Acute Lymphoblastic Leukemia
138. Analysis Of Alternative Splicing Associated With Aging And Neurodegeneration In The Human Brain
139. Analysis Of Bim (Bcl‐2 Like 11 Gene) Deletion Polymorphism In C Hinese Non‐Small Cell Lung Cancer Patients
140. Analysis Of Drug Resistance And The Role Of The Stem Cell Niche In Leukaemia
141. Analysis Of Glucose Homeostasis And Beta Cell Mass In A Mouse Model Of Type 2 Diabetes Deficient In The Pro-Apoptotic Protein Bim
142. Analysis Of Mirna Expression Profile Induced By Short Term Starvation In Breast Cancer Cells Treated With Doxorubicin
143. Analysis Of Mirna Expression Profiling In Mouse Spleen Affected By Acute Toxoplasma Gondii Infection
144. Analysis Of Novel Mechanisms Of E2F1 Induced Apoptosis
145. Analysis Of Post-Transcriptional And Architectural Regulatory Mechanisms Controlling Complement Receptor Gene Expression In B Cells
146. Analysis Of The Apoptotic Threshold At The Onset Of Embryonic Differentiation
147. Analysis Of The Role Of Two Autophagy Pathway Related Genes, Becn1 And Tsc1, In Murine Mammary Gland Development And Differentiation
148. Analysis Of The* Transcriptional Landscapes Of The Segmentation Clock In Mouse And Chick: Identification Of Novel Cyclic Genes
149. Anaplastic Thyroid Carcinoma: Molecular Tools For Diagnosis And Therapy
150. Androgen Receptor-Mediated Growth Suppression And Apoptosis Of Human Prostate Epithelial Cells
151. Androgen-Sensitized Apoptosis Of Hpr-1Ar Human Prostate Epithelial Cells
152. Angio-Lncrs: Lncrnas That Regulate Angiogenesis And Vascular Disease
153. Anti-Apoptotic BCL-2 Family Members In Development
154. Antiapoptotic Mcl-1 Is Critical For The Survival And Niche-Filling Capacity Of Foxp3+ Regulatory T Cells
155. Antibody-Independent Functions Of B Cells: A Focus On Cytokines
156. Anticancer Bioactive Peptide-3 Inhibits Human Gastric Cancer Growth By Targeting Mir-338-5P
157. Antigen Affinity, Costimulation, And Cytokine Inputs Sum Linearly To Amplify T Cell Expansion
158. Anti-Neoplastic Drugs Increase Caveolin-1-Dependent Migration, Invasion And Metastasis Of Cancer Cells
159. Antioxidant Treatment Regulates The Humoral Immune Response During Acute Viral Infection
160. Antioxidants And Polyphenols Mediate Mitochondrial Mediated Muscle Death Signaling In Sarcopenia
161. Antiproliferative And Proapoptotic Activities Of 4-Hydroxybenzoic Acid-Based Inhibitors Of Histone Deacetylases
162. Anti-Proliferative Bioactivity Against Ht-29 Colon Cancer Cells Of A Withanolides-Rich Extract From Golden Berry (Physalis Peruviana L.) Calyx Investigated By Foodomics
163. Anti-Toso Antibody Treatment Promotes T Cell Activation-Induced Cell Death (Aicd) In Vitro And In Vivo
164. Antonio Dıez-Juan, 2, 5 Vanessa Blanca, 2 Iván-J. Nunez-Gil, 7 Inigo Valiente, 2 Amparo Ruız-Sauri, 8 Pilar Sepu Lveda, 5 Malte Tiburcy, 4 Wolfram-H …
165. Apoptomirs: Small Molecules Have Gained The License To Kill
166. Apoptosis And Cancer: The Genesis Of A Research Field
167. Apoptosis Blocks Beclin 1-Dependent Autophagosome Synthesis
168. Apoptosis In Animal Models Of Virus-Induced Disease
169. Apoptosis In Spermatozoa And Its Role In Deteriorating Semen Quality
170. Apoptosis In The Fetal Testis Eliminates Developmentally Defective Germ Cell Clones
171. Apoptosis In The Germ Line
172. Apoptosis Induction And Regulation
173. Apoptosis Regulates Endothelial Cell Number And Capillary Vessel Diameter But Not Vessel Regression During Retinal Angiogenesis
174. Apoptosis Regulators Bim And Fas Function Concurrently To Control Autoimmunity And Cd8+ T Cell Contraction
175. Apoptosis Regulators Fas And Bim Cooperate In Shutdown Of Chronic Immune Responses And Prevention Of Autoimmunity
176. Apoptosis Regulators Fas And Bim Synergistically Control T‐Lymphocyte Homeostatic Proliferation
177. Apoptosis Signal-Regulating Kinase 1 Is A Direct Target Of E2F1 And Contributes To Histone Deacetylase Inhibitorinduced Apoptosis Through Positive Feedback Regulation …
178. Apoptosis-Related Bcl2-Family Members: Key Players In Chemotherapy
179. Apoptosis-Related Gene Expression In Glioblastoma (Ln-18) And Medulloblastoma (Daoy) Cell Lines
180. Apoptosis-Related Gene Expression In Tumor Tissue Samples Obtained From Patients Diagnosed With Glioblastoma Multiforme
181. Apoptosis-Related Genes Change Their Expression With Age And Hearing Loss In The Mouse Cochlea
182. Apoptosis‐Related Mitochondrial Dysfunction Defines Human Monocyte‐Derived Dendritic Cells With Impaired Immuno‐Stimulatory Capacities
183. Apoptotic And Non-Apoptotic Roles Of Caspases In Neuronal Physiology And Pathophysiology
184. Apoptotic Effects Of Etodolac In Breast Cancer Cell Cultures
185. Apoptotic Gene Expression By Human Periodontal Ligament Cells Following Cyclic Stretch
186. Apoptotic Role Of Ikk In T-All Therapeutic Response
187. Appendix 1: BCL-2 Family Members And Lymphocyte Homeostasis
188. Applied Bioinformatics Tools For Analysis Of Microrna-214 Expression And Prediction Of Its Potential Targets Genes In …
189. Approaches For Measuring Signalling Plasticity In The Context Of Resistance To Targeted Cancer Therapies
190. Arc Regulates Transcription Of Genes For Plasticity, Excitability And Alzheimer’S Disease
191. Archive For The ‘Nanotechnology For Drug Delivery’Category
192. Are Senescence And Exhaustion Intertwined Or Unrelated Processes That Compromise Immunity?
193. Aromatic Amino Acid Activation Of Signaling Pathways In Bone Marrow Mesenchymal Stem Cells Depends On Oxygen Tension
194. Aromatic Residues Link Binding And Function Of Intrinsically Disordered Proteins
195. Arsenic Trioxide Plus Px-478 Achieves Effective Treatment In Pancreatic Ductal Adenocarcinoma
196. Assessing The Anticancer Potential Of Natural Health Products (Lemongrass, Hibiscus, And Eleuthero Ginseng) Against Breast Cancer Models
197. Assessment Of Functional Phosphatidylinositol 3-Kinase Pathway Activity In Cancer Tissue Using Forkhead Box-O Target Gene Expression In A Knowledge-Based …
198. Assessment Of The Impact Of Deregulated Signal Transduction Pathways On The Radiotherapy Response Of Non-Small-Cell Lung Cancer
199. Assessment Of The Usefulness Of The Murine Cytotoxic T Cell Line Ctll-2 For Immunotoxicity Screening By Transcriptomics
200. Assignment1 Of Bcl2L11 To Human Chromosome Band 2P13 With Somatic Cell And Radiation Hybrids
201. Association Between Bim Deletion Polymorphism And Clinical Outcome Of Egfr-Mutated Nsclc Patient With Egfr-Tki Therapy: A Meta-Analysis
202. Association Between Bim Deletion Polymorphism And The Risk Of Non-Small Cell Lung Cancer In Chinese
203. Association Of Bim Deletion Polymorphism And Bim-Γ Rna Expression In Nsclc With Egfr Mutation
204. Association Of Tat With Promoters Of Pten And Pp2A Subunits Is Key To Transcriptional Activation Of Apoptotic Pathways In Hiv-Infected Cd4+ T Cells
205. Asxl1 And Bim Germ Line Variants Predict Response And Identify Cml Patients With The Greatest Risk Of Imatinib Failure
206. At‐101 Downregulates Bcl 2 And Mcl 1 And Potentiates The Cytotoxic Effects Of Lenalidomide And Dexamethasone In Preclinical Models Of Multiple Myeloma And W …
207. Atr Is A Novel Therapeutic Target For Medulloblastoma Identified By Its Role In Cerebellar Development
208. Attenuation Of Hedgehog/Gli Signaling By Nt1721 Extends Survival In Pancreatic Cancer
209. Attenuation Of Inflammatory Disease With Natural Compounds: A Role For Mirna
210. Atypical Presentation And Pathogenesis Of A Macaque Lymphocryptoviral‐Associated B‐Cell Lymphoma In A Cynomolgus Monkey
211. Aus Dem Zentrum Für Innere Medizin Der Universität Zu Köln Klinik Und Poliklinik Für Innere Medizin I Hämatologie Und Onkologie Direktor: Universitätsprofessor …
212. Autocrine Tgf-Β Protects Breast Cancer Cells From Apoptosis Through Reduction Of Bh3-Only Protein, Bim
213. Autoimmune Diseases
214. Autoimmunity Checkpoints As Therapeutic Targets In B Cell Malignancies
215. Autophagic Flux And Oxidative Capacity Of Skeletal Muscles During Acute Starvation
216. Autophagy And Ethanol Neurotoxicity
217. Autophagy As A Target For Hematological Malignancy Therapy
218. Autophagy Inhibition Mediates Apoptosis Sensitization In Cancer Therapy By Relieving Foxo3A Turnover
219. Autophagy Is Involved In Recombinant Newcastle Disease Virus (Rl-Rvg)-Induced Cell Death Of Stomach Adenocarcinoma Cells In Vitro
220. Autophagy Is Used As A Survival Program In Unfertilized Sea Urchin Eggs That Are Destined To Die By Apoptosis After Inactivation Of Mapk1/3 (Erk2/1)
221. Autophagy: A Double-Edged Sword For Neuronal Survival After Cerebral Ischemia
222. Autophagy: A Potential Key Contributor To The Therapeutic Action Of Mesenchymal Stem Cells
223. Autophagy: Regulation And Role In Development
224. Autoreactive T Cells Induce Necrosis And Not Bcl-2-Regulated Or Death Receptor-Mediated Apoptosis Or Ripk3-Dependent Necroptosis Of Transplanted Islets In A Mouse …
225. Azd6244 Inhibits Cisplatin-Induced Erk1/2 Activation And Potentiates Cisplatin-Associated Cytotoxicity In K-Ras G12D Preclinical Models
226. B7-H1 Limits The Entry Of Effector Cd8+ T Cells To The Memory Pool By Upregulating Bim
227. Bach2 Controls T Follicular Helper Cells By Direct Repression Of Bcl-6
228. Baff And Cd4+ T Cells Are Major Survival Factors For Long-Lived Splenic Plasma Cells In A B-Cell–Depletion Context
229. Baff Regulates B Cell Survival By Downregulating The Bh3-Only Family Member Bim Via The Erk Pathway
230. Baff, Il‐4 And Il‐21 Separably Program Germinal Center‐Like Phenotype Acquisition, Bcl6 Expression, Proliferation And Survival Of Cd40L‐Activated B Cells In Vitro
231. Baicalin Protects Mice Brain From Apoptosis In Traumatic Brain Injury Model Through Activation Of Autophagy
232. Bak Is A Predictive And Prognostic Biomarker For The Therapeutic Effect Of Docetaxel Treatment In Patients With Advanced Gastric Cancer
233. Bax Activation Is Initiated At A Novel Interaction Site
234. Bax And Tumor Suppressor Trp53 Are Important In Regulating Mutagenesis In Spermatogenic Cells In Mice
235. Bax-Bak1-Independent Lc3B Lipidation By Bh3 Mimetics Is Unrelated To Bh3 Mimetic Activity And Has Only Minimal Effects On Autophagic Flux
236. Bayesian Network To Infer Drug-Induced Apoptosis Circuits From Connectivity Map Data
237. Bb A Novel Bim Isoform Upregulated In Acute Lymphoblastic Leukemia After Glucocorticoid Monotherapy Confers A Novel Apoptosis Regulation Mechanism
238. BCL2 And Related Prosurvival Proteins Require Bak1 And Bax To Affect Autophagy
239. BCL-2 Double Take
240. BCL-2 Family Antagonists For Cancer Therapy
241. Bcl‐2 Family In Non‐Small Cell Lung Cancer: Its Prognostic And Therapeutic Implications
242. BCL2 Family Of Apoptosis-Related Genes: Functions And Clinical Implications In Cancer
243. BCL-2 Family Proteins In Breast Development And Cancer: Could Mcl-1 Targeting Overcome Therapeutic Resistance?
244. BCL-2 Is A Therapeutic Target For Hypodiploid B-Lineage Acute Lymphoblastic Leukemia
245. Bcl‐2 Levels Do Not Predict Azathioprine Treatment Response In Inflammatory Bowel Disease, But Inhibition Induces Lymphocyte Apoptosis And Ameliorates Colitis In …
246. BCL-2 Overexpression In Thyroid Carcinoma Cells Increases Sensitivity To BCL-2 Homology 3 Domain Inhibition
247. BCL2 Predicts Survival In Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma Treated With Chop-Like Therapy And Rituximab
248. Bcl2/Bcl-Xl Inhibition Induces Apoptosis, Disrupts Cellular Calcium Homeostasis, And Prevents Platelet Activation
249. Bcl2-Family Dysregulation In B-Cell Malignancies: From Gene Expression Regulation To A Targeted Therapy Biomarker
250. Bcl2L11 (Bim) Deletion Polymorphism Is Associated With Molecular Relapse After Abl Tyrosine Kinase Inhibitor Discontinuation In Patients With Chronic Myeloid …
251. Bcl2L11 Is Associated With Kawasaki Disease In Intravenous Immunoglobulin Responder Patients
252. Bcl2L11/Bim As A Dual-Agent Regulating Autophagy And Apoptosis In Drug Resistance
253. Bcl2L11/Bim: A Novel Molecular Link Between Autophagy And Apoptosis
254. Bcl2-Like 11 (Apoptosis Facilitator)(Bcl2L11; Bim)
255. Bcl2-Modifying Factor Promotes Germ Cell Loss During Murine Oogenesis
256. Bclb, Methylated In Hepatocellular Carcinoma, Is A Starvation Stress Sensor That Induces Apoptosis And Autophagy Through The Ampk-Mtor Signaling Cascade
257. Bcl-W Is Dispensable For The Sustained Survival Of Select Burkitt Lymphoma And Diffuse Large B-Cell Lymphoma Cell Lines
258. Bclw Mediates Survival Of Postmitotic Sertoli Cells By Regulating Bax Activity
259. Bcl-X L Directly Modulates Ras Signalling To Favour Cancer Cell Stemness
260. Bcl-Xl Protein Protects From C/Ebp Homologous Protein (Chop)-Dependent Apoptosis During Plasma Cell Differentiation
261. Bcl-Xl, A Mitochondrial Protein Involved In Successful Aging: From C. Elegans To Human Centenarians
262. Bcr-Induced Ca 2+ Signals Dynamically Tune Key Checkpoints That Control The Survival, Metabolic Reprogramming, And Proliferation Of Naïve B Cells
263. Becn1 Is Involved In The Initiation Of Mitophagy: It Facilitates Park2 Translocation To Mitochondria
264. Benzene-Poly-Carboxylic Acid Complex, A Novel Anti-Cancer Agent Induces Apoptosis In Human Breast Cancer Cells
265. Besides Pathology: Long Non-Coding Rna In Cell And Tissue Homeostasis
266. Bet Bromodomain Inhibition Triggers Apoptosis Of Nf1-Associated Malignant Peripheral Nerve Sheath Tumors Through Bim Induction
267. Bet Inhibition In Advanced Cutaneous T Cell Lymphoma Is Synergistically Potentiated By BCL2 Inhibition Or Hdac Inhibition
268. Bet-Inhibition By Jq1 Promotes Proliferation And Self-Renewal Capacity Of Hematopoietic Stem Cells
269. Better Living Through Chemistry: Caloric Restriction (Cr) And Cr Mimetics Alter Genome Function To Promote Increased Health And Lifespan
270. Bh 3‐Only Proteins
271. Bh3 Mimetic Obatoclax (Gx15-070) Mediates Mitochondrial Stress Predominantly Via Mcl-1 Inhibition And Induces Autophagy-Dependent Necroptosis In …
272. Bh3 Profiling Discriminates Response To Cytarabine-Based Treatment Of Acute Myelogenous Leukemia
273. Bh3-Only BCL-2 Family Member Bim Is Required For Apoptosis Of Autoreactive Thymocytes
274. Bh3‐Only Protein Bim Is Upregulated And Mediates The Apoptosis Of Cardiomyocytes Under Glucose And Oxygen‐Deprivation Conditions
275. Bh3-Only Protein Bim: An Emerging Target In Chemotherapy
276. Bh3‐Only Proteins
277. Bh3‐Only Proteins Bid And Bimel Are Differentially Involved In Neuronal Dysfunction In Mouse Models Of Huntington’S Disease
278. Bh3-Only Proteins Noxa, Bmf, And Bim Are Necessary For Arsenic Trioxide–Induced Cell Death In Myeloma
279. Bid And Bim Collaborate During Induction Of T Cell Death In Persistent Infection
280. Bim (BCL-2 Interacting Mediator Protein Or Bcl-2-Like Protein 11) And Cancer
281. Bim Contributes To The Progression Of Huntington’S Disease-Associated Phenotypes
282. Bim Deficiency Leads To Exacerbation And Prolongation Of Joint Inflammation In Experimental Arthritis
283. Bim Deficiency Protects Nod Mice From Diabetes By Diverting Thymocytes To Regulatory T Cells
284. Bim Deletion Polymorphism Accounts For Lack Of Favorable Outcome In Japanese Females With Follicular Lymphoma
285. Bim Deletion Polymorphism Predicts Poor Response To Egfr-Tkis In Nonsmall Cell Lung Cancer: An Updated Meta-Analysis
286. Bim Deletion Polymorphisms In Hispanic Patients With Non-Small Cell Lung Cancer Carriers Of Egfr Mutations
287. Bim Determines The Number Of Merocytic Dendritic Cells, A Cell Type That Breaks Immune Tolerance
288. Bim Is A Prognostic Biomarker For Early Prednisolone Response In Pediatric Acute Lymphoblastic Leukemia
289. Bim Is A Suppressor Of Myc-Induced Mouse B Cell Leukemia
290. Bim Is An Independent Prognostic Marker In Intrahepatic Cholangiocarcinoma
291. Bim Is Required To Sensitize Mantle Cell Lymphoma Cells For Killing By Bortezomib, But Not Ara-C, By Selective Inhibition Of Cdk4/Cdk6
292. Bim Is The Primary Mediator Of Myc-Induced Apoptosis In Multiple Solid Tissues
293. Bim Mediates Egfr Tyrosine Kinase Inhibitor-Induced Apoptosis In Lung Cancers With Oncogenic Egfr Mutations
294. Bim Mediates Imatinib-Induced Apoptosis Of Gastrointestinal Stromal Tumors: Translational Implications
295. Bim Mediates Synergistic Killing Of B-Cell Acute Lymphoblastic Leukemia Cells By BCL-2 And Mek Inhibitors
296. Bim Polymorphisms: Influence On Function And Response To Treatment In Children With Acute Lymphoblastic Leukemia
297. Bim Promoter Directly Targeted By Ebna3C In Polycomb-Mediated Repression By Ebv
298. Bim Regulates Bcr‐Induced Entry Of B Cells Into The Cell Cycle
299. Bim Regulation Mirrors Microrna 17∼ 92 Cluster Expression In Endothelial Cells In Vivo
300. Bim Upregulation By Histone Deacetylase Inhibitors Mediates Interactions With The BCL-2 Antagonist Abt-737: Evidence For Distinct Roles For Bcl-2, Bcl-Xl, And Mcl-1
301. Bim-Mediated Apoptosis And Oncogene Addiction
302. Bim’S Up First
303. Bioinformatics And Microarray Analysis Of Microrna Expression Profiles Of Murine Embryonic Stem Cells, Neural Stem Cells Induced From Escs And Isolated From E8· 5 …
304. Biological Implications Of Differential Expression Of Mitochondrial-Shaping Proteins In Parkinson’S Disease
305. Biological Principles Of Microrna-Mediated Regulation: Shared Themes Amid Diversity
306. Biomarkers Of Therapeutic Response To BCL2 Antagonists In Cancer
307. Biphasic Ros Production, P53 And Bik Dictate The Mode Of Cell Death In Response To Dna Damage In Colon Cancer Cells
308. Birc5/Survivin As A Target For Glycolysis Inhibition In High-Stage Neuroblastoma
309. Birc5/Survivin Enhances Aerobic Glycolysis And Drug Resistance By Altered Regulation Of The Mitochondrial Fusion/Fission Machinery
310. Bisphenol A (Bpa) And Cell Signaling Pathways
311. Blimp-1 Controls Plasma Cell Function Through The Regulation Of Immunoglobulin Secretion And The Unfolded Protein Response
312. Blood Expression Profiles Of Fragile X Premutation Carriers Identify Candidate Genes Involved In Neurodegenerative And Infertility Phenotypes
313. Blood First Edition Paper, Prepublished Online May 11, 2011; Doi 10.1182/Blood-2011-03-344812
314. Bmi1: A Biomarker Of Hematologic Malignancies
315. Bok Is A Genuine Multi-Bh-Domain Protein That Triggers Apoptosis In The Absence Of Bax And Bak
316. Borneol For Regulating The Permeability Of The Blood-Brain Barrier In Experimental Ischemic Stroke: Preclinical Evidence And Possible Mechanism
317. Bortezomib Interacts Synergistically With Belinostat In Human Aml And All Cells In Association With Perturbations In Nf-Κb And Bim
318. Both Intrinsic And Extrinsic Apoptotic Pathways Are Involved In Toll-Like Receptor 4 (Tlr4)-Induced Cell Death In Monocytic Thp-1 Cells
319. Bovine Micrornomics: Implications During Oocyte Maturation And Pathophysiology Of Endometrium
320. Braf Inhibitors Reverse The Unique Molecular Signature And Phenotype Of Hairy Cell Leukemia And Exert Potent Antileukemic Activity
321. Braf Signals To Pro-Apoptotic Bim To Enhance Arac Cytotoxicity Induced In Aml Cells By Vitamin D-Based Differentiation Agents
322. Braf V600E Mutation In Hairy Cell Leukemia: From Bench To Bedside
323. Brd4-Targeted Therapy Induces Myc-Independent Cytotoxicity In Gnaq/11-Mutatant Uveal Melanoma Cells
324. Breaking Good: The Inexorable Rise Of Btk Inhibitors In The Treatment Of Chronic Lymphocytic Leukaemia
325. Breast Cancer Cell Apoptosis With Phytoestrogens Is Dependent On An Estrogen-Deprived State
326. Breast Cancer Genetics In Young Women: What Do We Know?
327. Breast-And Salivary Gland-Derived Adenoid Cystic Carcinomas: Potential Post-Transcriptional Divergencies. A Pilot Study Based On Mirna Expression Profiling Of Four …
328. Breathe Easy: Microbes Protect From Allergies
329. Bromodomain (Brd) Inhibition As A Novel Strategy To Inhibit The Microphthalmia-Associated Transcription Factor (Mitf) Axis In Uveal Melanoma (Um)
330. Bromodomain And Extra-Terminal Motif Inhibitors: A Review Of Preclinical And Clinical Advances In Cancer Therapy
331. Brucella Suppress Innate Immunity By Down-Regulating Sting Expression In Macrophages
332. Burkitt Lymphoma: The Role Of Epstein‐Barr Virus Revisited
333. C10Orf10/Depp, A Transcriptional Target Of Foxo3, Regulates Ros-Sensitivity In Human Neuroblastoma
334. C10Orf10/Depp-Mediated Ros Accumulation Is A Critical Modulator Of Foxo3-Induced Autophagy
335. Caffeine-Induced Nuclear Translocation Of Foxo1 Triggers Bim-Mediated Apoptosis In Human Glioblastoma Cells
336. Calcium Signaling Alterations, Oxidative Stress, And Autophagy In Aging
337. Caml Regulates Bim-Dependent Thymocyte Death
338. Camp Signalling Of Bordetella Adenylate Cyclase Toxin Through The Shp‐1 Phosphatase Activates The Bimel‐Bax Pro‐Apoptotic Cascade In Phagocytes
339. Cancer Biomarkers In Body Fluids
340. Cancer Biomarkers In Body Fluids: Biomarkers In Circulation
341. Cancer Cell Line Identification By Short Tandem Repeat Profiling: Power And Limitations
342. Cancer Gene List–I (Ab)
343. Cancer Pharmacogenomics: Strategies And Challenges
344. Cancer Rnome: Evolution And Sustenance
345. Cancer Stem Cells In Chronic Myelogenous Leukemia
346. Cancer-Associated Fibroblasts (Cafs) Release Exosomal Micrornas That Dictate An Aggressive Phenotype In Breast Cancer Cells
347. Cancer-Related Issues Of Cd147
348. Candida Albicans Infection Leads To Barrier Breakdown And A Mapk/Nf‐Κb Mediated Stress Response In The Intestinal Epithelial Cell Line C2Bbe1
349. Canertinib-Induced Leukemia Cell Death Signaling: Effects Of A Pan-Erbb Inhibitor
350. Cardio-Mirnas And Onco-Mirnas: Circulating Mirna-Based Diagnostics For Non-Cancerous And Cancerous Diseases
351. Cardiomyocytes Capture Stem Cell-Derived, Anti-Apoptotic Microrna-214 Via Clathrin-Mediated Endocytosis In Acute Myocardial Infarction
352. Cardiovascular Effects Of Oral Calcium Sensitizers On Experimental Heart Failure
353. Cationic Nanoparticles: Friend Or Foe?
354. Caught In The Act–Protein Adaptation And The Expanding Roles Of The Pacs Proteins In Tissue Homeostasis And Disease
355. Causal Reasoning Identifies Mechanisms Of Sensitivity For A Novel Akt Kinase Inhibitor, Gsk690693
356. Ccaat/Enhancer Binding Protein Delta (Cebpd) Elevating Ptx3 Expression Inhibits Macrophage-Mediated Phagocytosis Of Dying Neuron Cells
357. Ccnd2 And Ccnd3 Hijack Immunoglobulin Light-Chain Enhancers In Cyclin D1− Mantle Cell Lymphoma
358. Cd19-Positive Antibody-Secreting Cells Provide Immune Memory
359. Cd28 And Cd86 Regulate Integrin Surface Expression In Multiple Myeloma
360. Cd4+ T Cell Production Of Il-10 And Regulation Of Immune Responses In Aging
361. Cd4+ T Cells From Patients With Primary Sclerosing Cholangitis Exhibit Reduced Apoptosis And Down‐Regulation Of Proapoptotic Bim In Peripheral Blood
362. Cd8Αα Intraepithelial Lymphocytes Arise From Two Main Thymic Precursors
363. Cdk5–Foxo3 Axis: Initially Neuroprotective, Eventually Neurodegenerative In Alzheimer’S Disease Models
364. Cell Competition Corrects Noisy Wnt Morphogen Gradients To Achieve Robust Patterning
365. Cell Competition Corrects Noisy Wnt Morphogen Gradients To Achieve Robust Patterning In The Zebrafish Embryo
366. Cell Cycle Progression Dictates The Requirement For BCL2 In Natural Killer Cell Survival
367. Cell Death And Endoplasmic Reticulum Stress: Disease Relevance And Therapeutic Opportunities
368. Cell Death In Cancer Therapy Of Lung Adenocarcinoma
369. Cell Death In The Pathogenesis Of Systemic Lupus Erythematosus And Lupus Nephritis
370. Cell-Type And Stimulus-Specific Regulation Of Jun And Bim By Egln3 In Multiple Models Of Neuronal Death
371. Cellular And Molecular Mechanisms Of Autoimmunity And Lupus Nephritis
372. Cellular Automata Modelling Of Biomolecular Networks Dynamics
373. Cellular Reprogramming By Epstein-Barr Virus Nuclear Antigens
374. Cellular Responses To Endoplasmic Reticulum Stress: Role Of
375. Cellular Responses To Hsv-1 Infection Are Linked To Specific Types Of Alterations In The Host Transcriptome
376. Central Cd4+ T Cell Tolerance: Deletion Versus Regulatory T Cell Differentiation
377. Cerebrospinal Fluid Micrornas Are Potential Biomarkers Of Temporal Lobe Epilepsy And Status Epilepticus
378. C-Flip Expression In Foxp3-Expressing Cells Is Essential For Survival Of Regulatory T Cells And Prevention Of Autoimmunity
379. Challenges And Opportunities Of Micrornas In Lymphomas
380. Changes In Ciap 2, Survivin And Bim El Expression Characterize The Switch From Autophagy To Apoptosis In Prolonged Starvation
381. Changes In Gene Expression Profiling Of Apoptotic Genes In Neuroblastoma Cell Lines Upon Retinoic Acid Treatment
382. Changes In The Apoptotic Gene Expression Profile In Cll Patients Treated With Rituximab Combined With Cladribine And Cyclophosphamide-Preliminary Results
383. Changes In The Cellular Microrna Profile By The Intracellular Expression Of Hiv-1 Tat Regulator: A Potential Mechanism For Resistance To Apoptosis And …
384. Chaperone-Mediated Autophagy Prevents Apoptosis By Degrading Bbc3/Puma
385. Characterising Acquired Resistance To Erlotinib In Non-Small Cell Lung Cancer Patients
386. Characterization And Anti-Cancer Effects Of Citralloaded Nanostructured Lipid Carrier In Breast Cancer Cells In Vitro And …
387. Characterization Of Apoptotic Activities During Chlamydia Trachomatis Infection In Primary Cervical Epithelial Cells
388. Characterization Of Ebv Nuclear Protein 3 (Ebna3) Genome Binding And Gene Regulation In Ebv Transformed Lymphoblastoid Cell Lines (Lcls)
389. Characterization Of Foxo3 In Ros And Dna Damage-Induced Hepatocellular Carcinoma
390. Characterization Of Kir2Ds1+ Decidual Natural Killer Cells In Healthy And Viral/Bacterial–Infected Human Pregnancy
391. Characterization Of Microrna Regulation And Function In Hypoxia Biology
392. Characterization Of Patient-Derived Tumor Xenografts (Pdxs) As Models For Estrogen Receptor Positive (Er+ Her2− And Er+ Her2+) Breast Cancers
393. Characterization Of Reciprocal Lmb1–4 Interval Mrl-Faslpr And C57Bl/6-Faslpr Congenic Mice Reveals Significant Effects From Lmb3
394. Characterization Of Regulatory Mechanisms For Bim Exon 3 Alternative Splicing
395. Characterization Of Trib2 Following Pi3K Inhibition
396. Characterizing Egfrviii-Independent Glioblastoma Maintenance
397. Characterizing Rna Targets Of Tdp-43
398. Characterizing The Rna Targets And Position-Dependent Splicing Regulation By Tdp-43
399. Checkpoint Blockade Immunotherapy Attenuates Mechanisms Ofcd8+ T Cell Tolerance For The Treatment Of Leukemia
400. Checks And Balances: E2F—Microrna Crosstalk In Cancer Control
401. Chemical Characteristics Of Non-Edible Cocoa Plant (Theobroma Cacao L.) Parts And Their Antiproliferative Activity Against …
402. Chemosensitivity Of Testicular Germ Cell Tumors Is Based On High Constitutive Noxa Protein Levels And A Functional P53 Response
403. Chemostat‐Based Transcriptional Analysis Of Growth Rate Change And Bcl‐2 Over‐Expression In Ns0 Cells
404. Chemotherapy‐Induced Apoptosis In Hepatocellular Carcinoma Involves The P53 Family And Is Mediated Via The Extrinsic And The Intrinsic Pathway
405. Cholangiocytes In The Pathogenesis Of Primary Sclerosing Cholangitis And Development Of Cholangiocarcinoma
406. Chromatin Reorganisation In Epstein-Barr Virus-Infected Cells And Its Role In Cancer Development
407. Chronic Lymphocytic Leukaemia
408. Chronic Myeloid Leukaemia
409. Chronic Myeloid Leukemia: An Overview Of Data From American Society Of Hematology 2014
410. Chrysin And Its Potential Antineoplastic Effect
411. Circular Rna Cesrp1 Sensitises Small Cell Lung Cancer Cells To Chemotherapy By Sponging Mir-93-5P To Inhibit Tgf-Β Signalling
412. Circulating And Tissue Micrornas As Biomarkers For Ovarian Cancer Prognosis
413. Circulating Microrna Biomarkers For Glioma And Predicting Response To Therapy
414. Cisplatin Inhibits Hippocampal Cell Proliferation And Alters The Expression Of Apoptotic Genes
415. Citrobacter Rodentium Alters The Mouse Colonic Mirnome
416. Cjun N-Terminal Kinase (Jnk) Activation Mediates Islet Amyloid-Induced Beta Cell Apoptosis In Cultured Human Islet Amyloid Polypeptide Transgenic Mouse …
417. Classification Of Helicobacter Pylori Virulence Factors: Is Caga A Toxin Or Not?
418. Clinical And Biologic Significance Of Myc Genetic Mutations In De Novo Diffuse Large B-Cell Lymphoma
419. Clinical Features Of Bim Deletion Polymorphism And Its Relation With Crizotinib Primary Resistance In Chinese Patients With Alk/Ros1 Fusion‐Positive Non–Small Cell …
420. Clinical Implications Of Mirnas In The Pathogenesis, Diagnosis And Therapy Of Pancreatic Cancer
421. Clinical Implications Of The Autophagy Core Gene Variations In Advanced Lung Adenocarcinoma Treated With Gefitinib
422. Clinical Implications Of The Bim Deletion Polymorphism In Advanced Lung Adenocarcinoma Treated With Gefitinib
423. Clinical Importance Of Bcl-2-Like 11 Deletion Polymorphism In Idiopathic Pulmonary Fibrosis
424. Clinical Manifestations And Pathogenesis Of Cutaneous Lymphomas: Current Status And Future Directions
425. Clinical Significance Of Bim Deletion Polymorphism In Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation
426. Clinical Significance Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Sensitivity And Resistance
427. Clustered Mirnas And Their Role In Biological Functions And Diseases
428. Clustering, Pathway Enrichment, And Protein-Protein Interaction Analysis Of Gene Expression In Neurodevelopmental Disorders
429. C-Myb Coordinates Survival And The Expression Of Genes That Are Critical For The Pre-Bcr Checkpoint
430. C-Myb Promotes The Survival Of Cd4+ Cd8+ Double-Positive Thymocytes Through Upregulation Of Bcl-Xl
431. C-Myc Dependent Expression Of Pro-Apoptotic Bim Renders Her2-Overexpressing Breast Cancer Cells Dependent On Anti-Apoptotic Mcl-1
432. Cns Infection And Immune Privilege
433. Coagulation Factor Xa Drives Tumor Cells Into Apoptosis Through Bh3-Only Protein Bim Up-Regulation
434. Co-Author Statement
435. Coinhibitory Pathways In Immunotherapy For Cancer
436. Colon Cancer Cell Apoptosis Is Induced By Combined Exposure To The N-3 Fatty Acid Docosahexaenoic Acid And Butyrate Through Promoter Methylation
437. Colon Cancer Chemoprotection Through Epigenetic Effects Of A Fish Oil/Pectin Diet
438. Colorectal Tumors Are Effectively Eradicated By Combined Inhibition Of Β-Catenin, Kras, And The Oncogenic Transcription Factor Itf2
439. Combating Malignant Melanoma With The Multifaceted Soy-Dervied Peptide Lunasin.
440. Combination Of Pan-Raf And Mek Inhibitors In Nras Mutant Melanoma
441. Combination Of Saha And Bortezomib Up‐Regulates Cdkn2A And Cdkn1A And Induces Apoptosis Of Epstein‐Barr Virus‐Positive Wp‐Restricted Burkitt Lymphoma And …
442. Combination Treatment With Doxorubicin And Gamitrinib Synergistically Augments Anticancer Activity Through Enhanced Activation Of Bim
443. Combinatorial Regulation Of Tissue Specification By Gata And Fog Factors
444. Combined Chip-Seq And Transcriptome Analysis Identifies Ap-1/Jund As A Primary Regulator Of Oxidative Stress And Il-1Β Synthesis In Macrophages
445. Combined Deficiency Of Proapoptotic Regulators Bim And Fas Results In The Early Onset Of Systemic Autoimmunity
446. Combining Afatinib And Cetuximab Synergistically Increases Their Cytotoxicity For Egfr T790M-Harboring Cells
447. Combining Bet And Hdac Inhibitors Synergistically Induces Apoptosis Of Melanoma And Suppresses Akt And Yap Signaling
448. Combining Epigenetic Drugs With Other Therapies For Solid Tumours—Past Lessons And Future Promise
449. Common Genetic Variants In Candidate Genes And Risk Of Familial Lymphoid Malignancies
450. Comparative Analysis Of Trans-Fats And Alpha-Linolenic Acid Administration On Cardiomyocyte Viability During Ischemia/Reperfusion Injury
451. Comparative Analysis Of Ttf‐1 Binding Dna Regions In Small‐Cell Lung Cancer And Non‐Small‐Cell Lung Cancer
452. Comparative Effects Of The Preventive Effect Of Pregnancy, Steroidal Hormones, And Hcg In The Transcriptomic Profile Of The Rat Mammary Gland
453. Comparative Expression Analysis Of Brain Tumours To Identify Biomarkers And Therapeutic Targets
454. Comparative Molecular Docking Analysis Of Cytoplasmic Dynein Light Chain Dynll1 With Pilin To Explore The Molecular Mechanism Of Pathogenesis Caused By …
455. Comparison Of Gene Expression Profiles In Human Cortical Neurons Treated With A Free Radical Generating Toxin, Tertiary Butylhydroperoxide (T-Buooh) And The …
456. Comparison Of Two Structurally Diverse Glucocorticoid Receptor Agonists: Cortivazol Selectively Regulates A Distinct Set Of Genes Separate From Dexamethasone In Cem …
457. Complement Is Dispensable For Neurodegeneration In Niemann-Pick Disease Type C
458. Complicated Life, Complicated Vegf-B
459. Compound A Attenuates Toll-Like Receptor 4-Mediated Paclitaxel Resistance In Breast Cancer And Melanoma Through Suppression Of Il-8
460. Compound Egfr Mutation Is Frequently Detected With Co-Mutations Of Actionable Genes And Associated With Poor Clinical Outcome In Lung Adenocarcinoma
461. Compound Porcine Cerebroside And Ganglioside Injection Attenuates Cerebral Ischemia–Reperfusion Injury In Rats By Targeting Multiple Cellular Processes
462. Comprehensive Gene Expression Profiles Of Nk Cell Neoplasms Identify Vorinostat As An Effective Drug Candidate
463. Computational Analyses Of Gene Expression Profiles Of Ovarian And Pancreatic Cancer
464. Computational Approaches For Intelligent Processing Ofbiomedical Data
465. Computational Prediction Of Microrna Targets: Thermodynamic, Probabilistic And Evolutionary Models Parameterized By Genome-Scale Experimental Data
466. Concomitant Targeting Of BCL2 With Venetoclax And Mapk Signaling With Cobimetinib In Acute Myeloid Leukemia Models
467. Concurrent Acetylation Of Foxo1/3A And P53 Due To Sirtuins Inhibition Elicit Bim/Puma Mediated Mitochondrial Dysfunction And Apoptosis In Berberine-Treated Hepg2 …
468. Connecting Genotypes To Drug Sensitivities In Her2 Positive Cancer Cell Lines
469. Consequences Of The Recurrent Myd88L265P Somatic Mutation For B Cell Tolerance
470. Construction Of A Cancer-Perturbed Protein-Protein Interaction Network For Discovery Of Apoptosis Drug Targets
471. Construction Of Cancer-Perturbed Protein–Protein Interaction Network Of Apoptosis For Drug Target Discovery
472. Context-Specific Regulation Of Cell Survival By A Mirna-Controlled Bim Rheostat
473. Contrasting Dynamic Responses In Vivo Of The Bcl-Xl And Bim Erythropoietic Survival Pathways
474. Contrasting Roles Of H3K4Me3 And H3K9Me3 In Regulation Of Apoptosis And Gemcitabine Resistance In Human Pancreatic Cancer Cells
475. Contribution Of Bruton’S Tyrosine Kinase In Progression, Migration And Toll-Like Receptor Induced Inflammation In Head And Neck Squamous Cell Carcinoma …
476. Contribution Of Micro Rna 24–3P And E Rk1/2 To Interleukin‐6‐Mediated Plasma Cell Survival
477. Contribution Of Micrornas To Radio-And Chemoresistance Of Brain Tumors And Their Therapeutic Potential
478. Contributions Of Eosinophils To Human Health And Disease
479. Contributions Of Rad9 To Tumorigenesis
480. Control Of Apoptosis By The BCL-2 Protein Family: Implications For Physiology And Therapy
481. Control Of B Lymphocyte Apoptosis By The Transcription Factor Nf-Κb
482. Control Of Immune Cell Homeostasis And Function By Lncrnas
483. Control Of Nf‐Kb Activity In Human Melanoma By Bromodomain And Extra‐Terminal Protein Inhibitor I‐Bet 151
484. Cooperating Events In Core Binding Factor Leukemia Development: A Dissertation
485. Co‐Ordinate But Disproportionate Activation Of Apoptotic, Regenerative And Inflammatory Pathways Characterizes The Liver Response To Acute Amebic Infection
486. Core Binding Factor (Cbf) Is Required For Epstein-Barr Virus Ebna3 Proteins To Regulate Target Gene Expression
487. Correlation Of Glucocorticoid-Mediated E4Bp4 Upregulation With Altered Expression Of Pro-And Anti-Apoptotic Genes In Cem Human Lymphoblastic Leukemia Cells
488. Correlations Between Gene Expression And Mercury Levels In Blood Of Boys With And Without Autism
489. Cpg Island Hypermethylation In Human Astrocytomas
490. Cpg Island Methylation Profiling In Human Salivary Gland Adenoid Cystic Carcinoma
491. Creb-Binding Protein (Cbp) Regulates Β-Adrenoceptor (Β-Ar)− Mediated Apoptosis
492. Crispr/Cas9 Library Screening For Drug Target Discovery
493. Crispr/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors
494. Crispr–Cas9 Genetic Analysis Of Virus–Host Interactions
495. Critical Functions For Stat5 Tetramers In The Maturation And Survival Of Natural Killer Cells
496. Critical Regulation Of Cd4+ T Cell Survival And Autoimmunity By Β-Arrestin 1
497. Critical Role Of Foxo3A In Alcohol-Induced Autophagy And Hepatotoxicity
498. Crizotinib Presented With Promising Efficacy But For Concomitant Mutation In Next-Generation Sequencing-Identified Ros1-Rearranged Non-Small-Cell Lung …
499. Cross Talk Between Cancer And Mesenchymal Stem Cells Through Extracellular Vesicles Carrying Nucleic Acids
500. Cross Talk Between Cellular Redox Status, Metabolism, And P53 In Neural Stem Cell Biology
501. Crosstalk Between Tgf-Β Signaling And The Microrna Machinery
502. Cross-Talk Between The Circadian Clock And The Cell Cycle In Cancer
503. Crystal Structure Of Tipe2 Provides Insights Into Immune Homeostasis
504. Ctsh Regulates Β-Cell Function And Disease Progression In Newly Diagnosed Type 1 Diabetes Patients
505. Ctsh Regulates: Cell Function And Disease Progression In Newly Diagnosed Type 1 Diabetes Patients
506. Cultures Of Hep-2 Cells Persistently Infected By Human Respiratory Syncytial Virus Differ In Chemokine Expression And Resistance To Apoptosis As Compared To …
507. Current Perspective On The Regulation Of Foxo4 And Its Role In Disease Progression
508. Cutting Edge: Bim Is Required For Superantigen-Mediated B Cell Death
509. Cutting Edge: Contributions Of Apoptosis And Anergy To Systemic T Cell Tolerance
510. Cutting Edge: Early Attrition Of Memory T Cells During Inflammation And Costimulation Blockade Is Regulated Concurrently By Proapoptotic Proteins Fas And Bim
511. Cutting Edge: Innate Memory Cd8+ T Cells Are Distinct From Homeostatic Expanded Cd8+ T Cells And Rapidly Respond To Primary Antigenic Stimuli
512. Cutting Edge: Regulatory T Cells Do Not Mediate Suppression Via Programmed Cell Death Pathways
513. Cyclic Amp Efflux Inhibitors As Potential Therapeutic Agents For Leukemia
514. Cyclic Amp Induces Ipc Leukemia Cell Apoptosis Via Cre-And Cdk-Dependent Bim Transcription
515. Cyclic Amp/Pka-Promoted Apoptosis: Insights From Studies Of S49 Lymphoma Cells
516. Cyclin B1 Interacts With The Bh3-Only Protein Bim And Mediates Its Phosphorylation By Cdk1 During Mitosis
517. Cyclin-Dependent Kinase 2 Inhibitor Su9516 Increases Sensitivity Of Colorectal Carcinoma Cells Caco-2 But Not Ht29 To Bh3 Mimetic Abt-737
518. Cyclon, A Novel Cytokine-Induced Protein Regulates Fas-Mediated T Cell Homeostasis
519. Cytokines And Long Noncoding Rnas
520. Cytoplasmatic Compartmentalization By Bcr‐Abl Promotes Tet2 Loss‐Of‐Function In Chronic Myeloid Leukemia
521. Cytoplasmic Functions Of The Tumour Suppressor P53
522. Cytosolic Dna Sensing In Organismal Tumor Control
523. Cytotoxic Effects Of Valproic Acid On Neuroendocrine Tumour Cells
524. Cytotoxic Properties Of Phosphinegold (I) Dithiocarbamates On Breast Carcinoma Cell Line Mcf-7
525. Damtc Regulates Cytoskeletal Reorganization And Cell Motility In Human Lung Adenocarcinoma Cell Line: An Integrated Proteomics And Transcriptomics …
526. Darinaparsin Induces A Unique Cellular Response And Is Active In An Arsenic Trioxide-Resistant Myeloma Cell Line
527. Dba/2J Haplotype On Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, And Increases Susceptibility To Atherosclerosis
528. Ddit3 And Kat2A Proteins Regulate Tnfrsf10A And Tnfrsf10B Expression In Endoplasmic Reticulum Stress-Mediated Apoptosis In Human Lung Cancer Cells
529. Death By Hdac Inhibition In Synovial Sarcoma Cells
530. Deciphering The Genetic Predisposition To Primary Sclerosing Cholangitis
531. Decitabine-Induced Changes In Human Myelodysplastic Syndrome Cell Line Skm-1 Are Mediated By Foxo3A Activation
532. Decreased Human Antigen R Expression Confers Resistance To Tyrosine Kinase Inhibitors In Epidermal Growth Factor Receptor-Mutant Lung Cancer By Inhibiting Bim …
533. Deep Sequencing Of Rna From Three Different Extracellular Vesicle (Ev) Subtypes Released From The Human Lim1863 Colon Cancer Cell Line Uncovers Distinct …
534. Degeneration Of Cochlear Sgns Caused By Salicylate
535. Delayed Triggering Of Oestrogen Induced Apoptosis That Contrasts With Rapid Paclitaxel-Induced Breast Cancer Cell Death
536. Deletion Of Serine/Arginine‐Rich Splicing Factor 3 In Hepatocytes Predisposes To Hepatocellular Carcinoma In Mice
537. Delineating The Biology Of Anaplastic Lymphoma Kinase (Alk) And Its Resistance To Crizotinib
538. Dependence On Myb Expression Is Attenuated In Myeloid Leukaemia With N-Terminal Cebpa Mutations
539. Der Mathematisch-Naturwissenschaftlichen Fakultät Der Eberhard Karls Universität Tübingen Zur Erlangung Des Grades Eines Doktors Der Naturwissenschaften …
540. Deregulated Cdk5 Triggers Multiple Neuro-Degenerative Pathways In Alzheimer’S Dis-Ease Models
541. Deregulated Mir335 That Targets Mapk1 Is Implicated In Poor Outcome Of Paediatric Acute Lymphoblastic Leukaemia
542. Deregulated Nkl Homeobox Genes In B-Cell Lymphoma
543. Deregulation And Therapeutic Potential Of Micrornas In Arthritic Diseases
544. Deregulation Of Mirnas Contributes To Development And Progression Of Prostate Cancer
545. Detailed Assessment Of Copy Number Alterations Revealing Homozygous Deletions In 1P And 13Q In Mantle Cell Lymphoma
546. Detection Of Bim (Bcl2L11) Polymorphic Variants In Chronic
547. Detection Of Microvesicle Mirna Expression In All Subtypes And Analysis Of Their Functional Roles
548. Developing Role Of B Cells In The Pathogenesis And Treatment Of Chronic Gvhd
549. Development And Validation Of A Canine-Specific Profiling Array To Examine Expression Of Pro-Apoptotic And Pro-Survival Genes In Retinal Degenerative Diseases
550. Development And Validation Of An Rnai Screen For Abt-737 Sensitizers
551. Development Of A Novel Anticancer Therapy By Targeting Apoptotic Signalling Pathways
552. Development Of Novel Oligonucleotide Therapeutic Molecules Targeting Micrornas For Tackling Brain Cancers
553. Developmental Acquisition Of Apoptosis In The Preimplantation Bovine Embryo: Returning To The Balance Of Life And Death
554. Developmental Arrest Of T Cells In Rpl22-Deficient Mice Is Dependent Upon Multiple P53 Effectors
555. Developmental Exposure To Cuprizone Reduces Intermediate-Stage Progenitor Cells And Cholinergic Signals In The Hippocampal Neurogenesis In Rat Offspring
556. Developmental Regulated Expression Of Anti-And Pro-Apoptotic BCL-2 Family Genes During Human Early Embryonic Development
557. Developmental Regulation Of Apoptosis In Healthy Tissues
558. Developmental Regulation Of Mitochondrial Apoptosis By C-Myc Governs Age-And Tissue-Specific Sensitivity To Cancer Therapeutics
559. Developmentally Regulated Expression Of Mef 2 C Limits The Response To Bcr Engagement In Transitional B Cells
560. Dexamethasone-Induced Cell Death Is Restricted To Specific Molecular Subgroups Of Multiple Myeloma
561. Diabetes Reduces Mesenchymal Stem Cells In Fracture Healing Through A Tnfα-Mediated Mechanism
562. Diabetic Cardiomyopathy And Post-Infarct Ventricular Remodelling
563. Diagnosing And Exploiting Cancer’S Addiction To Blocks In Apoptosis
564. Dicer Ablation Affects Antibody Diversity And Cell Survival In The B Lymphocyte Lineage
565. Dicer1 Deletion In Myeloid-Committed Progenitors Causes Neutrophil Dysplasia And Blocks Macrophage/Dendritic Cell Development In Mice
566. Dicer1 Is Required For Pigment Cell And Craniofacial Development In Zebrafish
567. Dicer-Dependent Micrornas Control Maturation, Function, And Maintenance Of Langerhans Cells In Vivo
568. Dictatorial Streaming Of Biomarkers In Some Diseases
569. Differences In Hepatotoxicity And Gene Expression Profiles By Anti-Diabetic Ppar Γ Agonists On Rat Primary Hepatocytes And Human Hepg2 Cells
570. Differences In Mwcnt-And Swcnt-Induced Dna Methylation Alterations In Association With The Nuclear Deposition
571. Differences In The Rate Of Oestrogen‐Induced Apoptosis In Breast Cancer By Oestradiol And The Triphenylethylene Bisphenol
572. Different Expression Of Micro Rna-126, 133A And 145 In Aorta And Saphenous Vein Samples Of Patients Undergoing Coronary Artery Bypass Graft Surgery
573. Differential Apoptotic Signaling In Primary Glial Cells Infected With Herpes Simplex Virus 1
574. Differential Dna Damage Signalling And Apoptotic Threshold Correlate With Mouse Epiblast-Specific Hypersensitivity To Radiation
575. Differential Effects Of Class I Isoform Histone Deacetylase Depletion And Enzymatic Inhibition By Belinostat Or Valproic Acid In Hela Cells
576. Differential Expression Of Micrornas In Ischemic Heart Disease
577. Differential Expression Of Micrornas In Thymic Epithelial Cells From Trypanosoma Cruzi Acutely Infected Mice: Putative Role In Thymic Atrophy
578. Differential Expression Of Mir-17∼ 92 Identifies BCL2 As A Therapeutic Target In Bcr-Abl-Positive B-Lineage Acute Lymphoblastic Leukemia
579. Differential Expression Of Pd-L1 And Immune Biomarkers By Age: Decreased Expression In Pediatric/Aya Patients With Advanced Cancer
580. Differential Gene Expression Patterns Of Ebv Infected Ebna-3A Positive And Negative Human B Lymphocytes
581. Differential Gene Expression Profile Associated To Apoptosis Induced By Dexamethasone In Cll Cells According To Ighv/Zap-70 Status
582. Differential Regulation Of Apoptosis-Associated Genes By Estrogen Receptor Alpha In Human Neuroblastoma Cells
583. Differential Sensitivity Of Target Genes To Translational Repression By Mir-17~ 92
584. Dihydroartemisinin Is A Hypoxia-Active Anti-Cancer Drug In Colorectal Carcinoma Cells
585. Direct Reversal Of Glucocorticoid Resistance By Akt Inhibition In Acute Lymphoblastic Leukemia
586. Discovery And Characterization Of Recurrent Gene Fusions In Prostate Cancer.
587. Discovery And Saturation Analysis Of Cancer Genes Across 21 Tumour Types
588. Discovery Of Sanggenon G As A Natural Cell-Permeable Small-Molecular Weight Inhibitor Of X-Linked Inhibitor Of Apoptosis Protein (Xiap)
589. Discovery Of Small-Molecule Enhancers Of Reactive Oxygen Species That Are Nontoxic Or Cause Genotype-Selective Cell Death
590. Disruption Of Imprinting In Cloned Mouse Fetuses From Embryonic Stem Cells
591. Disruption Of Microtubules In Plants Suppresses Macroautophagy And Triggers Starch Excess-Associated Chloroplast Autophagy
592. Dissecting The Cellular And Molecular Mechanisms Of Il-7-Mediated Leukemia T-Cell Survival Proliferation And Cell Growth
593. Dissecting The Molecular Damage To Stallion Spermatozoa: The Way To Improve Current Cryopreservation Protocols?
594. Distance Running Alters Peripheral Micrornas Implicated In Metabolism, Fluid Balance, And Myosin Regulation In A Sex-Specific Manner
595. Distinct Autophagy-Apoptosis Related Pathways Activated By Multi-Walled (Nm 400) And Single-Walled Carbon Nanotubes (Nist-Srm2483) In Human Bronchial …
596. Distinct Cellular Patterns Of Upregulated Chemokine Expression Supporting A Prominent Inflammatory Role In Traumatic Brain Injury
597. Distinctive Micrornas In Esophageal Tumor: Early Diagnosis, Prognosis Judgment, And Tumor Treatment
598. Disturbed Th17/Treg Balance, Cytokines, And Mirnas In Peripheral Blood Of Patients With Behcet’S Disease
599. Disulfide Isomerase Family-6 Mediates Cisplatin Resistance By Interfering With Apoptosis And Autophagy
600. Diverse Roles Of Mir-29 In Cancer
601. Dna Damage And The Balance Between Survival And Death In Cancer Biology
602. Dna Methylation And Chromatin Modifiers In Colorectal Cancer
603. Dna Methylation As Mechanism Of Apoptotic Resistance Development In Endometrial Cancer Patients
604. Dna Methylation Of Cmtm3, Sstr2, And Mdfi Genes In Colorectal Cancer
605. Dna Methylation Pattern Of Apoptosis‐Related Genes In Ameloblastoma
606. Do Mirnas Hold The Key To Controlling Ebv-Driven Tumorigenesis?
607. Does Elevated Intraocular Pressure Reduce Retinal Trkb-Mediated Survival Signaling In Experimental Glaucoma?
608. Donor Cd19 Car T Cells Exert Potent Graft-Versus-Lymphoma Activity With Diminished Graft-Versus-Host Activity
609. Dose-Dependent Folic Acid And Memantine Treatments Promote Synergistic Or Additive Protection Against Aβ (25–35) Peptide-Induced Apoptosis In Sh-Sy5Y Cells …
610. Downregulated Microrna-148B In Circulating Pbmcs In Chronic Myeloid Leukemia Patients With Undetectable Minimal Residual Disease: A Possible Biomarker …
611. Downregulation Of BCL2 By Mirnas Augments Drug-Induced Apoptosis–A Combined Computational And Experimental Approach
612. Downregulation Of E2F1 During Er Stress Is Required To Induce Apoptosis
613. Down‐Regulation Of Microrna 106B Is Involved In P21‐Mediated Cell Cycle Arrest In Response To Radiation In Prostate Cancer Cells
614. Down–Regulation Of The Lamin A/C In Neuronal Cells Correlates With Immature Phenotype
615. Drp1-Mediated Regulation Of Mitochondrial Dynamics Determines The Apoptotic Response Upon Embryonic Differentiation.
616. Drug Activity Screening Based On Microsomes-Hydrogel System In Predicting Metabolism Induced Antitumor Effect Of Oroxylin A
617. Drug-Induced Endoplasmic Reticulum And Oxidative Stress Responses Independently Sensitize Toward Tnfα-Mediated Hepatotoxicity
618. Drugs Targeting BCL-2 Family Members As An Emerging Strategy In Cancer
619. Dual Direction Crispr Transcriptional Regulation Screening Uncovers Gene Networks Driving Drug Resistance
620. Dual Inhibition Of BCL-2 And Bcl-Xl Strikingly Enhances Pi3K Inhibition-Induced Apoptosis In Human Myeloid Leukemia Cells Through A Gsk3-And Bim-Dependent …
621. Dual Inhibition Of Mcl-1 By The Combination Of Carfilzomib And Tg02 In Multiple Myeloma
622. Dual Leucine Zipper Kinase-Dependent Perk Activation Contributes To Neuronal Degeneration Following Insult
623. Dual T Cell–And B Cell–Intrinsic Deficiency In Humans With Biallelic Rltpr Mutationst And B Cell Deficiency In Humans With Rltpr Deficiency
624. Durable Adoptive Immunotherapy For Leukemia Produced By Manipulation Of Multiple Regulatory Pathways Of Cd8+ T-Cell Tolerance
625. Dux4-Induced Dsrna And Myc Mrna Stabilization Activate Apoptotic Pathways In Human Cell Models Of Facioscapulohumeral Dystrophy
626. Dynamic Involvement Of Atg5 In Cellular Stress Responses
627. Dynamic Mrna And Mirna Profiling Of Cho‐K1 Suspension Cell Cultures
628. Dynamic Regulation Of Hif Activity Is Essential For Normal B Cell Development
629. Dynamics Of Erythropoietic Survival Pathways In Vivo: A Dissertation
630. Dynamics Of Selected Dna Damage Response Proteins
631. Dynein Light Chain Induced Oligomerisation Of Bim And Bmf Regulates Apoptosis By Determining Their Stability And Neutralisation By Anti-Apoptotic BCL-2 …
632. Dynll/Lc8: A Light Chain Subunit Of The Dynein Motor Complex And Beyond
633. Dysregulated Genes And Mirnas In The Apoptosis Pathway In Colorectal Cancer Patients
634. Dysregulated Network Of Mirnas Involved In The Pathogenesis Of Multiple Sclerosis
635. Dysregulation Of Bmi1 And Microrna-16 Collaborate To Enhance An Anti-Apoptotic Potential In The Side Population Of Refractory Mantle Cell Lymphoma
636. Dysregulation Of Germinal Centres In Autoimmune Disease
637. Dysregulation Of Uterine Signaling Pathways In Progesterone Receptor-Cre Knockout Of Dicer
638. E Protein Transcription Factors Are Required For The Development Of Cd4+ Lineage T Cells
639. E2F1 Interacts With Bcl‐Xl And Regulates Its Subcellular Localization Dynamics To Trigger Cell Death
640. E2F1 Suppresses Wnt/Β-Catenin Activity Through Transactivation Of Β-Catenin Interacting Protein Icat
641. E2F1-Induced Apoptosis: Turning Killers Into Therapeutics
642. E2F1-Regulated Micrornas Impair Tgfβ-Dependent Cell-Cycle Arrest And Apoptosis In Gastric Cancer
643. E3 Ubiquitin Ligase Fbw7 Regulates The Survival Of Mature B Cells
644. Early-Stage Prostate Cancer: Biological Features And Modification By Dietary Intervention
645. Ebna3B-Deficient Ebv Promotes B Cell Lymphomagenesis In Humanized Mice And Is Found In Human Tumors
646. Ebna3C Directs Recruitment Of Rbpj (Cbf1) To Chromatin During The Process Of Gene Repression In Ebv Infected B Cells
647. Ebna3C Facilitates Rassf1A Downregulation Through Ubiquitin-Mediated Degradation And Promoter Hypermethylation To Drive B-Cell Proliferation
648. Ebv And Apoptosis
649. Ebv And Apoptosis: The Viral Master Regulator Of Cell Fate?
650. Ebv And Human Micrornas Co‐Target Oncogenic And Apoptotic Viral And Human Genes During Latency
651. Ebv Epigenetically Suppresses The B Cell-To-Plasma Cell Differentiation Pathway While Establishing Long-Term Latency
652. Ebv Finds A Polycomb-Mediated, Epigenetic Solution To The Problem Of Oncogenic Stress Responses Triggered By Infection
653. Ebv Latent Membrane Protein 2A Orchestrates P27Kip1 Degradation Via Cks1 To Accelerate Myc-Driven Lymphoma In Mice
654. Ebv Noncoding Rnas
655. Effect Of Atorvastatin On Aβ1–42‐Induced Alteration Of Sesn2, Sirt1, Lc3Ii And Tpp1 Protein Expressions In Neuronal Cell Cultures
656. Effect Of Brevetoxin And Brevetoxin Antagonists On Jurkat E6-1 Cell Proliferation, Survival, And Gene Expression
657. Effect Of Mir-21 And Mir-30B/C On Trail-Induced Apoptosis In Glioma Cells
658. Effect Of Rosemary Polyphenols On Human Colon Cancer Cells: Transcriptomic Profiling And Functional Enrichment Analysis
659. Effect Of Simvastatin On Cetuximab Resistance In Human Colorectal Cancer With Kras Mutations
660. Effect Of Temperature Downshift On The Transcriptomic Responses Of Chinese Hamster Ovary Cells Using Recombinant Human Tissue Plasminogen Activator …
661. Effectiveness Of Zinc-Phthalocyanine And Hypericin In Inducing Cell Death In Human Breast Cancer Cells (Mcf-7) Using Low Intensity Laser Irradiation (Lili)
662. Effector Regulatory T Cell Differentiation And Immune Homeostasis Depend On The Transcription Factor Myb
663. Effects Of A Particular Heptapeptide On The Ifn-Α-Sensitive Cml Cells
664. Effects Of Dlc1 Deficiency On Endothelial Cell Contact Growth Inhibition And Angiosarcoma Progression
665. Effects Of Epigenetic Pathway Inhibitors On Corticotroph Tumour Att20 Cells
666. Effects Of Epirubicin And Cisplatin Against 4T1 Breast Cancer Cells Are Enhanced By Myrtucommulone-A
667. Effects Of Glyceollin On Mrna Expression In The Female Mouse Brain.
668. Effects Of Hyperthermia And Subsequent Minocycline Treatment In Acute Ischemic Stroke
669. Effects Of Long Non-Coding Rna Linc00963 On Renal Interstitial Fibrosis And Oxidative Stress Of Rats With Chronic Renal Failure Via The Foxo Signaling Pathway
670. Effects Of Microrna-21 And Microrna-24 Inhibitors On Neuronal Apoptosis In Ischemic Stroke
671. Effects Of Mir-19B Overexpression On Proliferation, Differentiation, Apoptosis And Wnt/Β-Catenin Signaling Pathway In P19 Cell Model Of Cardiac Differentiation In …
672. Effects Of Motor Vehicle Exhaust On Male Reproductive Function And Associated Proteins
673. Effects Of Space Microgravity On The Trans-Differentiation Between Osteogenesis And Adipogenesis Of Human Marrow-Derived Mesenchymal Stem Cells
674. Efficacy Of Egfr Plus Tnf Inhibition In A Preclinical Model Of Temozolomide-Resistant Glioblastoma
675. Egfr And Met Receptor Tyrosine Kinase–Altered Microrna Expression Induces Tumorigenesis And Gefitinib Resistance In Lung Cancers
676. Egfr-Tki Resistance Due To Bim Polymorphism Can Be Circumvented In
677. Egfr-Tki Resistance Due To Bim Polymorphism Can Be Circumvented In Combination With Hdac Inhibition
678. Egfr-Tkis Plus Chemotherapy Demonstrated Superior Efficacy Than Egfr-Tkis Alone As First-Line Setting In Advanced Nsclc Patients With Egfr Mutation And Bim …
679. Egln3 Hydroxylase Stabilizes Bim-El Linking Vhl Type 2C Mutations To Pheochromocytoma Pathogenesis And Chemotherapy Resistance
680. Egr-1 Is Involved In Coronary Microembolization-Induced Myocardial Injury Via Bim/Beclin-1 Pathway-Mediated Autophagy Inhibition And Apoptosis Activation
681. Egr2-Dependent Gene Expression Profiling And Chip-Seq Reveal Novel Biologic Targets In T Cell Anergy
682. Elevated Bcr Signaling And Decreased Survival Of Lyn‐Deficient Transitional And Follicular B Cells
683. Elevated Csf1 Serum Concentration Predicts Poor Overall Survival In Women With Early Breast Cancer
684. Elevated Expression Of S100A8 And S100A9 Correlates With Resistance To The BCL-2 Inhibitor Venetoclax In Aml
685. Elevated T Cell Receptor Signaling Identifies A Thymic Precursor To The Tcrαβ+ Cd4− Cd8Β− Intraepithelial Lymphocyte Lineage
686. Elucidating The Genetics Of Vaccine-Induced Febrile Seizure Through A Gwas And Exome Sequencing
687. Elucidating The Microrna-203 Specific Biological Processes In Glioblastoma Cells From Comprehensive Rna-Sequencing Transcriptome Profiling
688. E-Mail: Sckiang@ Med. Cornell. Edu
689. Embracing Synthetic Lethality Of Novel Anticancer Therapies
690. Emerging Cytokine Networks In Colorectal Cancer
691. Emerging Functions Of Srsf1, Splicing Factor And Oncoprotein, In Rna Metabolism And Cancer
692. Emerging Insights On The Pathogenesis And Treatment Of Extranodal Nk/T Cell Lymphomas (Enktl)
693. Emerging Mechanisms Of Long Noncoding Rna Function During Normal And Malignant Hematopoiesis
694. Emerging Role Of Lncrnas In Systemic Lupus Erythematosus
695. Emerging Role Of Micrornas In The Treatment Of Hepatocellular Carcinoma
696. Emerging Role Of Mir-106B-25/Mir-17-92 Clusters In The Control Of Transforming Growth Factor Β Signaling
697. Emerging Roles Of Microrna In Modulating Cell‐Death Processes In Malignant Glioma
698. Emerging Roles Of Microrna In The Intracellular Signaling Networks Of Hepatocellular Carcinoma
699. Emerging Roles Of Micrornas In Ischemic Stroke: As Possible Therapeutic Agents
700. Emerging Roles Of Sestrins In Neurodegenerative Diseases: Counteracting Oxidative Stress And Beyond
701. Emerging Themes From Ebv And Kshv Microrna Targets
702. Emerging Treatment For Advanced Lung Cancer With Egfr Mutation
703. Emt: A Mechanism For Escape From Egfr-Targeted Therapy In Lung Cancer
704. Endoplasmic Reticulum Stress In Spinal And Bulbar Muscular Atrophy: A Potential Target For Therapy
705. Endoplasmic Reticulum Stress Responses
706. Endoplasmic Reticulum Stress Signaling As A Therapeutic Target In Malignant Pleural Mesothelioma
707. Endoplasmic Reticulum Stress, The Unfolded Protein Response, Autophagy, And The Integrated Regulation Of Breast Cancer Cell Fate
708. Entamoeba Histolytica Up-Regulates Microrna-643 To Promote Apoptosis By Targeting Xiap In Human Epithelial Colon Cells
709. Enu-Induced Mutagenesis Reveals A Role For The Bh4 Domain Of BCL-2 In Bone Homeostasis
710. Eosinophilic Solid And Cystic Renal Cell Carcinoma Mimicking Epithelioid Angiomyolipoma: Series Of 4 Primary Tumors And 2 Metastases
711. Epidemiology And Burden Of Alopecia Areata: A Systematic Review
712. Epidemiology: Clues To The Pathogenesis Of Burkitt Lymphoma
713. Epidermal Growth Factor Receptor Mutations In Lung Adenocarcinoma
714. Epidermal P65/Nf-B Signalling Is Essential For Skin Carcinogenesis
715. Epigenetic Crossroads Of The Epstein-Barr Virus B-Cell Relationship
716. Epigenetic Drugs For Cancer And Micrornas: A Focus On Histone Deacetylase Inhibitors
717. Epigenetic Dysregulation In Chronic Myeloid Leukaemia: A Myriad Of Mechanisms And Therapeutic Options
718. Epigenetic Impact On Ebv Associated B-Cell Lymphomagenesis
719. Epigenetic Modifier Kdm3A And Its Downstream Target Mcam Promote Growth And Metastasis In Ewing Sarcoma, The
720. Epigenetic Perspectives On Cancer Chemotherapy Response
721. Epigenetic Programming Defines Stem Cell Identity And Entry Into The Proliferative Compartment In Chronic Myeloid Leukaemia (Cml)
722. Epigenetic Regulation In Triple-Negative Breast Cancer: Tools To Identify Novel Microrna Pathways
723. Epigenetic Regulation Of Micrornas In Prostate Cancer
724. Epigenetic Repression Of Mir‐375 Is The Dominant Mechanism For Constitutive Activation Of The Pdpk 1/Rps 6 Ka 3 Signalling Axis In Multiple Myeloma
725. Epigenetic Reprogramming Of Host Genes In Viral And Microbial Pathogenesis
726. Epigenetic Roles In The Malignant Transformation Of Gastric Mucosal Cells
727. Epigenetic Silencing Of The Proapoptotic Gene Bim In Anaplastic Large Cell Lymphoma Through An Mecp2/Sin3A Deacetylating Complex
728. Epigenetics And Brain Cancer
729. Epigenetics And Expression Of Sfrp1 And Pparg And Epigenetic Effects Of Glucocorticoids In B-Cell Acute Lymphoblastic Leukaemia
730. Epigenetics And Mirna As Predictive Markers And Targets For Lung Cancer Chemotherapy
731. Epigenetics Of Autoimmune Diseases
732. Epigenetics Of Breast Cancer: Modifying Role Of Environmental And Bioactive Food Compounds
733. Epigenetics Of Lupus
734. Epigenetics Of T Cells Regulated By Polycomb/Trithorax Molecules
735. Epigenetics Of Virus-Induced Tumors: Perspectives For Therapeutic Targeting
736. Epigenetics, Nervous System Tumors, And Cancer Stem Cells
737. Epigonal Conditioned Media From Bonnethead Shark, Sphyrna Tiburo, Induces Apoptosis In A T-Cell Leukemia Cell Line, Jurkat E6-1
738. Epistatic Interactions In The Suppression Of Autoimmunity
739. Epithelial Cell Polarity, Stem Cells And Cancer
740. Epithelial-To-Mesenchymal Transition And Drug Resistance: Transitioning Away From Death
741. Epithelial-To-Mesenchymal Transition Antagonizes Response To Targeted Therapies In Lung Cancer By Suppressing Bim
742. Epstein Barr Virus Associated Lymphomas And Epithelia Cancers In Humans
743. Epstein-Barr Viral Micrornas Target Caspase 3
744. Epstein-Barr Virus (Ebv) Activates Nkl Homeobox Gene Hlx In Dlbcl
745. Epstein-Barr Virus (Ebv) Latent Protein Ebna3A Directly Targets And Silences The Stk39 Gene In B Cells Infected By Ebv
746. Epstein–Barr Virus And Burkitt’S Lymphoma
747. Epstein–Barr Virus And Cancer
748. Epstein-Barr Virus Encoded Ebna-3 Binds To Vitamin D Receptor And Blocks Activation Of Its Target Genes
749. Epstein-Barr Virus Encoded Microrna Bart7 Regulates Radiation Sensitivity Of Nasopharyngeal Carcinoma
750. Epstein-Barr Virus In The Pathogenesis Of Post-Transpant Lymphoproliferative Disease
751. Epstein-Barr Virus Infected Gastric Adenocarcinoma Expresses Latent And Lytic Viral Transcripts And Has A Distinct Human Gene Expression Profile
752. Epstein–Barr Virus Infection As An Epigenetic Driver Of Tumorigenesis
753. Epstein–Barr Virus Latent Genes
754. Epstein-Barr Virus Lmp1-Mediated Oncogenicity
755. Epstein-Barr Virus Nuclear Antigen 3 (Ebna3) Proteins Regulate Ebna2 Binding To Distinct Rbpj Genomic Sites
756. Epstein–Barr Virus Nuclear Antigen 3A Protein Regulates Cdkn2B Transcription Via Interaction With Miz-1
757. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression Of Cobll1 And The Adam28-Adamdec1 Locus Via Interaction With The Histone Lysine Demethylase Kdm2B
758. Epstein-Barr Virus Nuclear Protein Ebna3C Directly Induces Expression Of Aid And Somatic Mutations In B Cells
759. Epstein-Barr Virus Proteins Ebna3A And Ebna3C Together Induce Expression Of The Oncogenic Microrna Cluster Mir-221/Mir-222 And Ablate Expression Of …
760. Epstein–Barr Virus: A Master Epigenetic Manipulator
761. Epstein–Barr Virus: More Than 50 Years Old And Still Providing Surprises
762. Epstein-Barr Virus-Associated Gastric Cancer And Potential Mechanisms Of Oncogenesis
763. Epstein–Barr Virus-Associated Lymphomas
764. Epstein–Barr Virus-Associated Malignancies: Roles Of Viral Oncoproteins In Carcinogenesis
765. Er Stress: Autophagy Induction, Inhibition And Selection
766. Erg And Ap-1 As Determinants Of Glucocorticoid Response In Acute Lymphoblastic Leukemia
767. Ergosterol Purified From Medicinal Mushroom Amauroderma Rude Inhibits Cancer Growth In Vitro And In Vivo By Up-Regulating Multiple Tumor Suppressors
768. Erroneous Class Switching And False Vdj Recombination: Molecular Dissection Of T (8; 14)/Myc-Igh Translocations In Burkitt-Type Lymphoblastic Leukemia/B-Cell …
769. Er-Stress-Induced Transcriptional Regulation Increases Protein Synthesis Leading To Cell Death
770. Essential And Overlapping Functions For Mammalian Argonautes In Microrna Silencing
771. Essential Role Of Mirnas In Orchestrating The Biology Of The Tumor Microenvironment
772. Essential Versus Accessory Aspects Of Cell Death: Recommendations Of The Nccd 2015
773. Estradiol Enhances Cip2A Expression By The Activation Of P70 S6 Kinase
774. Estrogen Induces Apoptosis In Estrogen Deprivation-Resistant Breast Cancer Through Stress Responses As Identified By Global Gene Expression Across Time
775. Estrogen-Responsive Genes For Environmental Studies
776. Ets-1 Deficiency Alleviates Nonalcoholic Steatohepatitis Via Weakening Tgf-Β1 Signaling-Mediated Hepatocyte Apoptosis
777. Ets1 Inactivation Causes Innate Drug Resistance To Egfr Inhibitors
778. Etv6-Ntrk3 Fusion Oncogene Initiates Breast Cancer From Committed Mammary Progenitors Via Activation Of Ap1 Complex
779. Ev71 Infection Induces Neurodegeneration Via Activating Tlr7 Signaling And Il-6 Production
780. Evaluating Venetoclax And Its Potential In Treatment-Naïve Acute Myeloid Leukemia
781. Evaluation Of Paclitaxel Effects In The Pattern Of Expression Of Survival And Apoptotic Genes Regulators In Hela Cells
782. Evasion Of Apoptosis By Myofibroblasts: A Hallmark Of Fibrotic Diseases
783. Evasion Of Cell Death In Burkitt’S Lymphoma And Pancreatic Cancer Cells
784. Evidence For A Hierarchy Within Breast Cancer Stem Cells: Relevance To Metastasis And Therapy
785. Evidence For P53-Mediated Induction Of Wrap53A In Response To Dna Damage
786. Evidence For Potential Functionality Of Nuclearly-Encoded Humanin Isoforms
787. Evidence For The Importance Of Personalized Molecular Profiling In Pancreatic Cancer
788. Evolutionary Conservation Of Primate Lymphocryptovirus Microrna Targets
789. Ex Vivo Expanded Cord Blood Cd4 T Lymphocytes Exhibit A Distinct Expression Profile Of Cytokine‐Related Genes From Those Of Peripheral Blood Origin
790. Examining A New Class Of Dual Cdc7/Cdk9 Inhibitors
791. Exon-Level Transcriptome Profiling In Murine Breast Cancer Reveals Splicing Changes Specific To Tumors With Different Metastatic Abilities
792. Exosomal Mirnas In Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors And Therapeutic Agents
793. Exosomes Secreted From Gata-4 Overexpressing Mesenchymal Stem Cells Serve As A Reservoir Of Anti-Apoptotic Micrornas For Cardioprotection
794. Experimental Use Of Mouse Models Of Systemic Lupus Erythematosus
795. Exploiting Cell Death Pathways For Inducible Cell Elimination To Modulate Graft-Versus-Host-Disease
796. Exploiting Differential Rna Splicing Patterns: A Potential New Group Of Therapeutic Targets In Cancer
797. Exploiting Epigenetic Modifiers To Circumvent Melanoma Dual Resistance To Tcr-Engineered Immunotherapy- And Brafv600E-Kinase Inhibitor
798. Exploiting The Pro-Apoptotic Function Of Noxa As A Therapeutic Modality In Cancer
799. Exploratory Cohort Study And Meta-Analysis Of Bim Deletion Polymorphism In Patients With Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer …
800. Exploring Clinical And Genetic Factors To Optimize The Use Of Tyrosine Kinase Inhibitors In Clinical Practice
801. Exploring Genetic Interaction Manifolds Constructed From Rich Phenotypes
802. Exploring Interactions Between Epstein-Barr Virus Transcription Factor Zta And The Human Genome
803. Exploring The Pharmacological Mechanism Of Yanghe Decoction On Her2-Positive Breast Cancer By A Network Pharmacology Approach
804. Exposure To Cypermethrin And Mancozeb Alters The Expression Profile Of Thbs1, Spp1, Fez1 And Gpnmb In Human Peripheral Blood Mononuclear Cells
805. Expression And Dna Methylation Changes In Human Breast Epithelial Cells After Bisphenol A Exposure
806. Expression And Function Of Apoptosis Initiator Foxo3 In Granulosa Cells During Follicular Atresia In Pig Ovaries
807. Expression And Glucocorticoid-Regulation Of “Bam”, A Novel Bh3-Only Transcript In Acute Lymphoblastic Leukemia
808. Expression Of Apoptosis-Regulating Mirnas And Target Mrnas In Oral Squamous Cell Carcinoma
809. Expression Of Dual-Specificity Phosphatase 5 Pseudogene 1 (Dusp5P1) In Tumor Cells
810. Expression Of Mir-106B-25 Induced By Salvianolic Acid B Inhibits Epithelial-To-Mesenchymal Transition In Hk-2 Cells
811. Expression Of Mirnas In Adenoid Cystic Carcinomas Of The Breast And Salivary Glands
812. Expression Patterns Of Mir-221 And Its Target Caspase-3 In Different Cancer Cell Lines
813. Expression Profile Of Bcl-2, Bcl-Xl, And Mcl-1 Predicts Pharmacological Response To The BCL-2 Selective Antagonist Venetoclax In Multiple Myeloma Models
814. Expression Profiles Of Genes Associated With Mitochondria-Mediated Apoptosis And Their Roles In Liver Regeneration
815. Expression Profiles Of Long Noncoding Rnas And Messenger Rnas In Mn-Exposed Hippocampal Neurons Of Sprague–Dawley Rats Ascertained By …
816. Expression Profiling Of Blood Micrornas 885, 361, And 17 In The Patients With The Parkinson’S Disease: Integrating Interaction Data To Uncover The Possible …
817. Expression Profiling Of Clinical Specimens Supports The Existence Of Neural Progenitor-Like Stem Cells In Basal Breast Cancers
818. Expression, Regulation And Mechanism Of Action Of The Mir-17-92 Cluster In Tumor Cells
819. Extensive Co-Operation Between The Epstein-Barr Virus Ebna3 Proteins In The Manipulation Of Host Gene Expression And Epigenetic Chromatin Modification
820. Extensive Genetic Variation In Somatic Human Tissues
821. Extra-Adrenal Glucocorticoid Synthesis At Epithelial Barriers
822. Extracellular BCL2 Proteins Are Danger-Associated Molecular Patterns That Reduce Tissue Damage In Murine Models Of Ischemia-Reperfusion Injury
823. Extraintestinal Manifestations And Complications In Inflammatory Bowel Disease: From Shared Genetics To Shared Biological Pathways
824. Ezh2 Abnormalities In Lymphoid Malignancies: Underlying Mechanisms And Therapeutic Implications
825. Ezh2 Promotes Progression Of Small Cell Lung Cancer By Suppressing The Tgf-Β-Smad-Ascl1 Pathway
826. Facioscapulohumeral Dystrophy: Activating An Early Embryonic Transcriptional Program In Human Skeletal Muscle
827. Factors Associated With Efficacy Of First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Non-Small-Cell Lung Cancer
828. Fatal Hepatitis Mediated By Tumor Necrosis Factor Tnfα Requires Caspase-8 And Involves The Bh3-Only Proteins Bid And Bim
829. Fatty Acid Synthase Inhibition Induces Differential Expression Of Genes Involved In Apoptosis And Cell Proliferation In Ocular Cancer Cells
830. Fbw7 Controls Neural Stem Cell Differentiation And Progenitor Apoptosis Via Notch And C-Jun
831. Feasibility And Utility Of A Panel Testing For 114 Cancer‐Associated Genes In A Clinical Setting: A Hospital‐Based Study
832. Feasibility Study Of Targeted Sequencing-Based Molecular Pre-Screening Of Patients For Phase I Clinical Trials. Trial Of Oncopanel For Introduction Into Clinical Study …
833. Federica Rao, Flavio Rizzolio, Clara Rizzardi
834. Flip (L) Determines P53 Induced Life Or Death
835. Focal Adhesion Kinase Antagonizes Doxorubicin Cardiotoxicity Via P21Cip1
836. Follicular Growth And Atresia In Mammalian Ovaries: Regulation By Survival And Death Of Granulosa Cells
837. Forkhead Box Proteins: Tuning Forks For Transcriptional Harmony
838. Forkhead Box Transcription Factors As Context-Dependent Regulators Of Lymphocyte Homeostasis
839. Forkhead Box-O Transcription Factor: Critical Conductors Of Cancer’S Fate
840. Forkhead Transcription Factor Foxo1 In Adipose Tissue Regulates Energy Storage And Expenditure
841. Forward Genetic Analysis Of Mammalian Immunity
842. Foxo In B-Cell Lymphopoiesis And B Cell Neoplasia
843. Foxo Proteins’ Nuclear Retention And Bh3-Only Protein Bim Induction Evoke Mitochondrial Dysfunction-Mediated Apoptosis In Berberine-Treated Hepg2 Cells
844. Foxo Proteins: Regulation And Molecular Targets In Liver Cancer
845. Foxo Signaling Pathways As Therapeutic Targets In Cancer
846. Foxo Transcription Factors As Potential Therapeutic Targets In Neuroblastoma
847. Foxo Transcription Factors In Cancer Development And Therapy
848. Foxo Transcription Factors Throughout T Cell Biology
849. Foxo Transcription Factors: Key Regulators Of Cell Fate
850. Foxo1 Activation Is An Effector Of Syk And Akt Inhibition In Tonic Bcr Signal-Dependent Diffuse Large B-Cell Lymphomas
851. Foxo1 And Tcf7L2 Genes Involved In Metastasis And Poor Prognosis In Clear Cell Renal Cell Carcinoma
852. Foxo1 Is A Tumor Suppressor In Classical Hodgkin Lymphoma
853. Foxo1 Regulates Developmental Lymphangiogenesis By Upregulating Cxcr4 In The Mouse-Tail Dermis
854. Foxo1/3 And Pten Depletion In Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development
855. Foxo1/3 Depletion In Granulosa Cells Alters Follicle Growth, Death And Regulation Of Pituitary Fsh
856. Foxo3 Is Essential For Cd44 Expression In Pancreatic Cancer Cells
857. Foxo3 Is Expressed In Ovarian Tissues And Acts As An Apoptosis Initiator In Granulosa Cells Of Chickens
858. Foxo3 Promotes Apoptosis Of B Cell Receptor–Stimulated Immature B Cells, Thus Limiting The Window For Receptor Editing
859. Foxo3/Fkhrl1 Is Activated By 5-Aza-2-Deoxycytidine (5-Azadc) And Induces Silenced Caspase-8 In Neuroblastoma
860. Foxo3/Fkhrl1 Is Activated By 5-Aza-2-Deoxycytidine And Induces Silenced Caspase-8 In Neuroblastoma
861. Foxo3A From The Nucleus To The Mitochondria: A Round Trip In Cellular Stress Response
862. Foxo3A Inhibits Mitochondrial Fission And Protects Against Doxorubicin-Induced Cardiotoxicity By Suppressing Mief2
863. Foxo3A Links Vascular Smooth Muscle Cell Apoptosis, Matrix Breakdown, Atherosclerosis And Vascular Remodeling Through A Novel Pathway Involving Mmp13
864. Foxo3A Modulates Hypoxia Stress Induced Oxidative Stress And Apoptosis In Cardiac Microvascular Endothelial Cells
865. Foxo3A: A Novel Player In Thyroid Carcinogenesis?
866. Foxo3-Induced Reactive Oxygen Species Are Regulated By Bcl2L11 (Bim) And Sesn3
867. Foxo3-Mediated Chemo-Protection In High-Stage Neuroblastoma Depends On Wild-Type Tp53 And Sesn3
868. Foxos Could Play An Important Role During Influenza A Viruses Infection Via Microarray Analysis Based On Geo Database
869. Foxos Maintaining The Equilibrium For Better Or For Worse
870. Foxp1 Acts Through A Negative Feedback Loop To Suppress Foxo-Induced Apoptosis
871. From Worm To Human: Bioinformatics Approaches To Identify Foxo Target Genes
872. Function Of Il-2-Inducible T Cell Kinase (Itk) In Innate T Cells And Mast Cells
873. Functional Disparities Among BCL-2 Members In Tonsillar And Leukemic B-Cell Subsets Assessed By Bh3-Mimetic Profiling
874. Functional Dissection Of The Paired Domain Of Pax6 Reveals Molecular Mechanisms Of Coordinating Neurogenesis And Proliferation
875. Functional Genetics Of Type 1 Diabetes: Between Genes And Disease
876. Functional Integration Of Micrornas Into Oncogenic And Tumor Suppressor Pathways
877. Functional Interrogation Of Anti-Cancer Drug Resistance
878. Functional Links Between Microtubules, Autophagy And Leaf Starch Degradation In Plants
879. Functional Role And Oncogene-Regulated Expression Of The Bh3-Only Factor Bmf In Mammary Epithelial Anoikis And Morphogenesis
880. Functional Roles Of Alternative Splicing Factors In Human Disease
881. Functionally Distinct Subpopulations Of Cpg-Activated Memory B Cells
882. Future Options Of Molecular-Targeted Therapy In Small Cell Lung Cancer
883. Gadd45A Inhibits Autophagy By Regulating The Interaction Between Becn1 And Pik3C3
884. Gam/Zfp/Znf512B Is Central To A Gene Sensor Circuitry Involving Cell-Cycle Regulators, Tgfβ Effectors, Drosha And Micrornas With Opposite Oncogenic …
885. Gastric Cancer Biomarkers In Circulation
886. Gastric Cancer Literature
887. Gastrointestinal Stromal Tumors (Gist): Facing Cell Death Between Autophagy And Apoptosis
888. Gata-3 Regulates The Homeostasis And Activation Of Cd8+ T Cells
889. Gene Bi-Targeting By Viral And Human Mirnas
890. Gene Expression Analysis Of Head And Neck Squamous Cell Carcinoma Survival And Recurrence
891. Gene Expression During The Generation And Activation Of Mouse Neutrophils: Implication Of Novel Functional And Regulatory Pathways
892. Gene Expression Of Anti‐And Pro‐Apoptotic Proteins In Malignant And Normal Plasma Cells
893. Gene Expression Profile Analysis Of Sudhl6 Cells With Sirna‐Mediated Bcl11A Downregulation
894. Gene Expression Profile Changes In Neutrophils-From Sterile Compartments Into Sites Of Inflammation
895. Gene Expression Profiles Of No-And Hno-Donor Treated Breast Cancer Cells: Insights Into Tumor Response And Resistance Pathways
896. Gene Expression Profiles Of Proliferating Vs. G1/G0 Arrested Human Leukemia Cells Suggest A Mechanism For Glucocorticoid-Induced Apoptosis
897. Gene Expression Profiling After Treatment With The Histone Deacetylase Inhibitor Trichostatin A Reveals Altered Expression Of Both Pro-And Anti-Apoptotic Genes …
898. Gene Expression Profiling Of Leukemic Cells And Primary Thymocytes Predicts A Signature For Apoptotic Sensitivity To Glucocorticoids
899. Gene Expression Profiling Of Non-Hodgkin Lymphomas
900. Gene Expression Profiling Of Osteoblasts Subjected To Dexamethasone-Induced Apoptosis With/Without Gsk3Β-Shrna
901. Gene Expression Profiling Reveals The Profound Upregulation Of Hypoxia-Responsive Genes In Primary Human Astrocytes
902. Gene Expression Signatures Predictive Of Early Response And Outcome In High-Risk Childhood Acute Lymphoblastic Leukemia: A Children’S Oncology Group …
903. Gene Expression, And Fatigue In Puerto Rican Men During Radiotherapy For Prostate Cancer: An Exploratory Study
904. Gene Polymorphisms, Activation Of The Aryl Hydrocarbon Receptor, And Dna Damage: A Preliminary Investigation
905. Gene Regulation In The Immune System By Long Noncoding Rnas
906. Gene Set Analysis Of Gwas Data For Human Longevity Highlights The Relevance Of The Insulin/Igf-1 Signaling And Telomere Maintenance Pathways
907. Genes Identified Through Genome-Wide Association Studies Of Osteonecrosis In Childhood Acute Lymphoblastic Leukemia Patients
908. Genetic Alterations In Adult T Cell Leukemia
909. Genetic Analysis Of The Role Of Rbpj (Cbf1) In Epstein-Barr Virus Nuclear Antigen 3C-Mediated Gene Regulation
910. Genetic And Clinical Predictors Of Cd4 Lymphocyte Recovery During Suppressive Antiretroviral Therapy: Whole Exome Sequencing And Antiretroviral Therapy …
911. Genetic And Epigenetic Profiling Of Mantle Cell Lymphoma And Chronic Lymphocytic Leukemia
912. Genetic And Epigenetic Regulation Of Autophagy In Cancer
913. Genetic And Phenotypic Characterization Of The Lymphocytic Variant Of The Hypereosinophilic Syndrome: A Model Of T Lymphomagenesis
914. Genetic And Phenotypic Characterization Of The Lymphocytic Variant Of The Hypereosinophilic Syndrome: A Model Of T …
915. Genetic Landscape And Deregulated Pathways In B‐Cell Lymphoid Malignancies
916. Genetic Mechanisms Controlling Human Hair Growth
917. Genetic Modifiers Of The Breast Tumor Microenvironment
918. Genetic Predisposition To Corticosteroid: Related Complications Of Childhood Acute Lymphoblastic Leukemia (Call) Treatment
919. Genetic Variation In Cell Death Genes And Risk Of Non-Hodgkin Lymphoma
920. Genetic Variation In The BCL2 Pathway And Risk Of Non-Hodgkin Lymphoma
921. Genetic Variation In The Il7Ra/Il7 Pathway Increases Multiple Sclerosis Susceptibility
922. Genetically Distinct Clinical Subsets, And Associations With Asthma And Eosinophil Abundance, Within Eosinophilic Granulomatosis With Polyangiitis
923. Genetics And Biomarkers In Personalisation Of Lung Cancer Treatment
924. Genetics And Pharmacogenomics Of Diffuse Gliomas
925. Genetics In Primary Sclerosing Cholangitis
926. Genetics Of Lupus In Mice
927. Genetics Of Plant Diseases
928. Genetics Of Primary Sclerosing Cholangitis And Pathophysiological Implications
929. Genetics Of Sle In Mice
930. Genistein Modulation Of Immune-Associated Genes In Lncap Prostate Cancer Cell Line
931. Genome Surveillance In Pluripotent Stem Cells: Low Apoptosis Threshold And Efficient Antioxidant Defense
932. Genome-Scale Crispr-Mediated Control Of Gene Repression And Activation
933. Genome-Scale Discovery Of Protein-Coding And Lncrna Gene Function With Crispri And Crispra
934. Genome-Wide Association Analysis For Body Weight Identifies Candidate Genes Related To Development And Metabolism In Rainbow Trout (Oncorhynchus Mykiss)
935. Genome-Wide Association Analysis In Primary Sclerosing Cholangitis Identifies Two Non-Hla Susceptibility Loci
936. Genome-Wide Association Analysis Of Chronic Lymphocytic Leukaemia, Hodgkin Lymphoma And Multiple Myeloma Identifies Pleiotropic Risk Loci
937. Genome-Wide Association Studies Of Albuminuria: Towards Genetic Stratification In Diabetes?
938. Genome-Wide Association Study Identifies Multiple Risk Loci For Chronic Lymphocytic Leukemia
939. Genome-Wide Association Study Of Eosinophilic Granulomatosis With Polyangiitis Reveals Genomic Loci Stratified By Anca Status
940. Genome-Wide Dna Methylation In Chronic Myeloid Leukaemia
941. Genome-Wide Dna Methylation Profiling Of The Regenerative Mrl/Mpj Mouse And Two Normal Strains
942. Genome-Wide Gene Expression Profiling Reveals That Cd274 Is Up-Regulated New-Onset Type 1 Diabetes Mellitus
943. Genome-Wide Meta-Analysis In Alopecia Areata Resolves Hla Associations And Reveals Two New Susceptibility Loci
944. Genome-Wide Response Patterns In Stressed Hepatocytes
945. Genome-Wide Rnai Screen Identifies Mir-19 Targets In Notch-Induced Acute T-Cell Leukaemia (T-All)
946. Genome-Wide Rna-Mediated Interference Screen Identifies Mir-19 Targets In Notch-Induced T-Cell Acute Lymphoblastic Leukaemia
947. Genomic Alterations During P53-Dependent Apoptosis Induced By Γ-Irradiation Of Molt-4 Leukemia Cells
948. Genomic Analysis Of Transcribed Microsatellite Repeats In Psychiatric Disease And Primate Evolution
949. Genomic Characterization Of A Three-Dimensional Skin Model Following Exposure To Ionizing Radiation
950. Genomic Duplication And Overexpression Of Tjp2/Zo-2 Leads To Altered Expression Of Apoptosis Genes In Progressive Nonsyndromic Hearing Loss Dfna51
951. Genomic Profiling Of Mantle Cell Lymphoma
952. Genomic Profiling Of Microrna And Messenger Rna Reveals Deregulated Microrna Expression In Prostate Cancer
953. Genomic Profiling Toward Precision Medicine In Non-Small Cell Lung Cancer: Getting Beyond Egfr
954. Genomic Signatures In B-Cell Lymphoma: How Can These Improve Precision In Diagnosis And Inform Prognosis?
955. Genomics And Ovarian Response
956. Germline Variation In Apoptosis Pathway Genes And Risk Of Non-Hodgkin Lymphoma.
957. Germline Variation In Apoptosis Pathway Genes And Risk Of Non–Hodgkin’S Lymphoma
958. Glcci1 Is A Novel Protector Against Glucocorticoid-Induced Apoptosis In T Cells
959. Gliotoxin Is A Potent Notch 2 Transactivation Inhibitor And Efficiently Induces Apoptosis In Chronic Lymphocytic Leukaemia (Cll) Cells
960. Global Analysis Of B Cell Selection Using An Immunoglobulin Light Chain–Mediated Model Of Autoreactivity
961. Global Analysis Of Differential Gene Expression Related To Long-Term Sperm Storage In Oviduct Of Chinese Soft-Shelled Turtle Pelodiscus Sinensis
962. Global Analysis Of Gene Expression In Ngf-Deprived Sympathetic Neurons Identifies Molecular Pathways Associated With Cell Death
963. Global Dna Methylation Analysis Reveals Mir-214-3P Contributes To Cisplatin Resistance In Pediatric Intracranial Nongerminomatous Malignant Germ Cell Tumors
964. Global Gene Expression Changes Of In Vitro Stimulated Human Transformed Germinal Centre B Cells As Surrogate For Oncogenic Pathway Activation In Individual …
965. Global Microrna Gene Expression Profiles Analysis And Possible Role Of Microrna-5P And 3P Pairs In Human Colon Cancer Cells
966. Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes In Natural Killer Cell Lymphoma
967. Glucocorticoid Receptor-Mediated Apoptosis In Small-Cell Lung Cancer Requires Interaction With Bcl2
968. Glucocorticoid Resistance In Acute Lymphoblastic Leukemia: Bim Finally
969. Glucocorticoid Resistance In Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia
970. Glucocorticoid-Induced Osteoporosis In Children With 21-Hydroxylase Deficiency
971. Glucocorticoid-Mediated Bim Induction And Apoptosis Are Regulated By Runx2 And C-Jun In Leukemia Cells
972. Glucocorticoid-Mediated Co-Regulation Of Rcan1-1, E4Bp4 And Bim In Human Leukemia Cells Susceptible To Apoptosis
973. Glucocorticoids And Cancer
974. Glucocorticoids Paradoxically Facilitate Steroid Resistance In T Cell Acute Lymphoblastic Leukemias And Thymocytes
975. Gonadotropin Signaling In The Ovary
976. Gper Promotes Tamoxifen-Resistance In Er+ Breast Cancer Cells By Reduced Bim Proteins Through Mapk/Erk-Trim2 Signaling Axis
977. Grouper Iridovirus Giv66 Is A BCL-2 Protein That Inhibits Apoptosis By Exclusively Sequestering Bim
978. Growth Arrest And Dna Damage-Inducible 45Α Protects Against Nonalcoholic Steatohepatitis Induced By Methionine-And Choline-Deficient Diet
979. Growth Factor–Like Gene Regulation Is Separable From Survival And Maturation In Antibody-Secreting Cells
980. Growth-Inhibition Of Cell Lines Derived From B Cell Lymphomas Through Antagonism Of Serotonin Receptor Signaling
981. Guilty Bystanders: Nurse-Like Cells As A Model Of Microenvironmental Support For Leukemic Lymphocytes
982. Gvhd And Mir: Good Things In Small Packages
983. Haploinsufficiency For Nr3C1 Drives Glucocorticoid Resistance By Inactivation The Pi3K/Akt/Gsk3Β/Bim Pathway In Adult Acute Lymphoblastic Leukemia
984. Haploinsufficiency Of Nr3C1 Drives Glucocorticoid Resistance In Adult Acute Lymphoblastic Leukemia Cells By Down-Regulating The Mitochondrial Apoptosis …
985. Harnessing Noxa Demethylation To Overcome Bortezomib Resistance In Mantle Cell Lymphoma
986. Hax1-Mediated Processing Of Htra2 By Parl Allows Survival Of Lymphocytes And Neurons
987. Hdac Inhibitors Induce Tumor-Cell-Selective Pro-Apoptotic Transcriptional Responses
988. Hdac Inhibitors Prevent Inflammation-Mediated Inactivation Of The Forkhead Box Class O Transcription Factor Foxo1 In …
989. Head And Neck Cancer Biomarkers In Circulation
990. Head And Neck Tumors
991. Heat Shock Response Associated With Hepatocarcinogenesis In A Murine Model Of Hereditary Tyrosinemia Type I
992. Hedgehog Target Genes: Mechanisms Of Carcinogenesis Induced By Aberrant Hedgehog Signaling Activation
993. Helios Marks Strongly Autoreactive Cd4+ T Cells In Two Major Waves Of Thymic Deletion Distinguished By Induction Of Pd-1 Or Nf-Κb
994. Hematologic Malignancy Biomarkers In Proximal Fluids
995. Hemolytic E. Coli Promotes Colonic Tumorigenesis In Females
996. Hepatic Gene Expression Changes In Mice Associated With Prolonged Sublethal Microcystin Exposure
997. Hepatitis B Virus Inhibits Insulin Receptor Signaling And Impairs Liver Regeneration Via Intracellular Retention Of The Insulin Receptor
998. Hepatitis B Virus Upregulates Host Micrornas That Target Apoptosis-Regulatory Genes In An In Vitro Cell Model
999. Hepatocyte-Specific Smad7 Expression Attenuates Tgf-Β–Mediated Fibrogenesis And Protects Against Liver Damage
1000. Hepatoma Cells From Mice Deficient In Glycine N-Methyltransferase Have Increased Ras Signaling And Activation Of Liver Kinase B1
1001. Hereditary Hearing Loss: From Human Mutation To Mechanism
1002. Heterogeneous BCL-2 Family Expression In Waldenström Macroglobulinemia Determines Response To Inducers Of Intrinsic Apoptosis
1003. Heterogeneous Contributing Factors In Mpm Disease Development And Progression: Biological Advances And Clinical Implications
1004. Hhex Is Essential For Nk Cell Persistence By Repressing Bcl2L11-Dependent Apoptosis
1005. High Cip2A Levels Correlate With An Antiapoptotic Phenotype That Can Be Overcome By Targeting Bcl-X L In Chronic Myeloid Leukemia
1006. High Cip2A Levels Correlate With An Antiapoptotic Phenotype That Can Be Overcome By Targeting Bcl-Xl In Chronic Myeloid Leukemia. Leukemia
1007. High Glucose Augments Ros Generation Regulates Mitochondrial Dysfunction And Apoptosis Via Stress Signalling Cascades In Keratinocytes
1008. High Glucose Induced Oxidative Stress And Apoptosis In Cardiac Microvascular Endothelial Cells Are Regulated By Foxo3A
1009. Highly Disordered Proteins In Prostate Cancer
1010. High-Throughput Autoantibody Analysis In Malignant Pleural Effusion And Tuberculosis Pleural Effusion
1011. High-Throughput Microrna Profiling Of Pediatric High-Grade Gliomas
1012. Histone Deacetylase Inhibition In Colorectal Cancer Cells Reveals Competing Roles For Members Of The Oncogenic Mir‐17‐92 Cluster
1013. Histone Deacetylase Inhibition Protects Hearing Against Acute Ototoxicity By Activating The Nf-Κ B Pathway
1014. Histone Deacetylase Inhibitors Induce Autophagy Through Foxo1-Dependent Pathways
1015. Histone H2Ax Is Involved In Foxo3A-Mediated Transcriptional Responses To Ionizing Radiation To Maintain Genome Stability
1016. Homeostasis Of Naive And Memory T Cells
1017. Homeostatic Control Of Metabolic And Functional Fitness Of Treg Cells By Lkb1 Signalling
1018. Homeostatic Properties And Phenotypic Maturation Of Murine Cd4+ Pre-Thymic Emigrants In The Thymus
1019. Honokiol Radiosensitizes Squamous Cell Carcinoma Of The Head And Neck By Downregulation Of Survivin
1020. Host Genetics In Follicular Lymphoma
1021. How Does Epstein–Barr Virus (Ebv) Complement The Activation Of Myc In The Pathogenesis Of Burkitt’S Lymphoma?
1022. How To Stomach An Epigenetic Insult: The Gastric Cancer Epigenome
1023. Hox Gene Expression Predicts Response To BCL-2 Inhibition In Acute Myeloid Leukemia
1024. Hrk/Dp5 Contributes To The Apoptosis Of Select Neuronal Populations But Is Dispensable For Haematopoietic Cell Apoptosis
1025. Hsa-Microrna-181A Is A Regulator Of A Number Of Cancer Genes And A Biomarker For Endometrial Carcinoma In Patients: A Bioinformatic And Clinical Study And …
1026. Hsa-Mirna-17–A Potential Oncomir In Cml
1027. Hsf1-Mediated Bag3 Expression Attenuates Apoptosis In 4-Hydroxynonenal-Treated Colon Cancer Cells Via Stabilization Of Anti-Apoptotic BCL-2 Proteins
1028. Hspa8/Hsc70 Chaperone Protein: Structure, Function, And Chemical Targeting
1029. Hspb1 Facilitates Erk-Mediated Phosphorylation And Degradation Of Bim To Attenuate Endoplasmic Reticulum Stress-Induced Apoptosis
1030. Htlv-1 Bzip Factor Suppresses Apoptosis By Attenuating The Function Of Foxo3A And Altering Its Localization
1031. Human Bladder Cancer Cells Undergo Cisplatin-Induced Apoptosis That Is Associated With P53-Dependent And P53-Independent Responses
1032. Human Cd4+ Memory T Cells Are Preferential Targets For Bystander Activation And Apoptosis
1033. Human Glioma Growth Is Controlled By Microrna-10B
1034. Human Mir-221/222 In Physiological And Atherosclerotic Vascular Remodeling
1035. Human Skin-Derived Stem Cells As A Novel Cell Source For In Vitro Hepatotoxicity Screening Of Pharmaceuticals
1036. Hyperactivated Pi3Kδ Promotes Self And Commensal Reactivity At The Expense Of Optimal Humoral Immunity
1037. Hyperthermia: An Effective Strategy To Induce Apoptosis In Cancer Cells
1038. Hypogonadal Mouse, A Model To Study The Effects Of The Endogenous Lack Of Gonadotropins On Apoptosis
1039. Hypomethylating Agents Reactivate Foxo3A In Acute Myeloid Leukemia
1040. Hypoxia-Induced Modulation Of Apoptosis And BCL-2 Family Proteins In Different Cancer Cell Types
1041. I Hereby Declare That I Am The Sole Author Of This Thesis, Which Summarizes My Independent Work.
1042. Id2 Influences Differentiation Of Killer Cell Lectin-Like Receptor G1Hi Short-Lived Cd8+ Effector T Cells
1043. Id4 Regulates Mammary Gland Development By Suppressing P38Mapk Activity
1044. Idelalisib Promotes Bim-Dependent Apoptosis Through Akt/Foxo3A In Hepatocellular Carcinoma
1045. Identification And Characterization Of Downstream Effector Protein (S) Regulated By P53 And Prb
1046. Identification And Characterization Of Mirna Regulatory Networks
1047. Identification And Characterization Of Regulatory T Cells That Recognize Natural Epitopes
1048. Identification And Functional Characterization Of A De Novo Point Mutation Identified In A Patient With Non-Syndromal Microcephaly And Intellectual Disability
1049. Identification Of A Candidate Alternative Promoter Region Of The Human Bcl2L11 (Bim) Gene
1050. Identification Of A Gene Expression Signature Associated With Pediatric Aml Prognosis
1051. Identification Of A Genomic Enhancer That Enforces Proper Apoptosis Induction In Thymic Negative Selection
1052. Identification Of Aortic Arch-Specific Quantitative Trait Loci For Atherosclerosis By An Intercross Of Dba/2J And 129S6 Apolipoprotein E-Deficient Mice
1053. Identification Of Birc6 As A Novel Intervention Target For Neuroblastoma Therapy
1054. Identification Of Circulating Micrornas As Biomarkers In Glioblastoma
1055. Identification Of Common Tumour Suppressor Genes In Non-Hodgkin’S Lymphoma
1056. Identification Of Downstream Genes Of The Trps1 Transcription Factor
1057. Identification Of Further Components Of An Anticancer Defense System Composed Of Small Molecules Present In The Serum
1058. Identification Of Genomic Alterations Acquired During Treatment With Egfr-Tkis In Non-Small Cell Lung Cancer
1059. Identification Of Glucocorticoid Regulated Micrornas In Human Acute Lymphoblastic Leukemia Cells
1060. Identification Of Glucocorticoid-Regulated Genes And Inferring Their Network Focused On The Glucocorticoid Receptor In Childhood Leukaemia, Based On Microarray Data …
1061. Identification Of Glucocorticoid-Response Genes In Children With Acute Lymphoblastic Leukemia
1062. Identification Of Hub Genes And Key Pathways Associated With Atopic Dermatitis Via Integrated Bioinformatics
1063. Identification Of Important Regulators Of Colon Cancer Tumorigenesis By Functional Screening
1064. Identification Of In Vivo Dna-Binding Mechanisms Of Pax6 And Reconstruction Of Pax6-Dependent Gene Regulatory Networks During Forebrain And Lens Development
1065. Identification Of Intronic Micrornas Altered In Breast Cancer Through Microarray Host Gene Expression Analysis
1066. Identification Of Key Protein-Coding Genes And Lncrnas In Spontaneous Neutrophil Apoptosis
1067. Identification Of Microrna Targets
1068. Identification Of Micrornas Modulated By Dna Hypomethylating Drugs In Extranodal Nk/T-Cell Lymphoma
1069. Identification Of New Susceptibility Loci For Type 2 Diabetes And Shared Etiological Pathways With Coronary Heart Disease
1070. Identification Of Novel Direct Transcriptional Targets Of Glucocorticoid Receptor
1071. Identification Of Novel Pathways That Promote Anoikis Through Genome-Wide Screens
1072. Identification Of Novel Target Genes Specifically Activated By Deregulated E2F In Human Normal Fibroblasts
1073. Identification Of Predictive Biomarkers For The Histone Deacetylase Inhibitor Belinostat In A Panel Of Human Cancer Cell Lines
1074. Identification Of Recurrent Genomic Alterations In The Apoptotic Machinery In Cll Patients Treated With Venetoclax Monotherapy
1075. Identification Of Runx3 As A Component Of The Mst/Hpo Signaling Pathway
1076. Identification Of Side-And Shear-Dependent Micrornas Regulating Porcine Aortic Valve Pathogenesis
1077. Identification Of Specific Genes And Pathways Involved In Nsaids-Induced Apoptosis Of Human Colon Cancer Cells
1078. Identifikace A Funkční Charakterizace Prediktivních Faktorů U Multiformního Glioblastomu
1079. Identifying And Targeting Mechanisms Of Resistance To Braf Inhibitors
1080. Identifying Apoptosis-Related Transcriptomic Aberrations And Revealing Clinical Relevance As Diagnostic And Prognostic Biomarker In Hepatocellular Carcinoma
1081. Identifying The Role Of Janus Kinase 1 In Mammary Gland Development And Breast Cancer
1082. Identifying Therapeutic Targets By Combining Transcriptional Data With Ordinal Clinical Measurements
1083. Ifn-Γ Alters The Expression Of Diverse Immunity Related Genes In A Cell Culture Model Designed To Represent Maturing Neutrophils
1084. Il-12 And Type I Interferon Prolong The Division Of Activated Cd8 T Cells By Maintaining High-Affinity Il-2 Signaling In Vivo
1085. Il-2 Prevents Deletion Of Developing T-Regulatory Cells In The Thymus
1086. Il-2 Production By Self-Reactive Cd4 Thymocytes Scales Regulatory T Cell Generation In The Thymus
1087. Il-21 And Cd40L Signals From Autologous T Cells Can
1088. Il-21 And Cd40L Signals From Autologous T Cells Can Induce Antigen-Independent Proliferation Of Cll Cells
1089. Il-21 Promotes Allergic Airway Inflammation By Driving Apoptosis Of Foxp3+ Regulatory T Cells
1090. Il-21 Selectively Protects Cd62L+ Nkt Cells And Enhances Their Effector Functions For Adoptive Immunotherapy
1091. Il-21-Mediated Non-Canonical Pathway For Il-1Β Production In Conventional Dendritic Cells
1092. Il-7 Receptor Mutations And Steroid Resistance In Pediatric T Cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study
1093. Il-7 Signaling Must Be Intermittent, Not Continuous, During Cd8+ T Cell Homeostasis To Promote Cell Survival Instead Of Cell Death
1094. Immune Checkpoint Blockade In Infectious Diseases
1095. Immunobiology Of Long Noncoding Rnas
1096. Immunogenetic Effects Of Low Dose (Cem43 30) Magnetic Nanoparticle Hyperthermia And Radiation In Melanoma Cells
1097. Immunological Control Of Chronic Myeloid Leukemia Leading To Treatment-Free Remission
1098. Immunological Memory Cells
1099. Impact Of Bone Marrow Stromal Cells On BCL-2 Family Members In Chronic Lymphocytic Leukemia
1100. Impact Of Dietary Compounds On Cancer-Related Gut Microbiota And Microrna
1101. Impact Of Loss Of Nf‐Κb1, Nf‐Κb2 Or C‐Rel On Sle‐Like Autoimmune Disease And Lymphadenopathy In Faslpr/Lpr Mutant Mice
1102. Impact Of The Bim Deletion Polymorphism On Survival Among Patients With Completely Resected Non–Small-Cell Lung Carcinoma
1103. Impaired Removal Of Vβ8+ Lymphocytes Aggravates Colitis In Mice Deficient For B Cell Lymphoma‐2‐Interacting Mediator Of Cell Death (Bim)
1104. Impairment Of Insulin Receptor Substrate 1 Signaling By Insulin Resistance Inhibits Neurite Outgrowth And Aggravates Neuronal Cell Death
1105. Impairment Of Organ-Specific T Cell Negative Selection By Diabetes Susceptibility Genes: Genomic Analysis By Mrna Profiling
1106. Implicating The Mechanisms Of Adp-Ribosylation Factor Activation In The Resistance Of Invasive Breast Cancer Cells To Egfr Tyrosine Kinase Inhibitors
1107. Imprinted And X-Linked Non-Coding Rnas As Potential Regulators Of Human Placental Function
1108. Improved Risk Stratification In Multiple Myeloma Using A Microrna-Based Classifier
1109. Improving The Long‐Term Storage Of A Mammalian Biosensor Cell Line Via Genetic Engineering
1110. Improving The Preservation Of The Non-Heart-Beating-Donor Pancreas
1111. In Cancer Drug Resistance, Germline Matters Too
1112. In Situ Hybridization Analysis Of The Expression Of Mir-106B In Colonic Cancer
1113. In Vitro And In Vivo Activity Of A Novel Locked Nucleic Acid (Lna)-Inhibitor-Mir-221 Against Multiple Myeloma Cells
1114. In Vitro And In Vivo Antimelanoma Effect Of Ethyl Ester Cyclohexyl Analog Of Ethylenediamine Dipropanoic Acid
1115. In Vitro Cytotoxicity And Anticancer Effects Of Citral Nanostructured Lipid Carrier On Mda Mba-231 Human Breast Cancer Cells
1116. In Vivo 6-([18F] Fluoroacetamido)-1-Hexanoicanilide Pet Imaging Of Altered Histone Deacetylase Activity In Chemotherapy-Induced Neurotoxicity
1117. In Vivo Activation Of The Pi3K–Akt Pathway In Mouse Beta Cells By The Egfr Mutation L858R Protects Against Diabetes
1118. In Vivo Expression Of Mir-32 Induces Proliferation In Prostate Epithelium
1119. Inactivation Of Intergenic Enhancers By Ebna3A Initiates And Maintains Polycomb Signatures Across A Chromatin Domain Encoding Cxcl10 And Cxcl9
1120. Inactivation Of Pnkp By Mutant Atxn3 Triggers Apoptosis By Activating The Dna Damage-Response Pathway In Sca3
1121. Inaugural Article By A Recently Elected Academy Member: Estrogen Induces Apoptosis In Estrogen Deprivation-Resistant Breast Cancer Through Stress …
1122. Increased Lymphocyte Apoptosis In Mouse Models Of Colitis Upon Abt‐737 Treatment Is Dependent Upon Bim Expression
1123. In-Depth Duodenal Transcriptome Survey In Chickens With Divergent Feed Efficiency Using Rna-Seq
1124. Individualized Drug Screening Based On Next Generation Sequencing And Patient Derived Xenograft Model For Pancreatic Cancer With Bone Metastasis
1125. Individualizing Therapy For Acute Leukemia
1126. Induction Of Apoptosis By Hbi‐8000 In Adult T‐Cell Leukemia/Lymphoma Is Associated With Activation Of Bim And Nlrp3
1127. Induction Of Apoptosis In Dld-1 Colon Cancer Cells To Elucidate Apoptosis Mechanism Over Time
1128. Induction Of Autophagy By Arhi (Diras3) Alters Fundamental Metabolic Pathways In Ovarian Cancer Models
1129. Induction Of Bim Is Essential For Apoptosis Triggered By Egfr Kinase Inhibitors In Mutant Egfr-Dependent Lung Adenocarcinomas
1130. Induction Of Microrna-24 By Hif-1 Protects Against Ischemic Injury In Rat Cardiomyocytes.
1131. Induction Of P16Ink4A Is The Major Barrier To Proliferation When Epstein-Barr Virus (Ebv) Transforms Primary B Cells Into Lymphoblastoid Cell Lines
1132. Inferring Network Models Of Signal Transduction With Belief Propagation
1133. Inflammatory Cells And Their Non-Coding Rnas As Targets For Treating Myocardial Infarction
1134. Influence Of Bcl2L11 Polymorphism On Osteonecrosis During Treatment Of Childhood Acute Lymphoblastic Leukemia
1135. Influence Of Transcriptional Variants On Metastasis
1136. Ing5 Suppresses Breast Cancer Progression And Is Regulated By Mir-24
1137. Inhibition Of Bet Proteins And Histone Deacetylase (Hdacs): Crossing Roads In Cancer Therapy
1138. Inhibition Of Bromodomain And Extraterminal Domain Reduces Growth And Invasive Characteristics Of Chemoresistant Ovarian Carcinoma Cells
1139. Inhibition Of Diacylglycerol Kinase Α Restores Restimulation-Induced Cell Death And Reduces Immunopathology In Xlp-1
1140. Inhibition Of Embryonic Genes To Control Colorectal Cancer Metastasis
1141. Inhibition Of Glioma Growth By Flavokawain B Is Mediated Through Endoplasmic Reticulum Stress Induced Autophagy
1142. Inhibition Of Histone Deacetylases 1 And 6 Enhances Cytarabine-Induced Apoptosis In Pediatric Acute Myeloid Leukemia Cells
1143. Inhibition Of Inflammatory Signaling In Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities And Clonal Hematopoiesis
1144. Inhibition Of Late-Stage Autophagy Synergistically Enhances Pyrrolo-1, 5-Benzoxazepine-6-Induced Apoptotic Cell Death In Human Colon Cancer Cells
1145. Inhibition Of Mitochondrial Translation Overcomes Venetoclax Resistance In Aml Through Activation Of The Integrated Stress Response
1146. Inhibition Of Nanog/Nanogp8 Downregulates Mcl-1 In Colorectal Cancer Cells And Enhances The Therapeutic Efficacy Of Bh3 Mimetics
1147. Inhibition Of Pim1 Blocks The Autophagic Flux To Sensitize Glioblastoma Cells To Abt-737-Induced Apoptosis
1148. Inhibition Of Pluripotent Stem Cell-Derived Teratoma Formation By Small Molecules
1149. Inhibition Of The Inositol Kinase Itpkb Augments Calcium Signaling In Lymphocytes And Reveals A Novel Strategy To Treat Autoimmune Disease
1150. Inhibition Of Uv-C Light–Induced Apoptosis In Liver Cells By 2,3,7,8-Tetrachlorodibenzo-P-Dioxin
1151. Inhibitors Of Histone Deacetylases Target The Rb-E2F1 Pathway For Apoptosis Induction Through Activation Of Proapoptotic Protein Bim
1152. Inhibitory Role Of The Transcription Repressor Gfi1 In The Generation Of Thymus-Derived Regulatory T Cells
1153. Innate Immune Cells: A Morrbid Way Of Stayin’ Alive
1154. Innate Immunodeficiency Following Genetic Ablation Of Mcl1 In Natural Killer Cells
1155. Innovative Targeted Therapies For Chemorefractory B-Cell Non-Hodgkin Lymphomas
1156. Insight Into Disease Processes Of Fragil X Premutation Carriers Associated Pathologies: Expression-Profile Characterization And Identification Of A Novel Pathogenic …
1157. Insights Into The Molecular Mechanisms Of Methylmalonic Acidemia Using Microarray Technology
1158. Insulin Glargine And Insulin Have Identical Effects On Proliferation And Phosphatidylinositol 3-Kinase/Akt Signalling In Rat Thyrocytes And Human Follicular …
1159. Insulin-Like Growth Factor 1 Rescues R28 Retinal Neurons From Apoptotic Death Through Erk-Mediated Bimel Phosphorylation Independent Of Akt
1160. Integrated Analysis Reveals Microrna Networks Coordinately Expressed With Key Proteins In Breast Cancer
1161. Integrating Functional Genomics With Systems Biology To Discover Drivers And Therapeutic Targets Of Human Malignancies
1162. Integration Of Microrna Changes In Vivo Identifies Novel Molecular Features Of Muscle Insulin Resistance In Type 2 Diabetes
1163. Integrative Analysis For The Role Of Long Non-Coding Rnas In Radiation-Induced Mouse Thymocytes Responses
1164. Integrative Analysis Of Rare Copy Number Variants And Gene Expression Data In Alopecia Areata Implicates An Aetiological Role For Autophagy
1165. Integrative Biology—A Strategy For Systems Biomedicine
1166. Integrative Epigenomic Analysis Reveals Unique Epigenetic Signatures Involved In Unipotency Of Mouse Female Germline Stem Cells
1167. Integrative Genome-Wide Analysis Of Dna Methyltransferase 3A Reveals A Novel Model Of Transcriptional Regulation Modulated By Long Non-Coding Rnas
1168. Integrative Modelling Of Glucocorticoid Induced Apoptosis With A Systems Biology Approach
1169. Integrative Molecular Concept Modeling Of Prostate Cancer Progression
1170. Integrative Testis Transcriptome Analysis Reveals Differentially Expressed Mirnas And Their Mrna Targets During Early Puberty In Atlantic Salmon
1171. Interaction Among Apoptosis-Associated Sequence Variants And Joint Effects On Aggressive Prostate Cancer
1172. Interaction Between Treg Apoptosis Pathways, Treg Function And Hla Risk Evolves During Type 1 Diabetes Pathogenesis
1173. Interactions Between Osteopontin And Vascular Endothelial Growth Factor: Implications For Cancer
1174. Interactome Analysis Of Microtubule-Targeting Agents Reveals Cytotoxicity Bases In Normal Cells
1175. Interferon Regulatory Factor 4 Controls T H1 Cell Effector Function And Metabolism
1176. Interferon Regulatory Factor 4 Sustains Cd8+ T Cell Expansion And Effector Differentiation
1177. Interleukin 15–Mediated Survival Of Natural Killer Cells Is Determined By Interactions Among Bim, Noxa And Mcl-1
1178. Interleukin‐2‐Mediated Inhibition Of Dendritic Cell Development Correlates With Decreased Cd135 Expression And Increased Monocyte/Macrophage Precursors
1179. Interplay Of Notch, Bcr, And Cd40 Signaling During B Cell Differentiation, Activation, And Lymphomagenesis
1180. Interrogating The Mechanistic Basis For Cytokine-Mediated Glucocorticoid Resistance In Lymphoid-Driven Diseases
1181. Intersection Of Foxo-And Runx1-Mediated Gene Expression Programs In Single Breast Epithelial Cells During Morphogenesis And Tumor Progression
1182. Intestinal Microrna Response To Citrobacter Rodentium In The Presence And Absence Of Bifidobacterium Bifidum Mimbb75
1183. Intrinsic Heterogeneity In The Survival And Proliferation Capacities Of Naïve Cd8⁺ T Cells
1184. Intrinsic Resistance To Egfr-Tyrosine Kinase Inhibitors In Egfr-Mutant Non-Small Cell Lung Cancer: Differences And Similarities With Acquired Resistance
1185. Investigating Apoptosis Pathway In Chronic Lymphocytic Leukemia: Stromal Influence And Therapeutic Activation
1186. Investigating Dna Methylation Dynamics And Safety Of Human Embryonic Stem Cell Differentiation Toward Striatal Neurons
1187. Investigating Molecular Targets Of Phosphaplatins: A Class Of Novel Non-Dna-Binding Platinum Anticancer Agents In The Treatment Of Ovarian Cancer
1188. Investigating The Anti-Apoptotic Effects Of Shigella Flexneri Infection In Epithelial Cells
1189. Investigating The Regulation And Function Of The Nr4A Nuclear Receptors In Cancer
1190. Investigating The Role Of Epstein-Barr Virus Lytic Key Regulator Protein Zta In Transcriptional Regulation
1191. Investigation Of Endogenous And Adoptively Transferred T Cell Function In A Genetic Mouse Model Of Lung Adenocarcinoma
1192. Investigation Of Epithelial Canonical And Non-Canonical Nf-[Kappa] B Signaling In Lung Adenocarcinoma
1193. Investigation Of The Functions Of Candidate Mirnas In Camptothecin-Induced Apoptosis In Human Cells
1194. Involvement Of Autophagy Inhibition In Brucea Javanica Oil Emulsion‑Induced Colon Cancer Cell Death
1195. Involvement Of BCL2 Family Members In The Regulation Of Human Oocyte And Early Embryo Survival And Death: Gene Expression And Beyond
1196. Involvement Of Dnmt 3B Promotes Epithelial-Mesenchymal Transition And Gene Expression Profile Of Invasive Head And Neck Squamous Cell Carcinomas Cell …
1197. Involvement Of Microrna-181A And Bim In A Rat Model Of Retinal Ischemia-Reperfusion Injury
1198. Involvement Of Micrornas In Human Cancer: Discovery And Expression Profiling
1199. Involvement Of Mir17 Pathway In Glucocorticoid-Induced Cell Death In Pediatric Acute Lymphoblastic Leukemia
1200. Involvement Of Non-Coding Rnas In The Signaling Pathways Of Colorectal Cancer
1201. Involvement Of Phorbol-12-Myristate-13-Acetate-Induced Protein 1 In Goniothalamin-Induced Tp53-Dependent And-Independent Apoptosis In Hepatocellular Carcinoma …
1202. Irf4 At The Crossroads Of Effector T‐Cell Fate Decision
1203. Irreversible Pan‐Erbb Inhibitor Canertinib Elicits Anti‐Leukaemic Effects And Induces The Regression Of Flt3‐Itd Transformed Cells In Mice
1204. Is The Response Of Tumours Dependent On The Dietary Input Of Some Amino Acids Or Ratios Among Essential And Non-Essential Amino Acids? All That Glitters Is Not …
1205. Itch Genetically Interacts With Notch1 In A Mouse Autoimmune Disease Model
1206. It’S Time To Look Beyond Immunosuppression
1207. Janus Kinase 1 Is Essential For Inflammatory Cytokine Signaling And Mammary Gland Remodeling
1208. Jnk Activation Of Bim Promotes Hepatic Oxidative Stress, Steatosis, And Insulin Resistance In Obesity
1209. Jnk Phosphorylation Of Bim-Related Members Of The BCL2 Family Induces Bax-Dependent Apoptosis
1210. Jnk Promotes Epithelial Cell Anoikis By Transcriptional And Post-Translational Regulation Of Bh3-Only Proteins
1211. Joost W Van Der Heijden1, Ruud Oerlemans1, Willem F Lems1, Rik J Scheper2
1212. Journal Of Molecular And Genetic Medicine
1213. Juglanthraquinone C Induces Intracellular Ros Increase And Apoptosis By Activating The Akt/Foxo Signal Pathway In Hcc Cells
1214. Kaposi’S Sarcoma-Associated Herpesvirus Encodes An Ortholog Of Mir-155
1215. Key Roles Of Bim-Driven Apoptosis In Epithelial Tumors And Rational Chemotherapy
1216. Kinetics Of Gene Expression In Murine Cutaneous Graft-Versus-Host Disease
1217. Kinetics Of Il-10-Induced Gene Expression In Human Macrophages
1218. Knock-In Of A 25-Kilobase Pair Bac-Derived Donor Molecule By Traditional And Crispr/Cas9-Stimulated Homologous Recombination
1219. Lack Of Association Between Deletion Polymorphism Of Bim Gene And In Vitro Drug Sensitivity In B-Cell Precursor Acute Lymphoblastic Leukemia
1220. Lack Of Association Between The Bim Deletion Polymorphism And The Risk Of Lung Cancer With And Without Egfr Mutations
1221. Late Stages Of T Cell Maturation In The Thymus Involve Nf-Κb And Tonic Type I Interferon Signaling
1222. Latent Membrane Protein 1 (Lmp1) And Lmp2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas In A Cord Blood-Humanized Mouse Model But Are …
1223. Late-Onset Parkinsonism In Nfκb/C-Rel-Deficient Mice
1224. Leucemia Mieloide Crónica: Revisión De Los Datos De La Sociedad Americana De Hematología 2014
1225. Leveraging Genetic Findings For Precision Medicine In Vasculitis
1226. Life And Death In Peripheral T Cells
1227. Linc00152 Promotes Invasion Through A 3′-Hairpin Structure And Associates With Prognosis In Glioblastoma
1228. Linc00174 Down-Regulation Decreases Chemoresistance To Temozolomide In Human Glioma Cells By Regulating Mir-138-5P/Sox9 Axis
1229. Linc00261 Functions As A Competing Endogenous Rna To Regulate Bcl2L11 Expression By Sponging Mir-132-3P In Endometriosis
1230. Lineage-Specific Transcriptional Regulation Of Dicer By Mitf In Melanocytes
1231. Linking Cellular Stress Responses To Systemic Homeostasis
1232. Lipid Desaturation-Associated Endoplasmic Reticulum Stress Regulates Mycn Gene Expression In Hepatocellular Carcinoma Cells
1233. Lipidomic Biomarkers And Mechanisms Of Lipotoxicity In Non-Alcoholic Fatty Liver Disease
1234. Lipocalin 2 Modulates The Cellular Response To Amyloid Beta
1235. Lipotoxicity And The Gut-Liver Axis In Nash Pathogenesis
1236. Liver–Master And Servant Of Serum Proteome
1237. L-Lactate Regulates The Expression Of Synaptic Plasticity And Neuroprotection Genes In Cortical Neurons: A Transcriptome Analysis
1238. Lmp1 And Lmp2A Collaborate To Promote Epstein-Barr Virus (Ebv)-Induced B Cell Lymphomas In A Cord Blood-Humanized Mouse Model But Are Not Essential
1239. Lncrna Morrbid Regulates Myeloid Cell Survival Of Aml Driven By A Combination Of Flt3Itd And Epigenetic Mutations
1240. Lncrna Tug1 Sponges Microrna-9 To Promote Neurons Apoptosis By Up-Regulated Bcl2L11 Under Ischemia
1241. Localization And Characterization Of Murine Memory B Lymphocytes
1242. Long Noncoding Rna In Myeloid And Lymphoid Cell Differentiation, Polarization And Function
1243. Long Noncoding Rna Tells Myeloid Cells How Long To Live
1244. Long Non-Coding Rnas And Cell Death Following Ischemic Stroke
1245. Long Non-Coding Rnas And The Innate Immune Response
1246. Long Noncoding Rnas And The Regulation Of Innate Immunity And Host‐Virus Interactions
1247. Long Noncoding Rnas As Diagnostic And Therapeutic Targets For Ischemic Stroke
1248. Long Non-Coding Rnas As Local Regulators Of Pancreatic Islet Transcription Factor Genes
1249. Long Non-Coding Rnas In Diseases Related To Inflammation And Immunity
1250. Long Non-Coding Rnas In Hematopoietic Regulation
1251. Long Non-Coding Rnas In Immune Regulation And Their Potential As Therapeutic Targets
1252. Long Non-Coding Rnas In Ischemic Stroke
1253. Long Noncoding Rnas In The Immune Response
1254. Long Noncoding Rnas In The Pathophysiology Of Ischemic Stroke
1255. Long Non-Coding Rnas In The Regulation Of Myeloid Cells
1256. Lose Traf1, Lose Control
1257. Loss Of Bim In T Cells Results In BCL-2 Family Bh3-Member Compensation But Incomplete Cell Death Sensitivity Normalization
1258. Loss Of Bim Increases Mitochondrial Oxygen Consumption And Lipid Oxidation, Reduces Adiposity And Improves Insulin Sensitivity In Mice
1259. Loss Of Foxo1 Cooperates With Tmprss2–Erg Overexpression To Promote Prostate Tumorigenesis And Cell Invasion
1260. Loss Of Irf4 Results In Multiple Myeloma Cell Apoptosis Through The Transcriptional Up-Regulation Of The Bh3-Only Proteins Bmf And Bim
1261. Loss Of Keratinocytic Rxrα Combined With Activated Cdk4 Or Oncogenic Nras Generates Uvb-Induced Melanomas Via Loss Of P53 And Pten In The Tumor …
1262. Loss Of Mir-17~92 Results In Dysregulation Of Cftr In Nephron Progenitors
1263. Loss Of P53 Causes Stochastic Aberrant X-Chromosome Inactivation And Female-Specific Neural Tube Defects
1264. Loss Of Puma (Bbc 3) Does Not Prevent Thrombocytopenia Caused By The Loss Of Bcl‐Xl (Bcl 2L1)
1265. Loss Of The Death Receptor Cd95 (Fas) Expression By Dendritic Cells Protects From A Chronic Viral Infection
1266. Low Cleaved Caspase-7 Levels Indicate Unfavourable Outcome Across All Breast Cancers
1267. Low Expression Of Pro-Apoptotic BCL-2 Family Proteins Sets The Apoptotic Threshold In Waldenström Macroglobulinemia
1268. Low Phosphorylation Of Estrogen Receptor Α (Erα) Serine 118 And High Phosphorylation Of Erα Serine 167 Improve Survival In Er-Positive Breast Cancer
1269. Lrf Is An Essential Downstream Target Of Gata1 In Erythroid Development And Regulates Bim-Dependent Apoptosis
1270. Lung Cancer And Mirnas: A Possible Remedy For Anti-Metastatic, Therapeutic And Diagnostic Applications
1271. Lupus Nephritis The Role Of Apoptosis And Removal Of Apoptotic Cells In The Genesis Of Systemic Lupus Erythematosus
1272. Lymphocyte-Specific Chromatin Accessibility Pre-Determines Glucocorticoid Resistance In Acute Lymphoblastic Leukemia
1273. Lymphomirs: Micrornas With Regulatory Roles In Lymphomas
1274. Lymphoproliferative Disease And Autoimmunity In Mice With Increased Mir-17-92 Expression In Lymphocytes
1275. Macrophage Production And Activation Are Dependent On Trim33
1276. Mammalian Gonocyte And Spermatogonia Differentiation: Recent Advances And Remaining Challenges
1277. Mammary Development In The Embryo And Adult: A Journey Of Morphogenesis And Commitment
1278. Management Of Imatinib-Resistant Patients With Chronic Myeloid Leukemia
1279. Management Of Primary Sclerosing Cholangitis: Conventions And Controversies
1280. Manipulating Mirna Expression: A Novel Approach For Colon Cancer Prevention And Chemotherapy
1281. Mantle Cell Lymphoma
1282. Mantle Cell Lymphoma: Biology, Pathogenesis, And The Molecular Basis Of Treatment In The Genomic Era
1283. Mapk Pathway Activation Leads To Bim Loss And Histone Deacetylase Inhibitor Resistance: Rationale To Combine Romidepsin With An Mek Inhibitor
1284. Mapping Macrophage Polarization Over The Myocardial Infarction Time Continuum
1285. Marrubium Vulgare Ethanolic Extract Induces Proliferation Block, Apoptosis, And Cytoprotective Autophagy In Cancer Cells In Vitro
1286. Massively Parallel Microrna Profiling In The Haematologic Malignancies
1287. Mature Micrornas Identified In Highly Purified Nuclei From Hct116 Colon Cancer Cells
1288. Mcl-1 Drives Resistance Of Estrogen Receptor-[Alpha] Positive Breast Cancers To Targeted Therapies
1289. Mcl-1 Is Essential For The Survival Of Plasma Cells
1290. Mcl-1-Guardian Of The Ovarian Reserve: Characterization Of The Contribution Of Mcl-1 To Oocyte Survival
1291. Measles Virus Nucleocapsid Protein, A Key Contributor To Paget’S Disease, Increases Il-6 Expression Via Down-Regulation Of Foxo3/Sirt1 Signaling
1292. Mechanism And Functional Consequences Of Loss Of Foxo1 Expression In Endometrioid Endometrial Cancer Cells
1293. Mechanism Of Resistance To Targeted Molecular Therapy
1294. Mechanisms And Context Underlying The Role Of Autophagy In Cancer Metastasis
1295. Mechanisms Of B-Cell Oncogenesis Induced By Epstein-Barr Virus
1296. Mechanisms Of Central Tolerance For B Cells
1297. Mechanisms Of Doxorubicin Resistance In Hepatocellular Carcinoma
1298. Mechanisms Of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death
1299. Mechanisms Of Melanoma Resistance To Treatment With Braf And Mek Inhibitors
1300. Mechanisms Of Primary Resistance To Icotinib In Chinese Non-Small-Cell Lung Cancer Patients With Egfr Uncommon Mutations: A Multicenter Study.
1301. Mechanisms Of Programmed Cell Death In The Developing Brain
1302. Mechanisms Of Resistance To Egfr Tyrosine Kinase Inhibitors
1303. Mechanisms Of Resistance To Kinase Inhibitors And Strategies To Prevent The Development Of Drug Resistance
1304. Mechanisms Of Resistance To Pi3K And Akt Inhibitors
1305. Mechanisms Of Tetraploidy-Induced Tumorigenesis
1306. Mechanisms Of The Regulation Of Apoptosis
1307. Mechanisms That Link The Oncogenic Epithelial–Mesenchymal Transition To Suppression Of Anoikis
1308. Mechanisms Underlying Estrogen-Induced Inflammation In Estrogen-Deprived Breast Cancer Cells
1309. Mechanisms Underlying The Synergistic Interaction Of Filanesib With Pomalidomide And Dexamethasone (Fpd) In Multiple Myeloma
1310. Mechanistic Insight Into Alk Receptor Tyrosine Kinase In Human Cancer Biology
1311. Mechanistic Insights Into The Role Of Micrornas In Cancer: Influence Of Nutrient Crosstalk
1312. Mek 1/2 Inhibition By Binimetinib Is Effective As A Single Agent And Potentiates The Actions Of Venetoclax And Abt‐737 Under Conditions That Mimic The Chronic …
1313. Mek Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-All) Cells To Dexamethasone Through Modulation Of Mtor Activity And Stimulation …
1314. Membrane Bound Il21 Promotes Natural Killer Cell Expansion Through Mir 124-3P Mediated Regulation
1315. Memories That Last Forever: Strategies For Optimizing Vaccine T-Cell Memory
1316. Memory Responses Of Innate Lymphocytes And Parallels With T Cells
1317. Memory T Cell Rna Rearrangement Programmed By Heterogeneous Nuclear Ribonucleoprotein Hnrnpll
1318. Menin Controls The Memory Th2 Cell Function By Maintaining The Epigenetic Integrity Of Th2 Cells
1319. Metabolic Reprogramming Of Acute Lymphoblastic Leukemia Cells In Response To Glucocorticoid Treatment
1320. Metabolism Of Reactive Oxygen Species In Osteosarcoma And Potential Treatment Applications
1321. Methylation-Independent Repression Of Dnmt3B Contributes To Oncogenic Activity Of Dnmt3A In Mouse Myc-Induced T-Cell Lymphomagenesis
1322. Micellar Drug Delivery And Proteomics Analysis For Effective Treatment Of Resistant Prostate Cancer
1323. Micro Rna S And Lymphomagenesis: A Functional Review
1324. Microarray Analysis Of Nemorosone‐Induced Cytotoxic Effects On Pancreatic Cancer Cells Reveals Activation Of The Unfolded Protein Response (Upr)
1325. Microarray Analysis Of Transcriptional Responses To Infection By Herpes Simplex Virus Types 1 And 2 And Their Us3-Deficient Mutants
1326. Microarray And Real Time-Polymerase Chain Reaction Analysis Of Mammary Glands From Rats Fed Conjugated Linoleic Acid
1327. Microarray Study Of Gene Expression Profile To Identify New Candidate Genes Involved In The Molecular Mechanism Of Leptin-Induced Knee Joint Osteoarthritis In …
1328. Microclip Super Learning Framework Uncovers Functional Transcriptome-Wide Mirna Interactions
1329. Microrna 29B Functions In Acute Myeloid Leukemia
1330. Microrna And Cardiovascular Disease
1331. Microrna And Glial Tumors: Tiny Relation With Great Potential
1332. Microrna And Its Roles In Esophageal Cancer
1333. Microrna And Transcription Factor Co-Regulatory Network Analysis Reveals Mir-19 Inhibits Cyld In T-Cell Acute Lymphoblastic Leukemia
1334. Microrna As A Therapeutic Target In Cardiac Remodeling
1335. Microrna Control Of Apoptotic Programs In Cancer
1336. Microrna Control Of Epithelial–Mesenchymal Transition And Metastasis
1337. Microrna Deregulations In Gastric Cancer
1338. Microrna Dysregulation During Chemical Carcinogenesis
1339. Microrna Dysregulation In B-Cell Non-Hodgkin Lymphoma
1340. Microrna Dysregulation In Esophageal Neoplasia: The Biological Rationale For Novel Therapeutic Options
1341. Microrna Epigenetic Systems And Cancer
1342. Microrna Expression And Activity In T-Cell Acute Lymphoblastic Leukemia
1343. Microrna Expression In B-Cell Lymphomas
1344. Microrna Expression Profile In Human Macrophages In Response To Leishmania Major Infection
1345. Microrna Functions And Potential Clinical Utility In Glioblastoma
1346. Microrna Functions In Uv-Induced Cutaneous Squamous Cell Carcinoma
1347. Microrna In Cancer: New Hopes For Antineoplastic Chemotherapy
1348. Microrna In Leukemia: Tumor Suppressors And Oncogenes With Prognostic Potential
1349. Microrna In Lung Cancer: Novel Biomarkers And Potential Tools For Treatment
1350. Microrna In Lung Cancer: Role, Mechanisms, Pathways And Therapeutic Relevance
1351. Microrna In Malignant Lymphoma
1352. Microrna In Prostate, Bladder, And Kidney Cancer: A Systematic Review
1353. Microrna Involvement In Esophageal Carcinogenesis
1354. Microrna Involvement In Hepatocellular Carcinoma
1355. Microrna Involvement In Intestinal Tumorigenesis
1356. Microrna Involvement In The Onset And Progression Of Barrett’S Esophagus: A Systematic Review
1357. Microrna Networks In Pulmonary Arterial Hypertension: Share Mechanisms With Cancer?
1358. Microrna Profiling In Canine Multicentric Lymphoma
1359. Microrna Profiling Reveals Aberrant Microrna Expression In Adult Etp-All And Functional Studies Implicate A Role For Mir-222 In Acute Leukemia
1360. Microrna Regulation In Mammary Progenitor And Tumor-Initiating Cells
1361. Microrna Regulation Of Lymphocyte Tolerance And Autoimmunity
1362. Microrna Regulation Of Th2 Cell Function And Asthma Pathogenesis
1363. Microrna Regulation Of The Cell Cycle In Native Human Embryonic Stem Cells
1364. Microrna Signature Characterizes Primary Tumors That Metastasize In An Esophageal Adenocarcinoma Rat Model
1365. Microrna Signature In Human Normal And Tumoral Neural Stem Cells
1366. Microrna Signature Of Regulatory T Cells In Health And Autoimmunity
1367. Microrna Targeting In Heart: A Theoretical Analysis
1368. Microrna Therapeutics: Towards A New Era For The Management Of Cancer And Other Diseases
1369. Microrna/Mrna Regulatory Networks In The Control Of Skin Development And Regeneration
1370. Microrna-106B-25 Cluster Expression Is Associated With Early Disease Recurrence And Targets Caspase-7 And Focal Adhesion In Human Prostate Cancer
1371. Microrna-10A Inhibits A30P Α-Synuclein Aggregation And Toxicity By Targeting Proapoptotic Protein Bcl2L11
1372. Microrna-10B Downregulates Kit Expression Through Ncor2 In Diabetic Interstitial Cells Of Cajal
1373. Microrna-10B Downregulation Mediates Acute Rejection Of Renal Allografts By Derepressing Bcl2L11
1374. Microrna-10B Is A Prognostic Indicator In Colorectal Cancer And Confers Resistance To The Chemotherapeutic Agent 5-Fluorouracil In Colorectal Cancer Cells
1375. Microrna-10B Is Overexpressed And Critical For Cell Survival And Proliferation In Medulloblastoma
1376. Microrna-10B Promotes Migration And Invasion Through Klf4 And Hoxd10 In Human Bladder Cancer
1377. Microrna-126 Reduces Blood-Retina Barrier Breakdown Via The Regulation Of Vcam-1 And Bcl2L11 In Ischemic Retinopathy
1378. Microrna-137 Protects Neurons Against Ischemia/Reperfusion Injury Through Regulation Of The Notch Signaling Pathway
1379. Microrna-138 Promotes Acquired Alkylator Resistance In Glioblastoma By Targeting The Bcl-2-Interacting Mediator Bim
1380. Microrna-148A Is A Prognostic Oncomir That Targets Mig6 And Bim To Regulate Egfr And Apoptosis In Glioblastoma
1381. Microrna-155 Contributes To Enhanced Resistance To Apoptosis In Monocytes From Patients With Rheumatoid Arthritis
1382. Microrna-16 Regulates Bmi1 In The Clonogenic Side Population Of Refractory Mantle Cell Lymphoma
1383. Microrna-17 Acts As A Tumor Chemosensitizer By Targeting Jab1/Csn5 In Triple-Negative Breast Cancer
1384. Microrna-17-92 Cluster Regulates Osteoblast Proliferation And Differentiation
1385. Microrna-17-92 Down-Regulates Expression Of Distinct Targets In Different B-Cell Lymphoma Subtypes
1386. Microrna-181C Functions As A Protective Factor In A 1-Methyl-4-Phenylpyridinium Iodide-Induced Cellular Parkinson’S Disease Model Via Bcl2L11
1387. Microrna-184 Modulates Doxorubicin Resistance In Osteosarcoma Cells By Targeting Bcl2L1
1388. Microrna-19A And Microrna-19B Promote The Malignancy Of Clear Cell Renal Cell Carcinoma Through Targeting The Tumor Suppressor Rhob
1389. Microrna-19A And-19B Regulate Cervical Carcinoma Cell Proliferation And Invasion By Targeting Cul5
1390. Microrna-19A Functions As An Oncogene By Regulating Pten/Akt/Pakt Pathway In Myeloma
1391. Microrna-19B-1 Reverses Ischaemia-Induced Heart Failure By Inhibiting Cardiomyocyte Apoptosis And Targeting BCL2 L11/Bim
1392. Microrna-214 Protects The Mouse Heart From Ischemic Injury By Controlling Ca2+ Overload And Cell Death
1393. Microrna-221 Targets Bmf In Hepatocellular Carcinoma And Correlates With Tumor Multifocality
1394. Microrna-222 Promotes Drug Resistance To Doxorubicin In Breast Cancer Via Regulation Of Mir-222/Bim Pathway
1395. Microrna-24-3P Regulates Neuronal Differentiation By Controlling Hippocalcin Expression
1396. Microrna-25 Inhibits Cell Apoptosis Of Human Gastric Adenocarcinoma Cell Line Ags Via Regulating Ccne1 And Myc
1397. Microrna-25 Promotes Cell Migration And Invasion In Esophageal Squamous Cell Carcinoma
1398. Microrna-301A Promotes Growth And Migration By Repressing Tgfbr2 In Non-Small Cell Lung Cancer
1399. Microrna-32 Upregulation By 1, 25-Dihydroxyvitamin D3 In Human Myeloid Leukemia Cells Leads To Bim Targeting And Inhibition Of Arac-Induced Apoptosis
1400. Microrna-375 Is Downregulated In Gastric Carcinomas And Regulates Cell Survival By Targeting Pdk1 And 14-3-3Ζ
1401. Microrna‑494 Inhibits Apoptosis Of Murine Vascular Smooth Muscle Cells In Vitro
1402. Microrna-9 Mediates The Cell Apoptosis By Targeting Bcl2L11 In Ischemic Stroke
1403. Microrna-9 Regulates Neural Apoptosis In Methylmalonic Acidemia Via Targeting Bcl2L11
1404. Microrna-92A Drives Th1 Responses In The Experimental Autoimmune Encephalomyelitis
1405. Microrna‐Guided Gene Expression In Prostate Cancer: Literature And Database Overview
1406. Microrna-Mediated Regulation Of T Helper Cell Differentiation And Plasticity
1407. Microrna–Mrna Regulatory Network Study And Apoptosis Analysis On Bone Marrow Endothelial Cells Induced By Liver Cirrhosis Serum
1408. Micrornaome Of Vascular Smooth Muscle Cells: Potential For Microrna-Based Vascular Therapies
1409. Micrornas (Mirs) Precisely Regulate Immune System Development And Function In Immunosenescence Process
1410. Micrornas 155 And 125B Physiologically And Pathologically Regulate Hematopoiesis And Immunity
1411. Micrornas And Drug Resistance In Prostate Cancers
1412. Micrornas And Glucocorticoid-Induced Apoptosis In Lymphoid Malignancies
1413. Micrornas And Multiple Sclerosis
1414. Micrornas And The Heart: Small Things Do Matter
1415. Micrornas Are Essential For Differentiation Of The Retinal Pigmented Epithelium And Maturation Of Adjacent Photoreceptors
1416. Micrornas As Gatekeepers Of Apoptosis
1417. Micrornas As Mediators Of Viral Evasion Of The Immune System
1418. Micrornas As Pharmacological Targets In Cancer
1419. Micrornas As Putative Mediators Of Treatment Response In Prostate Cancer
1420. Micrornas As Regulators Of Apoptosis Mechanisms In Cancer
1421. Micrornas As Regulators Of Death Receptors Signaling
1422. Micrornas As Regulatory Elements In Immune System Logic
1423. Micrornas As Therapeutic Targets And Their Potential Applications In Cancer Therapy
1424. Micrornas As Tools And Effectors For Patient Treatment In Gastrointestinal Carcinogenesis
1425. Micrornas Dysregulation In Human Malignant Pleural Mesothelioma
1426. Micrornas En Route To The Clinic: Progress In Validating And Targeting Micrornas For Cancer Therapy
1427. Micrornas Expressed During Viral Infection: Biomarker Potential And Therapeutic Considerations
1428. Micrornas Expressed From Fshr And Aromatase Genes Target Important Ovarian Functions
1429. Micrornas Expression Profiles In Cardiovascular Diseases
1430. Micrornas Function As Tumor Suppressor Genes And Oncogenes
1431. Micrornas In Acute Leukemia: From Biological Players To Clinical Contributors
1432. Micrornas In Autophagy And Their Emerging Roles In Crosstalk With Apoptosis
1433. Micrornas In Barrett’S Esophagus And Esophageal Adenocarcinoma
1434. Micrornas In Breast Cancer
1435. Micrornas In Cancer (An Overview)
1436. Micrornas In Cancer: Biological Effects Of Micrornas In Colorectal Cancer
1437. Micrornas In Cancer: Biological Effects Of Micrornas In Colorectal Cancer Micrornas Em Cancro: Efeitos Biológicos De Micrornas No
1438. Micrornas In Cancer: From Bench To Bedside
1439. Micrornas In Cell Death And Cancer
1440. Micrornas In Colorectal Cancer: Small Molecules With Big Functions
1441. Micrornas In Gastric And Oesophageal Cancer-Associated Myofibroblasts
1442. Micrornas In Glioblastoma Multiforme Pathogenesis And Therapeutics
1443. Micrornas In Glioblastoma Pathogenesis And Therapy: A Comprehensive Review
1444. Micrornas In Glioblastoma: Role In Pathogenesis And Opportunities For Targeted Therapies
1445. Micrornas In Human Skin Ageing
1446. Micrornas In Mammalian Development
1447. Micrornas In Multiple Sclerosis And Experimental Autoimmune Encephalomyelitis
1448. Micrornas In Neurotoxicity
1449. Micrornas In Normal And Malignant Colon Stem Cells And Their Possible Role In Stem Cell Origin Of Colon Cancer
1450. Micrornas In Oncogenesis And Tumor Suppression
1451. Micrornas In Pathogenesis, Diagnosis, And Treatment Of Gastroesophageal Cancers
1452. Micrornas In Skin Tissue Engineering
1453. Micrornas In The Pathogenesis Of Cystic Kidney Disease
1454. Micrornas In The Prognosis And Therapy Of Colorectal Cancer: From Bench To Bedside
1455. Micrornas In Uterine Sarcomas And Mixed Epithelial–Mesenchymal Uterine Tumors: A Preliminary Report
1456. Micrornas Mediate The Cardioprotective Effect Of Angiotensin-Converting Enzyme Inhibition In Acute Kidney Injury
1457. Micrornas Of The Rpe Are Essential For Rpe Differentiation And Photoreceptor Maturation
1458. Micrornas Regulate Critical Genes Associated With Multiple Myeloma Pathogenesis
1459. Micrornas Regulate Dendritic Cell Development And Function
1460. Micrornas Shaping Cellular Reprogramming
1461. Micrornas Signature In Il-2-Induced Cd4+ T Cells And Their Potential Targets
1462. Micrornas, Tgf-Β Signaling, And The Inflammatory Microenvironment In Cancer
1463. Micrornas, The Immune System And Rheumatic Disease
1464. Micrornas: An Emerging Paradigm In Lung Cancer Chemoresistance
1465. Micrornas: Innovative Targets For Cerebral Ischemia And Stroke
1466. Micrornas: The Role In Autoimmune Inflammation
1467. Mimicking The Bim Bh3 Domain Overcomes Resistance To Egfr Tyrosine Kinase Inhibitors In Egfr-Mutant Non-Small Cell Lung Cancer
1468. Mir-103 Inhibits Proliferation And Sensitizes Hemopoietic Tumor Cells For Glucocorticoid-Induced Apoptosis
1469. Mir‐106A Is Frequently Upregulated In Gastric Cancer And Inhibits The Extrinsic Apoptotic Pathway By Targeting Fas
1470. Mir-106A Promotes Tumor Growth, Migration, And Invasion By Targeting Bcl2L11 In Human Endometrial Adenocarcinoma
1471. Mir-106B Exhibits An Anti-Angiogenic Function By Inhibiting Stat3 Expression In Endothelial Cells
1472. Mir-106B Promotes Cancer Progression In Hepatitis B Virus-Associated Hepatocellular Carcinoma
1473. Mir-106B-Responsive Gene Landscape Identifies Regulation Of Kruppel-Like Factor Family
1474. Mir-125A, Mir-139 And Mir-324 Contribute To Urocortin Protection Against Myocardial Ischemia-Reperfusion Injury
1475. Mir-133A Enhances The Protective Capacity Of Cardiac Progenitors Cells After Myocardial Infarction
1476. Mir-140-5P Attenuates Chemotherapeutic Drug-Induced Cell Death By Regulating Autophagy Through Inositol 1, 4, 5-Trisphosphate Kinase 2 (Ip3K2) In Human …
1477. Mir145-3P Promotes Autophagy And Enhances Bortezomib Sensitivity In Multiple Myeloma By Targeting Hdac4
1478. Mir‐148A Promotes Plasma Cell Differentiation And Targets The Germinal Center Transcription Factors Mitf And Bach2
1479. Mir-155 Controls Lymphoproliferation In Lat Mutant Mice By Restraining T-Cell Apoptosis Via Ship-1/Mtor And Pak1/Foxo3/Bim Pathways
1480. Mir-15A, Mir-16-1 And Mir-17-92 Cluster Expression Are Linked To Poor Prognosis In Multiple Myeloma
1481. Mir17~ 92 Is Essential For The Survival Of Hematopoietic Stem And Progenitor Cells By Restraining Pro-Apoptotic Bim
1482. Mir17~ 92 Restrains Pro-Apoptotic Bim To Ensure Survival Of Haematopoietic Stem And Progenitor Cells
1483. Mir-17∼ 92 Family Clusters Control Inkt Cell Ontogenesis Via Modulation Of Tgf-Β Signaling
1484. Mir-17-3P Inhibits Angiogenesis By Downregulating Flk-1 In The Cell Growth Signal Pathway
1485. Mir-17-5P Inhibitor Enhances Chemosensitivity To Gemcitabine Via Upregulating Bim Expression In Pancreatic Cancer Cells
1486. Mir-17-92 And Mir-106B-25 Clusters Regulate Beta Cell Mitotic Checkpoint And Insulin Secretion In Mice
1487. Mir-17-92 Cluster Components Analysis In Burkitt Lymphoma: Overexpression Of Mir-17 Is Associated With Poor Prognosis
1488. Mir-17-92 Cluster: An Apoptosis Inducer Or Proliferation Enhancer
1489. Mir-17–92 Cluster: Ups And Downs In Cancer And Aging
1490. Mir-17–92 Explains Myc Oncogene Addiction
1491. Mir-181 Targets Multiple BCL-2 Family Members And Influences Apoptosis And Mitochondrial Function In Astrocytes
1492. Mir-181B Promotes Chemoresistance In Breast Cancer By Regulating Bim Expression
1493. Mir-181B Regulates Autophagy In A Model Of Parkinson’S Disease By Targeting The Pten/Akt/Mtor Signaling Pathway
1494. Mir-192 Suppresses Apoptosis And Promotes Proliferation In Esophageal Aquamous Cell Caicinoma By Targeting Bim
1495. Mir-19B Enhances Proliferation And Apoptosis Resistance Via The Egfr Signaling Pathway By Targeting Pp2A And Bim In Non-Small Cell Lung Cancer
1496. Mir-19B Enhances Proliferation And Apoptosis Resistance Via The Epidermal Growth Factor Receptor Signalling Pathway By Targeting Pp2A And Bim In Non-Small Cell …
1497. Mir-200 Promotes The Mesenchymal To Epithelial Transition By Suppressing Multiple Members Of The Zeb2 And Snail1 Transcriptional Repressor Complexes
1498. Mir-200C Control Of Breast And Endometrial Cancer Progression
1499. Mir-23 Regulates Cell Proliferation And Apoptosis Of Vascular Smooth Muscle Cells In Coronary Heart Disease
1500. Mir-24 Alleviates Cardiomyocyte Apoptosis After Myocardial Infarction Via Targeting Bim
1501. Mir-24 In Diabetes
1502. Mir-24 Suppression Of Poz/Btb And At-Hook-Containing Zinc Finger Protein 1 (Patz1) Protects Endothelial Cell From Diabetic Damage
1503. Mir-24-3P Is Overexpressed In Hodgkin Lymphoma And Protects Hodgkin And Reed-Sternberg Cells From Apoptosis
1504. Mir-24-3P/Fgfr3 Signaling As A Novel Axis Is Involved In Epithelial-Mesenchymal Transition And Regulates Lung Adenocarcinoma Progression
1505. Mir-25 Reduces Pc-9/Bb4 Cell Apoptosis Sensitivity Induced By Gefitinib Through Downregulating Bim
1506. Mir-339 Promotes Development Of Stem Cell Leukemia/Lymphoma Syndrome Via Downregulation Of The Bcl2L11 And Bax Proapoptotic Genes
1507. Mir501-5P May Promote Proliferation And Survival In Clear Cell Kidney Carcinoma
1508. Mir‑629 Targets Foxo3 To Promote Cell Apoptosis In Gastric Cancer
1509. Mir‐92 Is A Key Oncogenic Component Of The Mir‐17–92 Cluster In Colon Cancer
1510. Mir-92A Family And Their Target Genes In Tumorigenesis And Metastasis
1511. Mir-92A Inhibits Myocardial Infarction-Induced Apoptosis By Targeting Pten
1512. Mir-92A Is A Critical Regulator Of The Apoptosis Pathway In Glioblastoma With Inverse Expression Of Bcl2L11 Corrigendum In/Or/32/3/1319
1513. Mir-92A Promotes Tumorigenesis Of Colorectal Cancer, A Transcriptomic And Functional Based Study
1514. Mir-92A Regulates Viability And Angiogenesis Of Endothelial Cells Under Oxidative Stress
1515. Mir-92A-3P Exerts Various Effects In Glioma And Glioma Stem-Like Cells Specifically Targeting Cdh1/Β-Catenin And Notch-1/Akt Signaling Pathways
1516. Mir-9-5P, Mir-124-3P, And Mir-132-3P Regulate Bcl2L11 In Tuberous Sclerosis Complex Angiomyolipoma
1517. Mir-9-5P, Mir-675-5P And Mir-138-5P Damages The Strontium And Lrp5-Mediated Skeletal Cell Proliferation, Differentiation, And Adhesion
1518. Miriad Roles For The Mir-17-92 Cluster In Development And Disease
1519. Mirna And Cancer: A Deadly Liaison?
1520. Mirna Dysregulation In Ischemic Stroke: Focus On Diagnosis, Prognosis, Therapeutic And Protective Biomarkers
1521. Mirna Expression In Human Intestinal Caco-2 Cells Is Comparably Regulated By Cis- And Trans-Fatty Acids
1522. Mirna Expression Profile Of Bone Marrow Resident Cells From Children With Neuroblastoma Is Not Significantly Different From That Of Healthy Children
1523. Mirna Function During Early Vertebrate Development
1524. Mirna Profiles As A Predictor Of Chemoresponsiveness In Wilms’ Tumor Blastema
1525. Mirna Profiling For Biomarker Discovery In Multiple Sclerosis: From Microarray To Deep Sequencing
1526. Mirna-221 And Mirna-222 Induce Apoptosis Via The Kit/Akt Signalling Pathway In Gastrointestinal Stromal Tumours
1527. Mirna-29B Inhibits Prostate Tumor Growth And Induces Apoptosis By Increasing Bim Expression
1528. Mirnas As Potential Therapeutic Targets For Age-Related Macular Degeneration
1529. Mirnas In Multiple Sclerosis: Regulating The Regulators
1530. Mirnas In Precancerous Lesions Of The Gastrointestinal Tract
1531. Mirnome Expression Is Deregulated In The Peripheral Lymphoid Compartment Of Multiple Myeloma
1532. Misregulation Of Pre-Mrna Alternative Splicing In Cancer
1533. Mitochondria And Cell Death: Outer Membrane Permeabilization And Beyond
1534. Mitochondria And Disease
1535. Mitochondria And Foxo3: Breath Or Die
1536. Mitochondrial Dysfunction Accounts For The Stochastic Heterogeneity In Telomere-Dependent Senescence
1537. Mitochondrial Dysfunction Induces Sesn2 Gene Expression Through Activating Transcription Factor 4
1538. Mitochondrial March5 Ubiquitin Ligase Abrogates Mcl1-Dependent Resistance To Bh3 Mimetics Via Stabilization Of Noxa
1539. Mitochondrial Reprogramming Underlies Resistance To BCL-2 Inhibition In Lymphoid Malignancies
1540. Mitochondrial Retrograde Signaling To The Endoplasmic-Reticulum Regulates Unfolded Protein Responses
1541. Modulating Foxo3 Transcriptional Activity By Small, Dbd-Binding Molecules
1542. Modulating Mitochondria-Mediated Apoptotic Cell Death Through Targeting Of BCL-2 Family Proteins
1543. Modulation Of Apoptosis Pathways By Oxidative Stress And Autophagy In Β Cells
1544. Modulation Of Enhancer Looping And Differential Gene Targeting By Epstein-Barr Virus Transcription Factors Directs Cellular Reprogramming
1545. Modulation Of Glucocorticoid Resistance In Pediatric T-Cell Acute Lymphoblastic Leukemia By Increasing Bim Expression With The Pi3K/Mtor Inhibitor Bez235
1546. Modulation Of Protein–Protein Interactions For The Development Of Novel Therapeutics
1547. Modulation Of Respiration And Mitochondrial Dynamics By Smac-Mimetics For Combination Therapy In Chemoresistant Cancer
1548. Modulation Of The Osteosarcoma Expression Phenotype By Micrornas
1549. Modulation Of Tumour-Related Signaling Pathways By Natural Pentacyclic Triterpenoids And Their Semisynthetic Derivatives
1550. Molecular Analysis Of Human Cancer Cells Infected By An Oncolytic Hsv-1 Reveals Multiple Upregulated Cellular Genes And A Role For Socs1 In Virus Replication
1551. Molecular And Genomic Landscape Of Peripheral T-Cell Lymphoma
1552. Molecular Aspects Of Cancer Cell Resistance To Chemotherapy
1553. Molecular Basis Of The Anti-Cancer Effects Of Genistein Isoflavone In Lncap Prostate Cancer Cells
1554. Molecular Biology And Genetics Of Lymphomas
1555. Molecular Biology Of Ebv In Relationship To Hiv/Aids-Associated Oncogenesis
1556. Molecular Biology Of Mantle Cell Lymphoma
1557. Molecular Cloning And Analysis Of The Catsper1 Gene Promoter
1558. Molecular Cloning Of Novel Alternatively Spliced Variants Of Bcl2L12, A New Member Of The BCL2 Gene Family, And Their Expression Analysis In Cancer Cells
1559. Molecular Defects Of Mef2 Family Proteins And Nac Proteins That Block Myogenesis And Promote Tumorigenesis In Rhabdomyosarcoma
1560. Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer
1561. Molecular Functions And Clinical Impact Of Thyroid Hormone-Triggered Autophagy In Liver-Related Diseases
1562. Molecular Genetics And Clinical Features Of Birt–Hogg–Dubé Syndrome
1563. Molecular Genetics Of Mantle Cell Lymphoma
1564. Molecular Insights Into Host Gene Regulation By Epstein-Barr Virus Nuclear Antigen Ebna3C
1565. Molecular Intricacies And The Role Of Er Stress In Diabetes
1566. Molecular Markers Of Apoptosis In Cancer Patients Exposed To Ionizing Radiation: The Post-Chornobyl View
1567. Molecular Mechanisms Conferring Resistance/Sensitivity To Glucocorticoid-Induced Apoptosis
1568. Molecular Mechanisms Contributing To Glucocorticoid Resistance In Lymphoid Malignancies
1569. Molecular Mechanisms Of Apoptosis Induced By Dexamethasone In Chronic Lymphocytic Leukemia
1570. Molecular Mechanisms Of Neurodegeneration Mediated By Dysfunctional Subcellular Organelles In Transmissible Spongiform Encephalopathies
1571. Molecular Mechanisms Underlying Delayed Apoptosis In Neutrophils From Multiple Trauma Patients With And Without Sepsis
1572. Molecular Modulation Of Estrogen-Induced Apoptosis In Long-Term Estrogen-Deprived Breast Cancer Cells
1573. Molecular Pathogenesis Of Mantle Cell Lymphoma: New Perspectives And Challenges With Clinical Implications
1574. Molecular Pathogenic Pathways In Extranodal Nk/T Cell Lymphoma
1575. Molecular Pathology Of Gastric Carcinoma
1576. Molecular Portrait Of Metastasis-Competent Circulating Tumor Cells In Colon Cancer Reveals The Crucial Role Of Genes Regulating Energy Metabolism And Dna Repair
1577. Molecular Profiling Of Regulatory T Cells In Pulmonary Sarcoidosis
1578. Molecular Regulation Of Auditory Hair Cell Death And Approaches To Protect Sensory Receptor Cells And/Or Stimulate Repair Following Acoustic Trauma
1579. Molecular Resolution Of The B Cell Landscape
1580. Molecularly Targeted Therapy For Infant All
1581. Monoallelic Germline Tsc1 Mutations Are Permissive For T Lymphocyte Development And Homeostasis In Tuberous Sclerosis Complex Individuals
1582. Monoclonal Antibody Therapies For Hematological Malignancies: Not Just Lineage-Specific Targets
1583. Morphogenesis Is The Key
1584. Mortalin-Mediated And Erk-Controlled Targeting Of Hif-1Α To Mitochondria Confers Resistance To Apoptosis Under Hypoxia
1585. Mouse Models Of Cell Death
1586. Mrna Of The Pro-Apoptotic Gene Bbc3 Serves As A Molecular Marker For Tnf-Α-Induced Islet Damage In Humans
1587. Msi2 Regulates The Aggressiveness Of Non Small Cell Lung Cancer (Nsclc)
1588. Mst1 Is A Key Regulator Of Beta Cell Apoptosis And Dysfunction In Diabetes
1589. Mst1 Is A Novel Regulator Of Apoptosis In Pancreatic Beta-Cells
1590. Mtor Signaling: New Networks For All
1591. Muc13 Protects Colorectal Cancer Cells From Death By Activating The Nf-Κb Pathway And Is A Potential Therapeutic Target
1592. Multifaceted Mechanisms For Cell Survival And Drug Targeting In Chronic Myelogenous Leukemia
1593. Multi-Omic Analysis Of B-Cell Lymphoma Reveals Novel Mechanisms Of Chemotherapeutic Drug Resistance
1594. Multi-Omics Analysis Of Chinese Hamster Ovary Cell-Based Biopharmaceutical Productionprocesses
1595. Multi‐Omics Study On The Impact Of Cysteine Feed Level On Cell Viability And Mab Production In A Cho Bioprocess
1596. Multiple Components Of The Spliceosome Regulate Mcl1 Activity In Neuroblastoma
1597. Multiple Functions Are Mediated By The Mirnas Of Epstein-Barr Virus
1598. Multiple Mechanisms Of Unfolded Protein Response–Induced Cell Death
1599. Multiplexed Division Tracking Dyes For Proliferation-Based Clonal Lineage Tracing
1600. Murine Cytomegalovirus Infection And Apoptosis In Organotypic Retinal Cultures
1601. Murine Models In Mantle Cell Lymphoma
1602. Murine Thymic Selection Quantified Using A Unique Method To Capture Deleted T Cells

Mus Musculus Forkhead Box O4

1. Mutagenic Effects Of Chromium (Iv) On Human Endothelial And Lung Epithelial Cells
2. Mutant Allele Frequency Predicts The Efficacy Of Egfr-Tkis In Lung Adenocarcinoma Harboring The L858R Mutation
3. Mutant P53-Dependent Alterations Of Cancer Metabolism And Tumor Microenvironment In Pancreatic Adenocarcinoma Cells
4. Mutant P53-R273H Mediates Cancer Cell Survival And Anoikis Resistance Through Akt-Dependent Suppression Of Bcl2-Modifying Factor (Bmf)
5. Mutation Burden In Cdkn2C, Cdk1 And E2F2 Is Associated With Differential Response To Targeting Cdk4/Cdk6 In Combination With Bortezomib In Mantle Cell …
6. Mutation In The Fgfr1 Tyrosine Kinase Domain Or Inactivation Of Pten Is Associated With Acquired Resistance To Fgfr Inhibitors In Fgfr1‐Driven Leukemia …
7. Mutation Of The Er Retention Receptor Kdelr1 Leads To Cell-Intrinsic Lymphopenia And A Failure To Control Chronic Viral Infection
8. Mutational Analysis And Long Term Outcome In Advanced Chronic Myelomonocytic Leukemia (Cmml) Treated By Decitabine: An Update Of The Gfm-Cmml-2007 Phase Ii …
9. Mutual Antagonism Of Tgf-Beta And Interleukin-2 In Cell Survival And Lineage Commitment Of Induced Regulatory T Cells
10. Mybl2 (B-Myb): A Central Regulator Of Cell Proliferation, Cell Survival And Differentiation Involved In Tumorigenesis
11. Myc Activation And Bcl2L11 Silencing By A Tumour Virus Through The Large-Scale Reconfiguration Of Enhancer-Promoter Hubs
12. Myc Mutation Profiling And Prognostic Significance In De Novo Diffuse Large B-Cell Lymphoma
13. Myc Pathway Activation In Triple-Negative Breast Cancer Is Synthetic Lethal With Cdk Inhibition
14. Mycn And Micrornas In Neuroblastoma
15. Mycn/C-Myc-Induced Micrornas Repress Coding Gene Networks Associated With Poor Outcome In Mycn/C-Myc-Activated Tumors
16. Mycobacterium Tuberculosis Induced Transcription In Macrophages: The Role Of Tpl2/Erk Signalling In The Negative Regulation Of Type I Interferon Production And …
17. Myeloid Cell Leukemia 1 (Mcl-1), An Unexpected Modulator Of Protein Kinase Signaling During Invasion
18. Myeloma Patient-Derived Mcl1 Point Mutations Can Influence Mcl1-Inhibitor Function
19. Nalp3 Inflammasome Upregulation And Casp1 Cleavage Of The Glucocorticoid Receptor Cause Glucocorticoid Resistance In Leukemia Cells
20. Nanocurcumin Restores Aberrant Mirna Expression Profile In Multiple Sclerosis, Randomized, Double‐Blind, Placebo‐Controlled Trial
21. Natural Compound Inducers Of Immunogenic Cell Death
22. Natural Killer Cell Memory In Infection, Inflammation And Cancer
23. Natural Killer Cells: Walking Three Paths Down Memory Lane
24. Natural Variation In The Parameters Of Innate Immune Cells Is Preferentially Driven By Genetic Factors
25. Nature Promises New Anticancer Agents: Interplay With The Apoptosis-Related BCL2 Gene Family
26. Nature Reviews| Molecular Cell Biology Volume 12| January 2011© 2011 Macmillan Publishers Limited. All Rights Reserved
27. Ncor1—A New Player On The Field Of T Cell Development
28. Necrotic, Apoptotic And Autophagic Cell Fates Triggered By Nanoparticles
29. Nerve Growth Factor Stimulates Cellular Proliferation Of Human Epithelial Ovarian Cancer
30. Network Analysis Of The Systemic Response To Fasciola Hepatica Infection In Sheep Reveals Changes In Fibrosis, Apoptosis, Toll-Like Receptors 3/4, And B Cell …
31. Neuroblastoma Therapy: What Is In The Pipeline?
32. Neuronal Apoptotic Pathways In Hiv-Associated Dementia, Alzheimer’S Disease, Parkinson’S Disease, And Huntington’S Disease
33. Neuroprotective Effect Of Tocotrienol-Rich Fraction And Α-Tocopherol Of Vitamin E Against Glutamate Toxicity In Neuronal …
34. Neuroprotective Strategies For Neurological Disorders By Natural Products: An Update
35. Neurotensin Receptor 1 Antagonist Sr48692 Improves Response To Carboplatin By Enhancing Apoptosis And Inhibiting Drug Efflux In Ovarian Cancer
36. New Concepts In The Management Of Alopecia Areata
37. New Frontiers In The Treatment Of Colorectal Cancer: Autophagy And The Unfolded Protein Response As Promising Targets
38. New Insights Into Pre-Bcr And Bcr Signalling With Relevance To B Cell Malignancies
39. New Insights Of Mir-145 Function And Regulation In Human Breast Cancer.
40. New Mechanisms For Old Drugs: Insights Into Dna-Unrelated Effects Of Platinum Compounds And Drug Resistance Determinants
41. New Nucleophilic Mechanisms Of Ros-Dependent Epigenetic Modifications: Comparison Of Aging And Cancer
42. New Paradigm Of T Cell Signaling: Learnin G From Malignancies
43. New Therapeutic Targets In The Intrinsic Apoptotic Pathway In Neuroblastoma
44. New Treatment Options In Hairy Cell Leukemia With Focus On Braf Inhibitors
45. Newborn Neurons Are Damaged In Vitro By A Low Concentration Of Silver Nanoparticles Through The Inflammatory Oxidative Stress Pathway
46. Newly Isolated Marine Bacterial Exopolysaccharides Enhance Antitumor Activity In Hepg2 Cells Via Affecting Key Apoptotic Factors And Activating Toll Like Receptors
47. Next-Generation Sequencing Of The Chinese Hamster Ovary Microrna Transcriptome: Identification, Annotation And Profiling Of Micrornas As Targets For …
48. Nfat5 Induction By The Pre–T-Cell Receptor Serves As A Selective Survival Signal In T-Lymphocyte Development
49. Nfil3 Is A Glucocorticoid-Regulated Gene Required For Glucocorticoid-Induced Apoptosis In Male Murine T Cells
50. Nf-Κb Signaling Regulates Epstein–Barr Virus Bamhi-Q-Driven Ebna1 Expression
51. Niacin
52. Nik As A Druggable Mediator Of Tissue Injury
53. Nk Cell Priming From Endogenous Homeostatic Signals Is Modulated By Cis
54. Nkl Homeobox Gene Activities In Normal And Malignant Myeloid Cells
55. N-Myc And Noncoding Rnas In Neuroblastoma
56. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms In The Progression From Nafld To Nash
57. Non-Canonical Functions Of Cell Cycle Cyclins And Cyclin-Dependent Kinases
58. Non-Coding Landscapes Of Colorectal Cancer
59. Non-Coding Rna Expression In Lung Adenocarcinoma: The Long And The Short Of It
60. Non-Coding Rna In Acute Ischemic Stroke: Mechanisms, Biomarkers And Therapeutic Targets
61. Noncoding Rna In Gastric Cancer With Potential Prognostic And Predictive Role
62. Non-Coding Rnas And Gastric Cancer
63. Noncoding Rnas And Stroke
64. Non-Coding Rnas As Potential Neuroprotectants Against Ischemic Brain Injury
65. Non-Coding Rnas In Mammary Gland Development And Disease
66. Non‐Coding Rnas: Biological Functions And Applications
67. Non-Genetic Resistant Mechanism To Egfr Tyrosine Kinase Inhibitory Therapy
68. Non-Genotoxic Mdm2 Inhibition Selectively Induces A Pro-Apoptotic P53 Gene Signature In Chronic Lymphocytic Leukemia Cells
69. Non-Hematopoietic And Hematopoietic Sirpα Signaling Differently Regulates Murine B Cell Maturation In Bone Marrow And Spleen
70. Non-Small-Cell Lung Cancers: A Heterogeneous Set Of Diseases
71. Not Only Mutations Matter: Molecular Picture Of Acute Myeloid Leukemia Emerging From Transcriptome Studies
72. Notch Inhibition Overcomes Resistance To Tyrosine Kinase Inhibitors In Egfr-Driven Lung Adenocarcinoma
73. Notch Promotes Survival Of Pre–T Cells At The Β-Selection Checkpoint By Regulating Cellular Metabolism
74. Notch1, Notch2, And Epstein-Barr Virus–Encoded Nuclear Antigen 2 Signaling Differentially Affects Proliferation And Survival Of Epstein-Barr Virus–Infected B Cells
75. Novel Anti-Apoptotic Micrornas 582-5P And 363 Promote Human Glioblastoma Stem Cell Survival Via Direct Inhibition Of Caspase 3, Caspase 9, And Bim
76. Novel Apoptosis-Inducing Agents For The Treatment Of Cancer, A New Arsenal In The Toolbox
77. Novel Benzo [B] Furans With Anti-Microtubule Activity Upregulate Expression Of Apoptotic Genes And Arrest Leukemia Cells In G2/M Phase
78. Novel Foxo1-Dependent Transcriptional Programs Control Treg Cell Function
79. Novel Insights Into Autoimmune Liver Diseases Provided By Genome-Wide Association Studies
80. Novel Insights Into Hyperthermia’S Therapeutic Effectiveness In Treating Malignant Melanoma
81. Novel Insights Into Mechanisms Of Glucocorticoid Actions And Sensitivity In The Airway Epithelium
82. Novel Methodologies To Generate Small Rna Expresión And Small Rna Sponges Lentiviral Libraries
83. Novel Microrna Prosurvival Cocktail For Improving Engraftment And Function Of Cardiac Progenitor Cell Transplantation
84. Novel Molecular Targets Of Genistein In Prostate
85. Novel Roles For Klf1 In Erythropoiesis Revealed By Mrna-Seq
86. Novel Roles For The Transcriptional Repressor Prdm1 In Human Natural Killer Cells And Identification Of An Inhibitor Of Its Interacting Methyltransferase G9A
87. Novel Targeted Therapeutics For Mantle Cell Lymphoma–What’S On The Horizon?
88. Noxa Genetic Amplification Or Pharmacologic Induction Primes Lymphoma Cells To BCL2 Inhibitor-Induced Cell Death
89. Nr4A Receptors Regulate Development And Death Of Labile Treg Precursors To Prevent Generation Of Pathogenic Self-Reactive Cells
90. Nrasg12D Oncoprotein Inhibits Apoptosis Of Preleukemic Cells Expressing Cbfβ-Smmhc Via Activation Of Mek/Erk Axis
91. Nuclear Foxo3 Predicts Adverse Clinical Outcome And Promotes Tumor Angiogenesis In Neuroblastoma
92. Nuclear Receptor Nr4A1 Modulates Both Regulatory T-Cell (Treg) Differentiation And Clonal Deletion
93. Nuclear Subdomains And Cancer
94. Nur77 Links Chronic Antigen Stimulation To B Cell Tolerance By Restricting The Survival Of Self-Reactive B Cells In The Periphery
95. Obatoclax And Paclitaxel Synergistically Induce Apoptosis And Overcome Paclitaxel Resistance In Urothelial Cancer Cells
96. Obatoclax Overcomes Resistance To Cell Death In Aggressive Thyroid Carcinomas By Countering Bcl2A1 And Mcl1 Overexpression
97. Oligonucleotide Therapeutics As A New Class Of Drugs For Malignant Brain Tumors: Targeting Mrnas, Regulatory Rnas, Mutations, Combinations, And Beyond
98. On The Development Of A Novel Targeted Mirna-Based Therapy Towards Glioblastoma
99. Oncogene Addiction: Resetting The Safety Switch?
100. Oncogene Function In Pre-Leukemia Stage Of Inv (16) Acute Myeloid Leukemia: A Dissertation
101. Oncogene-Directed Small Molecule Inhibitors For The Treatment Of Cutaneous Melanoma
102. Oncogenic Akt-Foxo3 Loop Favors Tumor-Promoting Modes And Enhances Oxidative Damage-Associated Hepatocellular Carcinogenesis
103. Oncogenic Grpr Overexpression In Prostate Carcinomas Harboring Ets Rearrangements: Uncovering Downstream Targets And Therapeutic Potential
104. Oncogenic K-Ras4B Dimerization Enhances Downstream Mapk Signaling
105. Oncogenic Mir-17/20A Forms A Positive Feed-Forward Loop With The P53 Kinase Dapk3 To Promote Tumorigenesis
106. Oncogenic Role Of Mir-223 In Notch3 Induced T Cell Acute Lymphoblastic Leukemia
107. Oncometabolites Mediate Alterations In Covalent Cytosine Modifications In Aml
108. Oncomir-17-5P: Alarm Signal In Cancer?
109. Onco-Mir-24 Regulates Cell Growth And Apoptosis By Targeting Bcl2L11 In Gastric Cancer
110. Only The Strong Survive
111. Oocytes And Early Embryos Selectively Express The Survival Factor Bcl2L10
112. Opposing Regulation Of Bim And BCL2 Controls Glucocorticoid-Induced Apoptosis Of Pediatric Acute Lymphoblastic Leukemia Cells
113. Optical Bistability By Two-Wave Mixing In Photorefractive Crystals
114. Optimization Of Therapeutics Against Lethal Pancreatic Cancer
115. Optimized Induction Of Mitochondrial Apoptosis For Chemotherapy-Free Treatment Of Bcr-Abl+ Acute Lymphoblastic Leukemia
116. Optimizing Epigenetic Therapies Of Hematological Malignancies: Identification Of Novel Epigenetic Biomarkers And Mechanistic Study Of 5-Aza-2′-Deoxycytidine
117. Oral Levosimendan Prevents Postinfarct Heart Failure And Cardiac Remodeling In Diabetic Goto-Kakizaki Rats
118. Oral Neutrophil Transcriptome Changes Result In A Pro-Survival Phenotype In Periodontal Diseases
119. Orchestrated Role Of Micrornas In Skin Development And Regeneration
120. Orchestrating B Cell Lymphopoiesis Through Interplay Of Il-7 Receptor And Pre-B Cell Receptor Signalling
121. Organelle-Specific Autophagy In Inflammatory Diseases: A Potential Therapeutic Target Underlying The Quality Control Of Multiple Organelles
122. Organelle-Specific Initiation Of Cell Death
123. Orthologous Crispr–Cas9 Enzymes For Combinatorial Genetic Screens
124. Otlertuzumab (Tru‐016), An Anti‐Cd37 Monospecific Adaptir™ Therapeutic Protein, For Relapsed Or Refractory Nhl Patients
125. Overcoming Emt-Driven Therapeutic Resistance By Bh3 Mimetics
126. Overcoming Imatinib Resistance Conferred By The Bim Deletion Polymorphism In Chronic Myeloid Leukemia With Splice-Switching Antisense Oligonucleotides
127. Overcoming Multiple Myeloma Drug Resistance In The Era Of Cancer ‘Omics’
128. Overcoming Steroid Resistance In T Cell Acute Lymphoblastic Leukemia
129. Overexpression Mir‐24‐3P Repressed Bim Expression To Confer Tamoxifen Resistance In Breast Cancer
130. Overexpression Of Foxo1 Causes Proliferation Of Cultured Pancreatic Β Cells Exposed To Low Nutrition
131. Overexpression Of Transcription Factor Sp1 Leads To Gene Expression Perturbations And Cell Cycle Inhibition
132. Oxidation Of The Aromatic Amino Acids Tryptophan And Tyrosine Disrupts Their Anabolic Effects On Bone Marrow Mesenchymal Stem Cells
133. Oxidative Stress
134. Oxidative Stress: The Mitochondria-Dependent And Mitochondria-Independent Pathways Of Apoptosis
135. P16Ink4A Sensitizes Human Leukemia Cells To Fas-And Glucocorticoid-Induced Apoptosis Via Induction Of Bbc3/Puma And Repression Of Mcl1 And Bcl2
136. P16Ink4A–Connecting Cell Cycle Control To Cell Death Regulation In Human Leukemia
137. P38 And Jnk Mapk Pathways Control The Balance Of Apoptosis And Autophagy In Response To Chemotherapeutic Agents
138. P52 Overexpression Increases Epithelial Apoptosis, Enhances Lung Injury, And Reduces Survival After Lipopolysaccharide Treatment
139. P53 Reactivating Peptides As A Novel Finding For Treatment Of Cancer
140. P53Sirna Therapy Reduces Cell Proliferation, Migration And Induces Apoptosis In Triple Negative Breast Cancer Cells
141. Paired Immunoglobulin-Like Receptor A Is An Intrinsic, Self-Limiting Suppressor Of Il-5–Induced Eosinophil Development
142. Pancreatic Alpha Cells Hold The Key To Survival
143. Paper I
144. Parallel Signaling Through Ire1Α And Perk Regulates Pancreatic Neuroendocrine Tumor Growth And Survival
145. Patents In Mirnas Biomarkers For Gastrointestinal Cancer Diagnostics
146. Pathogenesis Of Ischemic Stroke: Role Of Epigenetic Mechanisms
147. Pathogenic Mechanisms Following Ischemic Stroke
148. Pathological Epithelial Cell Apoptosis And Shedding In The Murine Small Intestine
149. Pathological Neoangiogenesis Depends On Oxidative Stress Regulation By Atm
150. Pathology, Genetic Alterations, And Targets Of Differentially Expressed Micrornas In Pancreatic Cancer
151. Pathophysiology Of Translational Regulation By Micrornas In Multiple Sclerosis
152. Pathway Activity Analysis Of Bulk And Single-Cell Rna-Seq Data
153. Pathway Activity Profiling Of Growth Factor Receptor Network And Stemness Pathways Differentiates Metaplastic Breast Cancer Histological Subtypes
154. Pathway Discovery In Mantle Cell Lymphoma By Integrated Analysis Of High-Resolution Gene Expression And Copy Number Profiling
155. Pathways Of Intrinsic Apoptosis In Neuroblastoma: Targets For Therapeutics And New Drug Development
156. Pd-L1 Mrna Expression In Egfr-Mutant Lung Adenocarcinoma
157. Pediatric Acute Myeloid Leukemia (Aml): From Genes To Models Towards Targeted Therapeutic Intervention
158. Peripheral Blood Biomarkers In Multiple Sclerosis
159. Peripheral Th17/Treg Imbalance In Elderly Patients With Ischemic Stroke
160. Peripheral Tolerance Of T Cells
161. Peripheral Tolerance Of T Cells In The Mouse
162. Perk-Dependent Repression Of Mir-106B-25 Cluster Is Required For Er Stress-Induced Apoptosis
163. Personalisation Of Dexamethasone In Childhood Acute Lymphoblastic Leukaemia
164. Personalization Of Dexamethasone Therapy In Childhood Acute Lymphoblastic Leukaemia
165. Personalized Medicine For Glioblastoma: Current Challenges And Future Opportunities
166. Pge2 Promotes Apoptosis Induced By Cytokine Deprivation Through Ep3 Receptor And Induces Bim In Mouse Mast Cells
167. Pharmaceutical Sciences And Research
168. Pharmacogenetic Considerations For Acute Lymphoblastic Leukemia Therapies
169. Pharmacogenetics And The Treatment Of Chronic Myeloid Leukemia: How Relevant Clinically? An Update
170. Pharmacogenetics Of Childhood Acute Lymphoblastic Leukemia
171. Phase 1 Study Of The Safety, Pharmacokinetics, And Antitumour Activity Of The Bcl 2 Inhibitor Navitoclax In Combination With Rituximab In Patients With Relapsed Or …
172. Phase Ii Study Of Biomarker-Guided Neoadjuvant Treatment Strategy For Iiia-N2 Non-Small Cell Lung Cancer Based On Epidermal Growth Factor Receptor Mutation …
173. Phenotype-Based Drug Screening Reveals Association Between Venetoclax Response And Differentiation Stage In Acute Myeloid Leukemia
174. Phenotypic Analysis Of Myo10 Knockout (Myo10 Tm2/Tm2) Mice Lacking Full-Length (Motorized) But Not Brain-Specific Headless Myosin X
175. Phenotypic Characteristics Of Aged Cd4+ Cd28Null T Lymphocytes Are Determined By Changes In The Whole‐Genome Dna Methylation Pattern
176. Phenotypical Characterization Of Microrna-106B Overexpression In Mcf10A Breast Cell Line
177. Phosphatases: The New Brakes For Cancer Development?
178. Phosphoproteomic Analysis Reveals An Intrinsic Pathway For Histone Deacetylase 7 Regulation That Controls Cytotoxic T Lymphocyte Function
179. Phosphoproteomic Analysis Reveals An Intrinsic Pathway For The Regulation Of Histone Deacetylase 7 That Controls The Function Of Cytotoxic T Lymphocytes
180. Phosphoproteomic Investigation Of Kinase Signalling Network Plasticity In Response To Chronic Pi3K And Mtorc1/2 Inhibition
181. Phosphorylated And Sumoylation-Deficient Progesterone Receptors Drive Proliferative Gene Signatures During Breast Cancer Progression
182. Phosphorylation Alters Bim‐Mediated Mcl‐1 Stabilization And Priming
183. Phototoxic Effects Of Zn Sulfophthalocyanine On Lung Cancer Cells (A549) Grown As A Monolayer And Three Dimensional Multicellular Tumour Spheroids
184. Phylogenomics Of Life-Or-Death Switches In Multicellular Animals: Bcl-2, Bh3-Only, And Bnip Families Of Apoptotic Regulators
185. Physiological And Pathological Roles For Micrornas In The Immune System
186. Pi 3 Kca Plays A Major Role In Multiple Myeloma And Its Inhibition With Byl 719 Decreases Proliferation, Synergizes With Other Therapies And Overcomes Stroma …
187. Pi3 Kinase Signals Bcr-Dependent Mature B Cell Survival
188. Pi3K/Akt Pathway And Its Mediators In Thyroid Carcinomas
189. Pi3K-And Mtor-Dependent Mechanisms Of Lapatinib Resistance And Resulting Therapeutic Opportunities
190. Pim1 Kinase Regulates Cell Death, Tumor Growth And Chemotherapy Response In Triple-Negative Breast Cancer
191. Pin1 Promotes Cell Death In Ngf‐Dependent Neurons Through A Mechanism Requiring C‐Jun Activity
192. Piperlongumine-Induced Nuclear Translocation Of The Foxo3A Transcription Factor Triggers Bim-Mediated Apoptosis In Cancer Cells
193. Pl-1 Spred1 Regulates The Self-Renewal Activity Of Hematopoietic Stem Cells
194. Placental Dysfunction Is Associated With Altered Microrna Expression In Pregnant Women With Low Folate Status
195. Plasma Microrna Panel Is A Novel Biomarker For Focal Segmental Glomerulosclerosis And Associated With Podocyte Apoptosis
196. Platelet-Rich Plasma Inhibits The Apoptosis Of Highly Adipogenic Homogeneous Preadipocytes In An In Vitro Culture System
197. Pleiotropic Effects Of Metformin On Cancer
198. Plzf Overexpression In T-All Cell Line Cem-C7H2-2C8 Downregulates Glucocorticoid Receptor (Gr) And Its Target Genes
199. Plzf/Zbtb16, A Glucocorticoid Response Gene In Acute Lymphoblastic Leukemia, Interferes With Glucocorticoid-Induced Apoptosis
200. Polycomb Protein Ezh2 Regulates E2F1-Dependent Apoptosis Through Epigenetically Modulating Bim Expression
201. Polycomb-Dependent Epigenetic Landscape In Adult T-Cell Leukemia
202. Polydatin Post-Treatment Alleviates Myocardial Ischaemia/Reperfusion Injury By Promoting Autophagic Flux
203. Pomalidomide In Combination With Dexamethasone Results In Synergistic Anti‐Tumour Responses In Pre‐Clinical Models Of Lenalidomide‐Resistant Multiple Myeloma
204. Positive And Negative Selection Of The T Cell Repertoire: What Thymocytes See (And Don’T See)
205. Postmortem Vs. Neoplastic Gene Expression: Clues To Cancer Development And Therapy
206. Post-Transcriptional Control Of Oncogene Expression In T-Cell Acute Lymphoblastic Leukemia (T-All): Mechanisms And Novel Therapeutic Opportunities
207. Posttranscriptional Regulation And Rna Binding Proteins In Cancer Biology
208. Post-Transcriptional Regulation Of Genes Related To Biological Behaviors Of Gastric Cancer By Long Noncoding Rnas And Micrornas
209. Posttranscriptional Regulation Of Splicing Factor Srsf1 And Its Role In Cancer Cell Biology
210. Potential Diagnostic, Prognostic And Therapeutic Targets Of Micrornas In Human Gastric Cancer
211. Potential Implications Of Long Noncoding Rnas In Autoimmune Diseases
212. Potential Mechanism Of Primary Resistance To Icotinib In Patients With Advanced Non–Small Cell Lung Cancer Harboring Uncommon Mutant Epidermal Growth Factor …
213. Potential Mechanisms Of Resistance To Venetoclax And Strategies To Circumvent It
214. Potential Role Of Histone Deacetylase Inhibitors In The Treatment Of Advanced Non-Small-Cell Lung Cancer
215. Potential Role Of Microrna-10B Down-Regulation In Cardiomyocyte Apoptosis In Aortic Stenosis Patients
216. Potential Roles Of Mir-106A In Breast Cancer
217. Prc2 Loss Induces Chemoresistance By Repressing Apoptosis In T Cell Acute Lymphoblastic Leukemia
218. Preclinical Activity Of Lbh589 Alone Or In Combination With Chemotherapy In A Xenogeneic Mouse Model Of Human Acute Lymphoblastic Leukemia
219. Preclinical Activity Of Lbh589 Alone Or In Combination With Chemotherapy In A Xenogeneic Mouse Model Of Human Acute Lymphoblastic Leukemia.
220. Preclinical Analysis Of The Γ-Secretase Inhibitor Pf-03084014 In Combination With Glucocorticoids In T-Cell Acute Lymphoblastic Leukemia
221. Prediction And Validation Of Transcription Factors Modulating The Expression Of Sestrin3 Gene Using An Integrated Computational And Experimental Approach
222. Prediction Of Potent Shrnas With A Sequential Classification Algorithm
223. Prediction Of Venetoclax Activity In Precursor B-All By Functional Assessment Of Apoptosis Signaling
224. Preferential Control Of Induced Regulatory T Cell Homeostasis Via A Bim/BCL-2 Axis
225. Preoperative Overnight Parenteral Nutrition (Tpn) Improves Skeletal Muscle Protein Metabolism Indicated By Microarray Algorithm Analyses In A Randomized Trial
226. Preparation Of The Standard Cell Lines For Reference Mutations In Cancer Gene-Panels By Genome Editing In Hek 293 T/17 Cells
227. Preventing Ototoxic Hearing Loss By Inhibiting Histone Deacetylases
228. Primary Immunodeficiencies Predisposed To Epstein‐Barr Virus‐Driven Haematological Diseases
229. Proapoptotic Bim Impacts B Lymphoid Homeostasis By Limiting The Survival Of Mature B Cells In A Cell-Autonomous Manner
230. Proapoptotic Bim Regulates Antigen-Specific Nk Cell Contraction And The Generation Of The Memory Nk Cell Pool After Cytomegalovirus Infection
231. Pro-Apoptotic Signaling Induced By Photo-Oxidative Er Stress Is Amplified By Noxa, Not Bim
232. Probing Tumor Phenotypes Using Stable And Regulated Synthetic Microrna Precursors
233. Problems Encountered In Bicistronic Ires-Gfp Expression Vectors Employed In Functional Analyses Of Gc-Induced Genes
234. Processing Of Cd74 By The Intramembrane Protease Sppl2A Is Critical For B Cell Receptor Signaling In Transitional B Cells
235. Profiling Microrna Expression In Fracture Healing In Diabetic Rat
236. Profiling Of Apoptosis Genes Identifies Distinct Types Of Primary Cutaneous Large B Cell Lymphoma
237. Profiling Of Virus-Encoded Micrornas In Epstein-Barr Virus-Associated Gastric Carcinoma And Their Roles In Gastric Carcinogenesis
238. Progesterone-Dependent Induction Of Phospholipase C-Related Catalytically Inactive Protein 1 (Prip-1) In Decidualizing Human Endometrial Stromal Cells
239. Progestins Regulate The Expression And Activity Of The Forkhead Transcription Factor Foxo1 In Differentiating Human Endometrium
240. Prognostic And Clinicopathological Significance Of Microrna-494 Overexpression In Cancers: A Meta-Analysis
241. Prognostic And Predictive Value Of A Microrna Signature In Adults With T-Cell Lymphoblastic Lymphoma
242. Prognostic Impact Of C-Rel Nuclear Expression And Rel Amplification And Crosstalk Between C-Rel And The P53 Pathway In Diffuse Large B-Cell Lymphoma
243. Programmed Cell Death And The Immune System
244. Programmed Cell Death In Ciri
245. Proliferation And Differentiation Programs Of Developing B Cells
246. Prolonged Early G1 Arrest By Selective Cdk4/Cdk6 Inhibition Sensitizes Myeloma Cells To Cytotoxic Killing Through Cell Cycle–Coupled Loss Of Irf4
247. Prostate Apoptosis Response Protein 4 Sensitizes Human Colon Cancer Cells To Chemotherapeutic 5-Fu Through Mediation Of An Nfκb And Microrna Network
248. Prostatic Preneoplasia And Beyond
249. Proteasome Inhibition Upregulates Bim And Induces Caspase-3-Dependent Apoptosis In Human Mast Cells Expressing The Kit D816V Mutation
250. Protective Effect Of Salidroside Against Diabetic Kidney Disease Through Inhibiting Bim-Mediated Apoptosis Of Proximal Renal Tubular Cells In Rats
251. Protective Effects Of Curcumin Against Doxorubicin-Induced Toxicity And Resistance: A Review
252. Protein Complex Hierarchy And Translocation Gene Products
253. Protein Kinase Cδ Regulates Nuclear Export Of Foxo1 Through Phosphorylation Of The Chaperone 14-3-3Ζ
254. Protein Kinase Networks Regulating Glucocorticoid-Induced Apoptosis Of Hematopoietic Cancer Cells: Fundamental Aspects And Practical Considerations
255. Protein Phosphatase 2A Inhibits Interferon Signaling Through The Jak Stat Pathway And Promotes Hepatitis C Viral Replication
256. Protein Tyrosine Phosphatases: Molecular Switches In Metabolism And Diabetes
257. Protein–Protein Interactions As Targets For Small-Molecule Therapeutics In Cancer
258. Proteins Associated With The Exon Junction Complex Also Control The Alternative Splicing Of Apoptotic Regulators
259. Proteomics Analysis Of Protein-Producing Chinese Hamster Ovary Cells During Apoptosis In Prolonged Cultivation
260. Proteostasis In Epicardial Versus Subcutaneous Adipose Tissue In Heart Failure Subjects With And Without Diabetes
261. Prrc2A And Bcl2L11 Gene Variants Influence Risk Of Non-Hodgkin Lymphoma: Results From The Interlymph Consortium
262. Psgl-1 Is An Immune Checkpoint Regulator That Promotes T Cell Exhaustion
263. Puerarin Modulates Autophagy To Ameliorate Cerebral Ischemia/Reperfusion Injury Through Jnk Signaling Pathway
264. Puma Regulates Germ Cell Loss And Primordial Follicle Endowment In Mice
265. Pushing The Limits Of Targeted Therapy In Chronic Myeloid Leukaemia
266. Quantifying Nk Cell Growth And Survival Changes In Response To Cytokines And Regulatory Checkpoint Blockade Helps Identify Optimal Culture And Expansion Conditions
267. Quantitative And Temporal Requirements Revealed For Zap70 Catalytic Activity During T Cell Development
268. Quantitative Dissection Of T Cell Negative Selection Mechanisms In The Thymus
269. Quantitative Proteomic Analysis Reveals Maturation As A Mechanism Underlying Glucocorticoid Resistance In B Lineage All And Re‐Sensitization By Jnk Inhibition
270. Quercetin Modulates Signaling Pathways And Induces Apoptosis In Cervical Cancer Cells
271. R A Re Cuta N Eo Us Tc El L Lym Phomas
272. Radiation Response And Regulation Of Apoptosis Induced By A Combination Of Trail And Chx In Cells Lacking Mitochondrial Dna: A Role For Nf-Κb–Stat3-Directed …
273. Radiotherapy And Cd40 Activation Separately Augment Immunity To Checkpoint Blockade In Cancer
274. Raf/Erk Drives The Proliferative And Invasive Phenotype Of Bmpr2-Silenced Pulmonary Artery Endothelial Cells
275. Randomized Phase 2 Study Of Otlertuzumab And Bendamustine Versus Bendamustine In Patients With Relapsed Chronic Lymphocytic Leukaemia
276. Rapamycin-Resistant And Torin-Sensitive Mtor Signaling Promotes The Survival And Proliferation Of Leukemic Cells
277. Rapeseed Protein-Derived Antioxidant Peptide Rap Ameliorates Nonalcoholic Steatohepatitis And Related Metabolic Disorders In Mice
278. Rare Case Of Low-Grade Extranodal Nk/T-Cell Lymphoma, Nasal Type, Arising In The Setting Of Chronic Rhinosinusitis And Harboring A Novel N-Terminal Kit …
279. Rare Cutaneous T-Cell Lymphomas
280. Rational Combination Therapy With Parp And Mek Inhibitors Capitalizes On Therapeutic Liabilities In Ras Mutant Cancers
281. Rationale For Targeting Bcl6 In Mll-Rearranged Acute Lymphoblastic Leukemia
282. Rationale For Targeting Bcl6 In Mll-Rearranged B-All
283. Rationale-Based Therapeutic Combinations With Pi3K Inhibitors In Cancer Treatment
284. Rbpj Expression In Regulatory T Cells Is Critical For Restraining Th 2 Responses
285. Real-Time Pcr Assay With High Resolution Melting For Egfr And Bim Mutation Of Lung Cancer
286. Recent Advances And Future Directions In Targeting The Secretory Apparatus In Multiple Myeloma
287. Recipient BCL2 Inhibition And Nk Cell Ablation Form Part Of A Reduced Intensity Conditioning Regime That Improves Allo-Bone Marrow Transplantation Outcomes
288. Reciprocal Regulation Of Pkb And Foxo Proteins Through Feed-Back Signalling
289. Recovering Drug-Induced Apoptosis Subnetwork From Connectivity Map Data
290. Redox Regulation Of B Cell Activation And The Anti-Viral Humoral Immune Response
291. Redox Regulation Of T Cell Activation And Function During Viral Infection
292. Redox-Related Neuronal Death And Crosstalk As Drug Targets: Focus On Epilepsy
293. Reduced Erg Dosage Impairs Survival Of Hematopoietic Stem And Progenitor Cells
294. Redundant Role For Early Growth Response Transcriptional Regulators In Thymocyte Differentiation And Survival
295. Reflecting On 25 Years With Myc
296. Regulating The Regulators: Emerging Roles Of Cellular Micrornas During Influenza A Virus Infection
297. Regulation And Function Of Mitophagy In Development And Cancer
298. Regulation And Function Of Oncogenic Splicing Factor Srsf1
299. Regulation Of Alternative Vegf-A Mrna Splicing Is A Therapeutic Target For Analgesia
300. Regulation Of Antagonistic Signaling Components By Mir-430 Micrornas
301. Regulation Of Apoptosis In Health And Disease: The Balancing Act Of BCL-2 Family Proteins
302. Regulation Of Autophagy By Mirnas And Their Emerging Roles In Tumorigenesis And Cancer Treatment
303. Regulation Of Autophagy By Stress-Responsive Transcription Factors
304. Regulation Of Bim In Glucocorticoid‐Mediated Osteoblast Apoptosis
305. Regulation Of Bim In Health And Disease
306. Regulation Of Brca1/P21 Axis By Prolactin
307. Regulation Of Cell Cycle Associated Genes By Microrna And Transcription Factor
308. Regulation Of Cholesterol Homeostasis By A Novel Long Non-Coding Rna Laser
309. Regulation Of Endoderm Formation And Left-Right Asymmetry By Mir-92 During Early Zebrafish Development
310. Regulation Of Endoplasmic Reticulum Calcium Homeostasis In Pancreatic Β Cells
311. Regulation Of Erk1/2 Signaling In Melanoma
312. Regulation Of Foxo Stability And Activity By Mdm2 E3 Ligase
313. Regulation Of Foxp3 Expression In Myeloid Cells In Response To All-Trans-Retinoic Acid, Interleukin 2 And Transforming Growth Factor Β
314. Regulation Of Fungal Gene Expression Via Short Open Reading Frames In The Mrna 5′ Untranslated Region
315. Regulation Of Gene Expression By Cis-Acting Long Non-Coding Rnas
316. Regulation Of Gene Expression In The Nervous System
317. Regulation Of Heat-Induced Apoptosis By Loss Of Mir-23A-Dependent Control Of Noxa In Human Cells And Its Suppression By Hsp70
318. Regulation Of Hematopoiesis And Immune Responses By Long Non-Coding Rnas
319. Regulation Of Human Epidermal Keratinocyte Survival And Differentiation
320. Regulation Of Immune Cell Development Through Soluble Inositol-1, 3, 4, 5-Tetrakisphosphate
321. Regulation Of Immunity To Visceral Leishmania In A Non-Human Primate Model Of Infection
322. Regulation Of Mcl-1 By Srsf1 And Srsf5 In Cancer Cells
323. Regulation Of Microrna Using Promising Dietary Phytochemicals: Possible Preventive And Treatment Option Of Malignant Mesothelioma
324. Regulation Of Micrornas By Natural Compounds: Implications For Cancer Therapy
325. Regulation Of Mirna Pathway And Roles Of Micrornas In Tumorigenesis And Metastasis
326. Regulation Of Neutrophil Senescence By Micrornas
327. Regulation Of Tgfβ And Bmp Signalling In Human B Cells By Latent Epstein-Barr Virus
328. Regulation Of The Long Non-Coding Rna Fam83H-As1 By Human Papillomavirus In Cervical Cancer
329. Regulation Of The Proapoptotic Bh3-Only Protein Bim By Glucocorticoids, Survival Signals And Proteasome In Chronic Lymphocytic Leukemia Cells
330. Regulation Of The Proto-Oncogene Erg By Micrornas And The Role Of Micrornas In The Distinct Etp-All Subgroup Of T-All
331. Regulatory Effects Of Antitumor Agent Matrine On Foxo And Pi3K-Akt Pathway In Castration-Resistant Prostate Cancer Cells
332. Regulatory Network Analysis Of Micrornas And Genes In Imatinib-Resistant Chronic Myeloid Leukemia
333. Regulatory Role Of Mir-93 In Autophagy Induction
334. Regulatory Roles Of Micro-Rnas In T Cell Autoimmunity
335. Regulatory T Cell Identity: Formation And Maintenance
336. Regulatory T Cells In Cancer Patients And Their Roles In Cancer Development/Progression
337. Rela-Induced Interferon Response Negatively Regulates Proliferation
338. Remembering One’S Id/E-Ntity: E/Id Protein Regulation Of T Cell Memory
339. Renal Dysplasia In The Neonate
340. Renal Stromal Mi Rna S Are Required For Normal Nephrogenesis And Glomerular Mesangial Survival
341. Repaglinide Silences The Foxo3/Lumican Axis And Represses The Associated Metastatic Potential Of Neuronal Cancer Cells
342. Repair With Stem Cell Derivatives.
343. Repression Of Birc5/Survivin By Foxo3/Fkhrl1 Sensitizes Human Neuroblastoma Cells To Dna Damage-Induced Apoptosis
344. Repression Of Choroidal Neovascularization Through Actin Cytoskeleton Pathways By Microrna-24
345. Repression Of Noxa By Bmi1 Contributes To Deguelin‐Induced Apoptosis In Non‐Small Cell Lung Cancer Cells
346. Repression Of P53-Target Gene Bbc3/Puma By Mysm1 Is Essential For The Survival Of Hematopoietic Multipotent Progenitors And Contributes To Stem Cell …
347. Repression Of Srf Target Genes Is Critical For Myc‐Dependent Apoptosis Of Epithelial Cells
348. Repression Of The Bh3-Only Molecule Pmaip1/Noxa Impairs Glucocorticoid Sensitivity Of Acute Lymphoblastic Leukemia Cells
349. Repurposing Ribosome-Targeting Antibiotics To Overcome Resistance To Venetoclax In Acute Myeloid Leukemia
350. Requirement For Prc1 Subunit Bmi1 In Host Gene Activation By Epstein-Barr Virus Potein Ebna3C
351. Requirement For Prc1 Subunit Bmi1 In Host Gene Activation By Epstein–Barr Virus Protein Ebna3C
352. Requirement For Rictor In Homeostasis And Function Of Mature B Lymphoid Cells
353. Rescue Of Established Cd8+ T Cell Tolerance With Il-2 Cytokine/Antibody Complexes: Implications For Immunotherapy
354. Rescue Of Tolerant Cd8+ T Cells During Cancer Immunotherapy With Il2: Antibody Complexes
355. Research Outputs/Résultats De Recherche
356. Research Progress On The Relationship Between Lung Cancer Drug-Resistance And Micrornas
357. Research Resource: Transcriptional Response To Glucocorticoids In Childhood Acute Lymphoblastic Leukemia
358. Resistance Mechanisms After Tyrosine Kinase Inhibitors Afatinib And Crizotinib In Non-Small Cell Lung Cancer, A Review Of The Literature
359. Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Patients With Non-Small-Cell Lung Cancer Patients Harboring Egfr Mutations
360. Resistance To Paclitaxel Is Associated With A Variant Of The Gene BCL2 In Multiple Tumor Types
361. Resistance To Tyrosine Kinase Inhibitors In Different Types Of Solid Cancer
362. Resisting Resistance: Targeted Therapies In Lung Cancer
363. Rest And The Regulation Of Stress Resistance, Brain Aging, And Alzheimer’S Disease
364. Restimulation-Induced Apoptosis Of T Cells Is Impaired In Patients With X-Linked Lymphoproliferative Disease Caused By Sap Deficiency
365. Resveratrol, Micrornas, Inflammation, And Cancer
366. Retrotransposon Derepression Leads To Activation Of The Unfolded Protein Response And Apoptosis In Pro-B Cells
367. Reverse Phase Protein Array Identification Of Triple-Negative Breast Cancer Subtypes And Comparison With Mrna Molecular Subtypes
368. Reverse-Phase Protein Array Analysis To Identify Biomarker Proteins In Human Pancreatic Cancer
369. Reversion Of Epigenetically Mediated Bim Silencing Overcomes Chemoresistance In Burkitt Lymphoma
370. Reversion Of Epigenetically-Mediated Bim Silencing Overcomes Chemoresistance In Burkitt Lymphoma
371. Rhob Upregulation Leads To Either Apoptosis Or Cytostasis Through Differential Target Selection
372. Right-And Left-Sided Colorectal Cancers Display Distinct Expression Profiles And The Anatomical Stratification Allows A High Accuracy Prediction Of Lymph Node Metastasis
373. Rings Of Good And Evil: Ring Finger Ubiquitin Ligases At The Crossroads Of Tumour Suppression And Oncogenesis
374. Ripk1 Regulates Survival Of Human Melanoma Cells Upon Endoplasmic Reticulum Stress Through Autophagy
375. Risk Of Non–Hodgkin Lymphoma Associated With Germline Variation In Genes That Regulate The Cell Cycle, Apoptosis, And Lymphocyte Development
376. Rna Sequencing Analyses Of Gene Expression During Epstein-Barr Virus Infection Of Primary B Lymphocytes
377. Rna Sequencing Identifies Dysregulation Of The Human Pancreatic Islet Transcriptome By The Saturated Fatty Acid Palmitate
378. Rna Splicing Factors As Oncoproteins And Tumour Suppressors
379. Role And Regulatory Mechanisms Of Heat Shock Factor 2
380. Role Of Autophagy Activation In Alleviating Alcohol Neurotoxicity
381. Role Of BCL-2 Protein Family Members And Associated Mitochondrial Factors In Hypoxia-Mediated Resistance Of Tumor Cells To Apoptosis And Radiotherapy
382. Role Of Bim And Kinases In The Synergistic Induction Of Cell Death By Trail And Chemotherapy
383. Role Of Bim Deletion Polymorphism And Bim Expression As Predictive Biomarkers To Maximize The Benefit Of Egfr-Tki Treatment In Egfr-Positive Nsclc
384. Role Of Coiled Coil Domain Containing Protein 69 (Ccdc69) In Ovarian Cancer Chemoresistance
385. Role Of Ebna-3 Family Proteins In Ebv Associated B-Cell Lymphomagenesis
386. Role Of Foxo3 In Classical Hodgkin Lymphoma
387. Role Of Host And Pathogen-Derived Micrornas In Immune Regulation During Infectious And Inflammatory Diseases
388. Role Of Micro Rna In The Pathogenesis Of Malignant Lymphoma
389. Role Of Microrna In Macrophage Polarized Activation
390. Role Of Microrna-221/-222 In Cancer Development And Progression
391. Role Of Micrornas In Cancers Of The Female Reproductive Tract: Insights From Recent Clinical And Experimental Discovery Studies
392. Role Of Micrornas In Gastric Cancer
393. Role Of Micrornas In Glucocorticoid‑Resistant B‑Cell Precursor Acute Lymphoblastic Leukemia
394. Role Of Micrornas In Haemopoiesis, Heart Hypertrophy And Cancer
395. Role Of Micrornas In Stem/Progenitor Cells And Cardiovascular Repair
396. Role Of Micrornas In The Immune System, Inflammation And Cancer
397. Role Of Micrornas In The Regulation Of Normal T Cell Development And Pathogenesis
398. Role Of Mir-323B-5P In Inflammation, Oxidative Stress And Apoptosis During Cerebral Ischemia/Reperfusion Injury
399. Role Of Mitochondrial Translocator Protein (18 Kda) On Mitochondrial-Related Cell Death Processes
400. Role Of Msc-Derived Galectin 3 In The Aml Microenvironment
401. Role Of Pld3 Rare Variants In European Non-Familial Alzheimer’S Disease
402. Role Of Radiation-Induced Tgf-Beta Signaling In Cancer Therapy
403. Role Of Sirtuins In Kidney Disease
404. Role Of Smarce1 And Bhlhe40 In Breast Cancer Metastasis
405. Role Of Sox11 And Genetic Events Cooperating With Cyclin D1 In Mantle Cell Lymphoma
406. Role Of The Microtubule-Associated Tppp/P25 In Parkinson’S And Related Diseases And Its Therapeutic Potential
407. Role Of Transforming Growth Factor Β-Regulated Microrna In Breast Cancer Progression
408. Roles And Clinical Implications Of Micrornas In Acute Lymphoblastic Leukemia
409. Roles Of Ctcf And Yy1 In T Cell Receptor Gene Rearrangement And T Cell
410. Roles Of Micrornas In B Lymphocyte Physiology And Oncogenesis
411. Roles Of Micrornas In Pressure Overload-And Ischemia-Related Myocardial Remodeling
412. Roles Of The Mir-17~ 92 Cluster Of Micrornas In Myc-Driven Tumoigenisis
413. Roles Of Thyroid Hormone-Associated Micrornas Affecting Oxidative Stress In Human Hepatocellular Carcinoma
414. Romidepsin In Peripheral And Cutaneous T‐Cell Lymphoma: Mechanistic Implications From Clinical And Correlative Data
415. Ros & Energy Production Pathways In The Determination Of Resistance/Sensitivity To Glucocorticoids-Induced Apoptosis In Acute Lymphoblastic Leukaemia
416. Rosuvastatin Enhances The Therapeutic Efficacy Of Adipose-Derived Mesenchymal Stem Cells For Myocardial Infarction Via Pi3K/Akt And Mek/Erk Pathways
417. Rrbs And The Epigenetic Effects Of Steroids In All
418. Runt-Related Transcription Factor Runx3 Is A Target Of Mdm2-Mediated Ubiquitination
419. Secretomics Identifies Follistatin As A Predictive Biomarker For Response To Treatment With Tyrosine Kinase Inhibitors In Synovial Sarcoma
420. Selection And Characterization Of Chicken Polyclonal Antibody Resistant Isolates Of Influenza A Virus
421. Selection In The Germinal Center
422. Selective Estrogen-Induced Apoptosis In Breast Cancer
423. Selective Glucocorticoid Receptor Translational Isoforms Reveal Glucocorticoid-Induced Apoptotic Transcriptomes
424. Selective Targeting Of Pro-Inflammatory Th1 Cells By Microrna-148A-Specific Antagomirs In Vivo
425. Selenium Induces A Multi‐Targeted Cell Death Process In Addition To Ros Formation
426. Selenoprotein P Promotes The Development Of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target
427. Self-Consumption: The Interplay Of Autophagy And Apoptosis
428. Semaphorin 3A Is A Retrograde Cell Death Signal In Developing Sympathetic Neurons
429. Sensing The Environment Through Sestrins: Implications For Cellular Metabolism
430. Sensitivity To Antitubulin Chemotherapeutics Is Regulated By Mcl1 And Fbw7
431. Sensitization Of Melanoma Cells For Trail-Induced Apoptosis By Activation Of Mitochondrial Pathways Via Bax
432. Sequential Gene Regulatory Events Leading To Glucocorticoid-Evoked Apoptosis Of Cem Human Leukemic Cells: Interactions Of Mapk, Myc And Glucocorticoid Pathways
433. Sequential Induction Of Effector Function
434. Sequential Induction Of Effector Function, Tissue Migration And Cell Death During Polyclonal Activation Of Mouse Regulatory T-Cells
435. Serine 574 Phosphorylation Alters Transcriptional Programming Of Foxo3 By Selectively Enhancing Apoptotic Gene Expression
436. Sertoli Cell Dicer Is Essential For Spermatogenesis In Mice
437. Serum Microrna‐150 Predicts Prognosis For Early‐Stage Non‐Small Cell Lung Cancer And Promotes Tumor Cell Proliferation By Targeting Tumor Suppressor Gene …
438. Sestrin Family Of Genes And Their Role In Cancer-Related Fatigue
439. Sestrin2 As A Novel Biomarker And Therapeutic Target For Various Diseases
440. Sestrin2 Decreases Renal Oxidative Stress, Lowers Blood Pressure, And Mediates Dopamine D2 Receptor–Induced Inhibition Of Reactive Oxygen Species …
441. Sestrins Are Gatekeepers In The Way From Stress To Aging And Disease
442. Sestrins At The Interface Of Ros Control And Autophagy Regulation In Health And Disease
443. Sestrins Link Tumor Suppressors With The Ampk-Tor Signaling Network
444. Sestrins Orchestrate Cellular Metabolism To Attenuate Aging
445. Sestrins: A New Kid For Stroke Treatment?
446. Sexual Dimorphism Of Rat Liver Gene Expression: Regulatory Role Of Growth Hormone Revealed By Deoxyribonucleic Acid Microarray Analysis
447. Shared Genetic Factors Involved In Celiac Disease, Type 2 Diabetes And Anorexia Nervosa Suggest Common Molecular Pathways For Chronic Diseases
448. Shared Molecular Signatures Across Neurodegenerative Diseases And Herpes Virus Infections Highlights Potential Mechanisms For Maladaptive Innate Immune …
449. Shca Regulates Thymocyte Proliferation Through Specific Transcription Factors And A C-Abl-Dependent Signaling Axis
450. Short-Lived Antigen Recognition But Not Viral Infection At A Defined Checkpoint Programs Effector Cd4 T Cells To Become Protective Memory
451. Signal Transducer And Activator Of Transcription 3 (Stat3) Mutations Underlying Autosomal Dominant Hyper-Ige Syndrome Impair Human Cd8+ T-Cell Memory …
452. Signalling Strength Determines Proapoptotic Functions Of Sting
453. Signals Delivered By Interleukin-7 Regulate The Activities Of Bim And Jund In T Lymphocytes
454. Silica Nanoparticle-Induced Oxidative Stress And Mitochondrial Damage Is Followed By Activation Of Intrinsic Apoptosis Pathway In Glioblastoma Cells
455. Simultaneous Activation And Inhibition Of Autophagy Sensitizes Cancer Cells To Chemotherapy
456. Single Nucleotide Polymorphisms Of P53, P21, Cyp1A1, Fas, And Benzo (Α) Pyrene As Risk Factors In Cervical Carcinoma
457. Single-Walled And Multi-Walled Carbon Nanotubes Induce Sequence-Specific Epigenetic Alterations In 16 Hbe Cells
458. Sirtuins And Renal Diseases: Relationship With Aging And Diabetic Nephropathy
459. Sizing Up The Key Determinants Of The Cd8+ T Cell Response
460. Skin Mild Hypoxia Enhances Killing Of Uvb-Damaged Keratinocytes Through Reactive Oxygen Species-Mediated Apoptosis Requiring Noxa And Bim
461. Small And Long Non-Coding Rnas In Cardiac Homeostasis And Regeneration
462. Small Molecule–Mediated Simultaneous Induction Of Apoptosis And Autophagy
463. Small Molecules, Big Effects: The Role Of Micrornas In Regulation Of Cardiomyocyte Death
464. Small Non-Coding Rnas In Regulation Of Course And Therapeutic Efficacy In Acute Myeloid Leukemia
465. Small Rna And Its Application In Andrology And Urology
466. Small Rna Profiling Reveals Deregulated Phosphatase And Tensin Homolog (Pten)/Phosphoinositide 3-Kinase (Pi3K)/Akt Pathway In Bronchial Smooth Muscle Cells …
467. Smarce1 Regulates Metastatic Potential Of Breast Cancer Cells Through The Hif1A/Ptk2 Pathway
468. Snai1 Regulates Cell Lineage Allocation And Stem Cell Maintenance In The Mouse Intestinal Epithelium
469. Snail1 Suppresses Tgf-Β-Induced Apoptosis And Is Sufficient To Trigger Emt In Hepatocytes
470. Soluble Epoxide Hydrolase Inhibition Attenuates Vascular Remodeling And Is Protective Against Cerebral Ischemia
471. Sorafenib Sensitizes Hepatocellular Carcinoma Cells To Physiological Apoptotic Stimuli
472. Sox7 Regulates Mapk/Erk-Bim Mediated Apoptosis In Cancer Cells
473. Specialized Proteasome Subunits Have An Essential Role In The Thymic Selection Of Cd8+ T Cells
474. Splenic Cd4+ T Cells Have A Distinct Transcriptional Response Six Hours After The Onset Of Sepsis
475. Splice Variants As Cancer Biomarkers
476. Splicing Modulation Sensitizes Chronic Lymphocytic Leukemia Cells To Venetoclax By Remodeling Mitochondrial Apoptotic Dependencies
477. Splicing Regulator Slu7 Preserves Survival Of Hepatocellular Carcinoma Cells And Other Solid Tumors Via Oncogenic Mir-17-92 Cluster Expression
478. Splicing-Factor Alterations In Cancers
479. Spontaneous Hepatocellular Carcinoma After The Combined Deletion Of Akt Isoforms
480. Spontaneous Loss Of B Lineage Transcription Factors Leads To Pre-B Leukemia In Ebf1+/–Bcl-X L Tg Mice
481. Srp55 Regulates A Splicing Network That Controls Human Pancreatic Β-Cell Function And Survival
482. Srsf2 P95H Initiates Myeloid Bias And Myelodysplastic/Myeloproliferative Syndrome From Hemopoietic Stem Cells
483. Stage-Specific Functions Of Leukemia/Lymphoma-Related Factor (Lrf) In The Transcriptional Control Of Osteoclast Development
484. State Of The Art In Microrna As Diagnostic And Therapeutic Biomarkers In Chronic Lymphocytic Leukemia
485. Statistical Analysis Of Pathobiochemical Signatures In Bile Duct Ligated Mice
486. Statistical Methods In Admixture Mapping: Mixed Model Based Testing And Genome-Wide Significance Thresholds
487. Steel Factor Controls Midline Cell Death Of Primordial Germ Cells And Is Essential For Their Normal Proliferation And Migration
488. Stem Cell Potency And The Ability To Contribute To Chimeric Organisms
489. Stem Cell Treatment After Cerebral Ischemia Regulates The Gene Expression Of Apoptotic Molecules
490. Stepwise Detection And Evaluation Reveal Mir-10B And Mir-222 As A Remarkable Prognostic Pair For Glioblastoma
491. Steroids And Related Compounds: Basic And Clinical Aspects
492. Sting-Dependent Paracriny Shapes Apoptotic Priming Of Breast Tumors In Response To Anti-Mitotic Treatment
493. Strategically Timing Inhibition Of Phosphatidylinositol 3-Kinase To Maximize Therapeutic Index In Estrogen Receptor Alpha–Positive, Pik3Ca-Mutant Breast Cancer
494. Strategies To Improve Radiotherapy With Targeted Drugs
495. Strategies To Overcome Resistance Mechanisms In T-Cell Acute Lymphoblastic Leukemia
496. Stromal Cell-Contact Dependent Pi3K And April Induced Nf-Κb Signaling Complement Each Other To Prevent Mitochondrial-And Endoplasmic Reticulum Stress Induced …
497. Structural And Functional Studies Of The Cell Cycle Regulator, Rgc-32
498. Structural And Mechanistic Features Of Protein O Glycosylation Linked To Cd8+ T-Cell Apoptosis
499. Structural Insights Into BCL2 Pro-Survival Protein Interactions With The Key Autophagy Regulator Becn1 Following Phosphorylation By Stk4/Mst1
500. Studies Of Glucocorticord Resistance In Chronic Lymphocytic Leukaemia
501. Studies Of Suppression Using Monoclonal Regulatory T Cells And The Importance Of Co-Receptor Lck Coupling Ratios For Negative Selection
502. Studies On Drug Resistance And Molecular Biomarkers In Acute Myeloid Leukemia
503. Study Of Protein Interaction In Apoptotic Pathway In Diabetes
504. Studying Apoptosis In The Zebrafish
505. Suberoylanilide Hydroxamic Acid (Saha) And Cladribine Synergistically Induce Apoptosis In Nk‐Lgl Leukaemia
506. Subtle Changes In The Levels Of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
507. Superior Efficacy Of Cotreatment With Bet Protein Inhibitor And BCL2 Or Mcl1 Inhibitor Against Aml Blast Progenitor Cells
508. Supplemental Data Apoptosis Regulators Fas And Bim Cooperate In Shutdown Of Chronic Immune Responses And Prevention Of Autoimmunity
509. Supplemental Table 1. Summary Of Screening Results.
510. Supplementary Table 1 Proteins Reported To Bind Directly To 14-3-3S With Relevant Interaction Sites Indicated A. Mammalian Proteins; B. Non-Mammalian Animal …
511. Suppression Of B-Cell Development Genes Is Key To Glucocorticoid Efficacy In Treatment Of Acute Lymphoblastic Leukemia
512. Suppression Of Bim By Microrna-19A May Protect Cardiomyocytes Against Hypoxia-Induced Cell Death Via Autophagy Activation
513. Suppression Of Brd4 Inhibits Human Hepatocellular Carcinoma By Repressing Myc And Enhancing Bim Expression
514. Suppression Of Fip200 And Autophagy By Tumor-Derived Lactate Promotes Naive T Cell Apoptosis And Affects Tumor Immunity
515. Suppression Of The Intrinsic Apoptosis Pathway By Synaptic Activity
516. Surface Functionalization And Analysis Thereof For An Ovarian Cancer Diagnostic Biosensor
517. Surviv For Survival Analysis Of Mrna Isoform Variation
518. Surviving Sepsis: BCL-2 Overexpression Modulates Splenocyte Transcriptional Responses In Vivo
519. Sweet Killing In Obesity And Diabetes: The Metabolic Role Of The Bh3-Only Protein Bim
520. Synchronizing Transcriptional Control Of T Cell Metabolism And Function
521. Synergistic Activity Of Bet Protein Antagonist-Based Combinations In Mantle Cell Lymphoma Cells Sensitive Or Resistant To Ibrutinib
522. Synergistic Apoptotic Effects Of Bortezomib And Methylstat Inhibitor On Different Multiple Myeloma Cell Lines
523. Synergistic Cooperation And Crosstalk Between Myd88L265P And Mutations That Dysregulate Cd79B And Surface Igm
524. Synergistic Cytotoxicity Between Tamoxifen And The Plant Toxin Persin In Human Breast Cancer Cells Is Dependent On Bim Expression And Mediated By Modulation Of …
525. Synergistic Induction Of Cell Death In Haematological Malignancies By Combined Phosphoinositide-3-Kinase And Bet Bromodomain Inhibition.
526. Synergistic Inhibition Of Pancreatic Adenocarcinoma Cell Growth By Trichostatin A And Gemcitabine
527. Synergy Of BCL2 And Histone Deacetylase Inhibition Against Leukemic Cells From Cutaneous T-Cell Lymphoma Patients
528. System Of Markers Based On The Methylation Of A Group Of Proapoptotic Genes In Combination With Microrna In The Diagnosis Of Breast Cancer
529. Systematic Analysis Of Time-Series Gene Expression Data On Tumor Cell-Selective Apoptotic Responses To Hdac Inhibitors
530. Systematic Gene Expression Profile Of Hypothalamus In Calorie-Restricted Mice Implicates The Involvement Of Mtor Signaling In Neuroprotective Activity
531. Systematic Identification Of Recognition Motifs For The Hub Protein Lc8
532. Systems Genetics Identifies Sestrin 3 As A Regulator Of A Proconvulsant Gene Network In Human Epileptic Hippocampus
533. T And B‐Cell Signaling In Activated Pi3K Delta Syndrome: From Immunodeficiency To Autoimmunity
534. T Cell Acute Lymphoblastic Leukemia: Notching The Way Toward A Better Treatment Outcome
535. T Cell Bim Levels Reflect Responses To Anti–Pd-1 Cancer Therapy
536. T Cell Receptor Signalling In The Control Of Regulatory T Cell Differentiation And Function
537. T Cell Subsets In Peripheral Blood Of Women With Recurrent Implantation Failure
538. T Cells Require Foxo1 To Populate The Peripheral Lymphoid Organs
539. T Follicular Helper Cell Subsets And The Associated Cytokine Il-21 In The Pathogenesis And Therapy Of Asthma
540. Tacc3 Transcriptionally Upregulates E2F1 To Promote Cell Growth And Confer Sensitivity To Cisplatin In Bladder Cancer
541. Target Identification, Therapeutic Application And Maturation Mechanism Of Micrornas
542. Target Prediction And Validation Of Micrornas Expressed From Fshr And Aromatase Genes In Human Ovarian Granulosa Cells
543. Targeted Deletion Reveals Essential And Overlapping Functions Of The Mir-17∼ 92 Family Of Mirna Clusters
544. Targeted Disruption Of Mir-17-92 Impairs Mouse Spermatogenesis By Activating Mtor Signaling Pathway
545. Targeted Inhibition Of Pi3Ka/D Is Synergistic With BCL-2 Blockade In Genetically Defined Subtypes Of Dlbcl
546. Targeted Inhibition Of Pi3Kα/Δ Is Synergistic With BCL-2 Blockade In Genetically Defined Subtypes Of Dlbcl
547. Targeted Metabolomics Reveals Differential Biological Effects Of Nanoplastics And Nanozno In Human Lung Cells
548. Targeted Oma1 Therapies For Cancer
549. Targeted Silencing Of S100A8 Gene By Mir-24 To Increase Chemotherapy Sensitivity Of Endometrial Carcinoma Cells To Paclitaxel
550. Targeting Anti‐Apoptotic Bcl 2 Family Proteins In Haematological Malignancies–From Pathogenesis To Treatment
551. Targeting Anti-Apoptotic BCL-2 Proteins In Cancer: The Importance Of Intermolecular Interactions And Protein Turnover
552. Targeting Autophagy In Multiple Myeloma
553. Targeting BCL2 Family In Human Myeloid Dendritic Cells: A Challenge To Cure Diseases With Chronic Inflammations Associated With Bone Loss
554. Targeting Bcl-Xl Improves The Efficacy Of Bromodomain And Extra-Terminal Protein Inhibitors In Triple-Negative Breast Cancer By Eliciting The Death Of Senescent Cells
555. Targeting Bet Proteins Improves The Therapeutic Efficacy Of BCL-2 Inhibition In T-Cell Acute Lymphoblastic Leukemia
556. Targeting Cdk In Triple-Negative Breast Cancer
557. Targeting Childhood, Adolescent And Young Adult Non‐Hodgkin Lymphoma: Therapeutic Horizons
558. Targeting Class I Pi3Ks In The Treatment Of T-Cell Acute Lymphoblastic Leukemia
559. Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-Resistant Prostate Cancer
560. Targeting Ezh2 In Multiple Myeloma—Multifaceted Anti-Tumor Activity
561. Targeting Forkhead Box Transcription Factors Foxm1 And Foxo In Leukemia
562. Targeting Innate And Adaptive Immune Responses To Cure Chronic Hbv Infection
563. Targeting Melanoma’S Mcl1 Bias Unleashes The Apoptotic Potential Of Braf And Erk1/2 Pathway Inhibitors
564. Targeting Mir-155 Inhibits Survival Of Melanoma Cells By Upregulating Foxo3A
565. Targeting Mir-375 In Gastric Cancer
566. Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia To Venetoclax Treatment
567. Targeting Mrna Processing As An Anticancer Strategy
568. Targeting Prosurvival BCL2 Signaling Through Akt Blockade Sensitizes Castration‐Resistant Prostate Cancer Cells To Enzalutamide
569. Targeting Signaling And Apoptotic Pathways Involved In Chemotherapeutic Drug-Resistance Of Hematopoietic Cells
570. Targeting Steroid Resistance In T-Cell Acute Lymphoblastic Leukemia
571. Targeting The BCL-2 Family In B Cell Lymphoma
572. Targeting The Crosstalk Between Tumor Cells And Microenvironment: A New Therapeutic Approach For The Treatment Of Lymphoid Neoplasms
573. Targeting The Emt Transcription Factor Twist1 Overcomes Resistance To Egfr Inhibitors In Egfr-Mutant Non-Small-Cell Lung Cancer
574. Targeting The Epigenome In Lung Cancer: Expanding Approaches To Epigenetic Therapy
575. Targeting The Phosphatidylinositol 3‐Kinase/Akt/Mechanistic Target Of Rapamycin Signaling Pathway In B‐Lineage Acute Lymphoblastic Leukemia: An Update
576. Targeting The Ubiquitin Proteasome System: Beyond Proteasome Inhibition
577. Targeting Wnt/Ezh2/Microrna-708 Signaling Pathway Inhibits Neuroendocrine Differentiation In Prostate Cancer
578. T-Cell Acute Lymphoblastic Leukemia From Mirna Perspective: Basic Concepts, Experimental Approaches, And Potential Biomarkers
579. T-Cell Receptor Signal Strength And Epigenetic Control Of Bim Predict Memory Cd8+ T-Cell Fate
580. T-Cell Receptors And Human Leukocyte Antigens In Primary Sclerosing Cholangitis
581. T-Cell Stimuli Independently Sum To Regulate An Inherited Clonal Division Fate
582. Tcf19 Is A Novel Islet Factor Necessary For Proliferation And Survival In The Ins-1 Β-Cell Line